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Abstract 
Chronic low back pain costs the community, and several authors have suggested that 
individuals often attempt to exaggerate chronic low back pain. Currently no reliable 
and valid scale for assessing malingering in chronic pain populations exists, and there is 
a large difference in opinion on the ability of experts using clinical judgment to detect 
malingering. The current study seeks to provide a validation for the Barkemeyer-
Callon-Jones Malingering Detection Scale (MDS) which has purported to be able to 
identify individuals attempting to malinger neurological conditions and pain. A 
simulation design was used, as in previous research, because it is difficult to identify 
actual malingerers in a known groups design. Thirty-two men with chronic low back 
pain were divided into two groups of sixteen. One group was asked to simulate 
malingering for the purposes of gaining an increased compensation while the other 
group is asked to be as honest as possible. The hypotheses tested were whether the 
responses to the MDS can: discriminate between simulating malingerers and controls, 
show an increased focus on severity rather than description of pain by simulating 
malingerers, show a relationship between malingering scores and reported pain levels, 
show that prior litigation contributes to either MDS scores or reported pain levels. 
Significance was assessed using chi square, !-test, bivariate correlation and two 
ANOV As. While the MDS was able to discriminate to a significant level between 
participants asked to malinger and those being honest, methodological issues suggest 
that levels of pre-assessment injury contribute to malingering scores and that conscious 
intent is what separates malingering from psychological disorders (abnormal illness 
behaviour) is context bound. Litigation has no effect on reported pain level or MDS 
scores. 
r 
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Introduction 
Pain costs the community. lt was recently estimated that pain cost the Australian 
community 15 billion dollars in direct and indirect costs (Pain Drain, 1997). 
The purpose of the current research is to validate a structured interview tool, the 
Barkemeyer-Callon-Jones Malingering Detection Scale (1989) (MDS) (See Appendix 1), 
which purports to detect individuals attempting to malinger for pain and neurological 
conditions. If successful the scale could be.used to recoup some of this loss to Australia 
for chronic pain. However, prior to using this scale as part of legal proceedings there 
needs to be significantly more experimental assessment of this instrument. Specifically, 
the very small research base of this instrument means that currently it could not be used 
under the Daubert rules (Daubert v Merrell Dow Pharmaceuticals, 1993) of scientific 
validity in the court room. Australian courts, while not directly following this precedent, 
adhere to many of the concepts of expert evidence founded by this decision. In fact, 
other than validation procedures completed by the authors of the scale, this scale has only 
been cited on four occasions (Dannebaum & Lanyon, 1993; Cunnien, 1997; Smith, 1997; 
Hall & Pritchard, 1996). 
The conditions that will be assessed for use with the MDS are simulated malingering, 
chronic low back pain and the effect of previous litigation. The difference between this 
method and previous methods of validating malingering scales is that all participants will 
have the knowledge (all participants have suffered from chronic low back pain some time 
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in their life) to successfully malinger. First, an examination will be made of the different 
issues in assessing chronic low back pain that encompass the high level of suspicion 
towards this problem in regards to malingering. Second, an analysis will be conducted on 
the different issues involved in malingering and malingering research, especially in 
regard to pain disorders. Third, an analysis of the methods of assessing malingering will 
be completed, and their applicability to the current study discussed. Fourth, the impact of 
previous litigation will be examined in regard to both reported back pain and 
malingering. Finally, the methodological issues in the validation study (Calion, Jones, 
Barkemeyer & Brantley, 1989) already completed will be examined, then the purpose of 
the current study, its limitations and hypotheses as generated by the previous research 
will discussed. 
Issues involved in Chronic Low Back Pain (CLBP) 
This section explores the rationale behind pain assessment and demonstrates the need for 
an effective means of measuring both chronic pain and malingering. This section is 
broken into two subsections. The first looks at the issues pertaining generally to chronic 
low back pain, while the second focuses on specific issues in back pain assessment. 
Several issues are canvassed in the first section: the definition of chronic pain; the 
importance of focusing on only one form of chronic pain (lower back); the cost of chronic 
low back pain; yearly prevalence rates of chronic low back pain; difficulty of relying on 
objective imaging measures to reliably assess pathology of lower back and the incidence 
of malingering in chronic low back pain populations. The second part addresses the 
specific issues of: gender differences in pain assessment, reliance on objective tests 
r Validation of the MDS 
(imaging) is limited by the technology, differences between chronic low back pain 
patients and general community, pain assessment tools, effect of background of the 
patient, the subjectivity of the pain experience, the range of possible external goals for 
individuals with chronic low back pain and the application of the Barkemeyer Calion 
Jones Malingering Detection Scale within pain settings. 
Definition of chronic pain 
3 
There are two elements to this definition. Firstly, the definition of chronic is currently 
defined by the WorkCover Authority of Western Australia as three months for low back 
pain, as most back pain injuries are resolved in two months. However, both the DSM IV 
and Turk and Melzack (1992) have suggested that the definition of chronic pain is six 
months. This will not affect the current study, however it is important to recognise the 
differences in label during the transition from acute to chronic. Secondly, pain has been 
defined as "an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage" (International Association 
for the Study of Pain, 1979, 249). It is generally accepted that the definition of lower 
back is the lumbar spine and most back pain is centred in this area (Waddell & Turk, 
1992). Haldeman (1996) noted that "many of the assumptions made for acute back pain 
e.g. a direct correlation between symptamology, disability, and pathology- seem to 
breakdown when dealing with the patient in chronic pain" (p. 112). 
Comparison of'difl'erent pain conditions in research 
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Research involving pain assessment has often included different causes of pain (Turk & 
Melzack, 1992). For instance myofascial syndrome may be compared with whiplash 
injury. The issue is that the quality and quantity of different pain can vary substantially, 
yet it is often evaluated as simply representing a general level of pain. Melzack and 
Dubissson ( 1976), when evaluating the McGill Pain Questionnaire for discriminative 
ability with different clinical pain syndromes, found that it could distinguish between the 
syndromes. In fact, through the clustering of verbal pain descriptors in the questionnaire 
the type of pain syndrome could be determined with 77% accuracy on the basis of eight 
diagnostic categories. Looking at this result in an assessment context suggests that the 
type of pain will influence the assessment procedure. The fact that verbal descriptors are 
used in structured interview settings, similar to the current study, suggests the need to 
limit the assessment of any new instrument to only one pain syndrome. It is interesting to 
note that in their widely cited book on pain assessment Melzack and Turk (1992) 
included individual chapters for assessing chronic back pain, orofacial pain, myofascial 
pain, headaches and cancer pain. 
Decision to focus on only those with chronic low back pain 
The decision to focus only on chronic low back pain was made for a number of reasons. 
The first is that when validating a pain assessment tool, or tools that measure issues 
relating to that pain, as the current study is doing, it is important to focus on one pain 
syndrome at a time. Each syndrome has different effects and meanings for sufferers 
hence the decision to largely separate ditierent pain syndromes by Ronald Melzack and 
Dennis when editing, arguably the seminal book in the area, Handbook of Pain 
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Assessment. Early research by Melzack and Dubuisson (1976), already discussed, 
clearly supports this approach. Second, is the staggering cost and effect that back pain, 
and particularly chronic back pain has on our society. Finally, Leavitt (1984) has 
suggested that due to its complexity chronic low back pain is the most likely syndrome to 
be malingered. For these reasons chronic low back pain was selected as the most 
appropriate syndrome to be assessed in this validation of the Barkemeyer Calion Jones 
Malingering Detection Scale. 
Costs o( chronic low back pain 
The Work Cover Authority of Western Australia has estimated that chronic low back pain 
cost the state $105 million in the 91/92 period, $112 million in the 94/95 period and $81 
million in the 96/97 period (WorkCover, 1998). In America, chronic pain affects 11 
million people and costs $100 billion a year with 80% of this figure due to unexpected 
traumatic injuries (Weintraub, 1995). Of this figure, a significant proportion relates to 
chronic low back pain. Cats-Baril and Froymeyer (as cited in Haldeman, 1996) have 
suggested that the treatment of spinal disorder by 1990, in America, cost approximately 
23.5 billion dollars but Leavitt (1985) has suggested that as many as 10% of people with 
chronic low back pain may be malingering. If this is the case then a significant amount 
of money, time of medical personnel, and drugs could be saved if those who do not suffer 
from genuine pain can be identified. 
Yearly prevalence rates 
Each year some 15%-20% of the population experience/report back pain (Andrews as 
cited in Haldeman, 1996) and surveys of working people show that 50% of this group 
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report some symptoms of back pain at some point in their career (Sternbach as cited in 
Haldeman, 1996). Back pain affects up to 80% of the population at some time during 
adult life (Murtagh as cited in Giles & Crawford, 1997). Back pain remains the most 
common cause of disability for persons under the age of 45 years (Cunningham & Kelsey 
as cited in Haldeman, 1996). In Western Australia it is second only to the common cold 
for work absences (WorkCover, 1998) and this is similar to American trends (Deyo & 
Tsui-Wu as cited in Giles & Crawford, 1997). Haldeman states that "despite the 
advances in understanding and the proliferation of diagnostic tests and treatment 
methods, there is still no evidence that there has been any decrease in the frequency or 
severity of neck and back pain"(l996, p. 103). This may be the reason that Giles and 
Crawford note that "the epidemic increase of sickness in the low back pain syndromes is 
actually threatening the social welfare system in societies with socialized medicine" 
(1997, p. 44). 
Differences between chronic low hack pain patients and general community 
The decision to use chronic low back pain sufferers in both the experimental and control 
groups appears to have been supported by research. Specifically it has been shown that 
chronic pain patients view and react to pain differently from healthy participants and 
other those with other pain conditions. It would not be productive to ask healthy controls 
to malinger as previous studies have done (Leavitt, 1985; Clayer, Bookless & Ross, 
1984) as they often have very little appreciation of the effects of chronic conditions. 
Peters and Schmidt (1991) measured pain perception threshold, maximal pain tolerance 
and pain discrimination between chronic low back pain patients and healthy controls. 
This was done by giving electric shocks to both groups and using forced choice answers 
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for participants to indicate which shock hurt the most and how quickly they perceive it. 
All participants completed a state-trait anxiety test prior to the experiment with chronic 
low back pain patients showing higher levels of anxiety. The results indicated that 
chronic low back pain patients are generally less sensitive to experimental pain than 
healthy controls; not only for pain perception threshold but also for pain tolerance, but are 
both more anxious about imminent pain and are generally have more anxiety than those 
who do not suffer from chronic low back pain. 
Two theories were put forward by Peters and Schmidt (1991) to explain this result. The 
first is the adaptation level theory (Naliboff & Cohen as cited in Peters & Schmidt, 1991) 
which states that chronic pain patients are less inclined to label a stimulus as painful and 
would not consider experimental pain as severe because of their extensive experience 
with pain. The second theory is that pain inhibits pain due to the activation of the diffuse 
noxious inhibitory controls (DNIC) (Roby-Brami, Busse!, Willer & LeBars as cited in 
Peters & Schmidt, 1991 ). This suggests that when two concurrent pains occur the body 
decides to reduce sensitivity to one of these sensations of pain. In addition to 
physiological issues, Kames, Naliboff, Heinrich and Schag (as cited in Fishbain, Cutler, 
Rosomoff & Rosomoff, 1 994) demonstrated that chronic pain patients have greater issues 
than chronic illness patients in areas such as sleep, finances, appearance, body 
deterioration, inactivity, social activities, family/friends contact, assertion, medical 
interaction and marital difficulty. Waddell and Turk (1992) noted that chronic low back 
pain can severely impact on the levels of depression, avoidance of any movement likely 
to cause pain and a resulting problem with mobility; more than do most other chronic 
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pain conditions. This appears to be a relatively consistent result in Turk and Melzack 
(1992), Cherkin, Deyo, Wheeler and Ciol (1995) and Haldeman (1996) with comments 
from many of the participants in the current study supporting this premise about the 
global issues associated with chronic low back pain. Mendelson (1984a) found that those 
experiencing chronic low back pain had significant elevations of depression, neuroticism, 
state anxiety and trait anxiety when compared to the normal population. Overall, these 
results suggest that individuals who suffer from chronic low back pain are in the best 
position to malinger this disorder due to the specificity of symptoms and the fact that they 
present much differently to healthy participants. 
Issues in pain assessment that impact on the present study 
Gender differences in pain assessment 
In a similar area, the differences in male and female perception of pain has received 
surprisingly little scrutiny (Turk & Melzack, 1992). While some results show males have 
a higher tolerance to pain than females (Feine, Bushnell, Miron & Duncan as cited in 
Craig, Prkachin & Grunanu, 1992) others research have found the reverse (Craig, Hyde & 
Patrick as cited in Craig ct a!., 1992). Hargraves (1996) found that men have higher pain 
thresholds than women for acute pain. Overall, these results suggest that rather than 
introduce possible gender differences into the reporting of pain, females could be 
assessed in later validation studies. ln regards to malingering, little is known about the 
different methods the different genders use to malinger (Hall & Pritchard, 1996), 
although Leavitt (1991) suggests that there are no differences. This will not be assessed 
as part of this study. 
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Reliance on objective tests (imaging) is limited by the technology 
Barkemeyer et al. (1989) notes that if the patient has a demonstrable injury then 
immediately he/she should not be considered a malingerer. The MDS does not need to be 
used. Part of the difficulty with back pain, in general, is the complexity of the spine's 
relationship with the nervous system. As Giles and Crawford (1997) note "pain may 
originate from different spinal tissues such as muscles, ligaments, dura mater, 
intervertebral discs, zygapophysial (facet) joint, and other spinal related joints such as 
sacroiliac joints" (Giles & Crawford, 1997, 44). In an analysis of 900 patients referred to 
an outpatient othropedic clinic Waddell (1982) suggested that based on clinical history 
patients could be divided into three broad diagnostic groups: 1) those with simple 
mechanical low back pain, 2) those with nerve root pain and 3) those with serious spinal 
pathology. Giles and Crawford ( 1997) note that back pain of mechanical origin is far 
more prevalent than back pain due to traumatic, inflammatory or other pathological 
processes. The latter represent only approximately 19% of cases (Ghormley, 1958 as 
cited in Giles & Crawford, 1997). Regardless of type of injury Resnick (1994) suggests 
that all people are ready to use illness for their own purposes. Malingering may involve, 
not the fact that pain exists but rather whether it was an injury sustained where a duty of 
care is owed or an individual is covered by a form of insurance. An evaluation of such 
deception, certainly should accompany any evaluation of a personal injury claim, but it 
will not be the focus of this study. Similarly, the type of injury the participants sustained 
will not be categorised other than whether they have experienced chronic low back pain 
at some point. 
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Specifically, Giles and Crawford (1997) suggest that when evaluating a patient with 
spinal pain of mechanical origin, multifactorial etiologies are possible but an inability to 
directly scrutinise the painful structures makes this difficult. As a result of this 
uncertainty, a tentative diagnosis is made on the basis of a precise case history, a routine 
physical examination, and the use of imaging or laboratory procedures. All this 
information generally indicates is that pathology can be eliminated. The actual cause of 
the pain remains obscure. Giles and Crawford (1997) suggest that 
diagnostic problems relate to 1) inadequacies in the precise anatomical 
knowledge of the spine, 2) the possibility of multiple causes of pain at a given 
level of the spine, and 3) limitations of the diagnostic yield of many imaging 
procedures such as plain film radiography, myleography, computerized 
tomography CT), magnetic resonance imaging (MRI) and bone scans (p. 45). 
Certainly, there have been significant improvements in the resolution in spinal imaging 
(Deyo as cited in Giles & Crawford, 1997) however small abnormalities can still remain 
undetected. This has lead to the conclusion that despite 
multidisciplinary interest, it is still only rarely possible to validate a diagnosis in 
cases where the pain arises from the spine and, because it is not possible to 
establish the pathological basis of back pain in 80%-85% of cases this leads to 
uncertainty and suspicion (towards) some patients 
(Giles & Crawford, J 997, p. 45). 
The imaging techniques used are not applicable to all cases of back pain and, even at the 
most sophisticated level of MRJ, have problems detecting soft tissue pathology. 
Sometimes using plain film radiography there is a discrepancy between the degree of pain 
and the severity and radiographic changes (Stockwell as cited in Giles & Crawford, 
1997). Finally, Giles and Crawford (1997) state that "it is imperative that, in the absence 
of a compelling reason to do so, physicians do not label patients as neurotic or 
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malingering when it is not possible to demonstrate objectively through imaging that they 
are, in fact, not fabricating symptoms" (p, 47). 
Possil>le external goals for iudividllafs with chronic low back pain 
It is possible to be awarded damages or benefits through the no-fault workers' 
compensation systems or through common law claims for negligence. This can lead to 
abuse by individuals or groups. Workers' compensation systems are particularly 
vulnerable as low back pain is the most common type of compensated injury 
(WorkCover, 1998). Chaffin's (as cited in Waikar, Aghazadeh & Schlegel, 1991) 
findings indicate the type of work that is significant in low back pain compensation; 
specifically physically strenuous employment. It is for this reason that males were d1e 
focus in this study as they are more likely to suffer chronic low back pain due to 
employment in industries such as mining and construction. Interestingly recent 
WorkCover statistics (WorkCover, 1998) indicate that office workers are just as likely to 
suffer chronic low back pain in Western Australia due to poor posture and sitting for long 
periods of time. It is important to recognise that these workers are generally more likely 
to be female and, while research is inconclusive, they do appear to possess different 
tolerances and attitudes towards pain compared to men (Feine, Bushnell, Miron & 
Duncan as cited in Craig, Prkachin & Grunanu, 1992), which complicates cross gender 
studies. 
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Su!Jjective nature ofpain 
Probably the greatest difficulty in the area of pain assessment lies in the inability of 
objective pain assessment (Rudy, Turk & Brody, 1992) to conclusively indicate the level 
of pain that an individual is experiencing (Dworkin & Whitney, 1992). Put simply, 
while the tissue trauma may be identical, one patient may report much higher levels of 
pain for biological reasons (less sensitivity in noinceptors, higher levels of endorphins), 
for social reasons (level of anxiety at the time, level of perceived spousal support) and for 
numerous other reasons (prior experience with pain). Given these reasons there is a 
strong reliance on the subjective responses of the individual in pain. Self report is the 
most common form of pain assessment yet "is likely to represent only a subset of what 
the individual is feeling, thinking, or prepared to admit at a particular time"( Craig eta!., 
1992, 258). Lantham (1987) states "pain is exactly where and how much the patient 
states it is" (p. 8). Chapman and Brena (1995) suggest that "self-report data often have 
(been) found to have questionable validity, as significant discrepancies between self-
reports and observed behaviours have been found among chronic pain patients for 
.... activity level, social interaction and medication use" (p. 178). Overall, if one accepts 
that self report is often the major source of information, given possible external goals it 
can lead to the increased possibility of malingering. 
An interesting experiment that attempted to combine the concept of physiological 
assessment and self report was completed by Salamy, Wolk and Shucard (1983). In this 
experiment, 7 chronic pain patients and 7 non-patient controls were separately asked a 
variety of questions related to pain, emotional state and neutral topics. All the 
Validation of the MDS 13 
participants were assessed on specific physiological measures which have been suggested 
to be useful in the detection of deception: skin potential (sweat glands) and heart rate. 
Participants were assessed at specific points for each question on baseline, anticipation, 
reception, processing and responding. It was found that the processing of pain questions 
produced significantly larger changes in pain patients than in the non-pain controls. This 
may be a potential method of detecting malingering at an early point, however 
considerably more research is needed, as the number of participants is clearly very low. 
What this does indicate, is the futility of relying on polygraph or 'lie detector' tests in this 
area, as it will be virtually impossible to differentiate between someone lying 
(presumably about their pain) and a genuine pain patient discussing their pain. 
Incidence of malingering in chronic low back pain populations 
There are few estimates of the variations in the level of malingering in pain populations 
(Leavitt & Sweet, 1986). Probably the most often cited evidence of malingering in a pain 
setting is the change in pain self-report before and after litigation (Main & Spanswick, 
I 995) however this change has not been found in all studies (Mendelson, 1984a; 1992; 
Suter, 1998). Several authors (Leavitt, 1985; Main & Spanswick, 1995; Lees-Haley, 
1986; Leavitt & Sweet, 1986; Chapman & Brena, 1995) have suggested that chronic low 
back pain patients not only present differently to those in other pain populations but they 
are overly represented in populations judged to be malingering. In Leavitt and Sweet's 
(1986) findings 60% of orthopedic surgeons surveyed estimated that malingering in low 
back pain occurs in 5% of cases. In Chapman and Brena's study approximately 10% of 
the low back pain patients were found to be inconsistent in their pain behaviour, and this 
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was interpreted as malingering: This finding gives support to Leavitt's (1985) earlier 
assertion that up to 10% of low back pain patients are malingering to some degree. 
The reason why pain is chosen by those wishing to deceive, it could be assumed, is 
partially due to the strong reliance on self report in the assessment procedures however an 
additional explanation has been suggested. Lees-Haley (1986) suggested that pain is 
potentially easier to fake than psychiatric disorders, as it does not require specialised 
psychological knowledge of the disorder because we have all experienced pain at some 
• 
time. Ossipov (as cited in Cornell & Hawk,.l989) stated that "every malingerer is an 
actor who portrays his illness as he understands it" (p. 382). Studies, such as Salamy et 
al. (1983) appear to dispute this conclusion and as Lees-Haley (1986) offers no evidence 
other than clinical experience, more research is needed before a conclusion can be drawn. 
Eflect of' background on pain patients 
The background of individuals can have an effect on how they experience pain. A study 
by Hargraves (1996) found that individuals who participated in regular aerobic exercise 
showed higher pain tolerance than those who were competing in either anaerobic activity 
or no activity at all. Research by Ryan and Foster (I 967) noted that those who played 
sport showed significantly higher pain tolerance and taking this result even further Ryan 
and Kovack ( 1966) showed that those who played contact sports reported higher pain 
tolerance than those who did not play contact sport or any sport at all. This result does 
indicate the importance of viewing chronic pain as a unique state and when assessing an 
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individual for pain the importance of looking at his/her history for episodes of chronic 
pain to allow for a lowering in the perception of current pain 
Pain assessment tools looking at the intensity of pain 
There are an enormous range of pain assessment tools for assessing the intensity of pain 
• 
ranging from the assessment of facial expressions to the fear and avoidance behaviour 
towards pain. The greatest difference lies in what the pain assessment is aiming to 
achieve, whether for diagnosis where a description is needed (i.e. tearing, sharp) or a 
management tool, to quickly gauge the level of intensity rather than the quality of the 
pain. The pain assessment technique used in the current study, the Numeric Rating Scale 
(NRS) was chosen for a number of reasons. First, it is the most widely used in the 
medical setting (Jensen & Karoly, 1992). Second, because of its use of numbers rather 
than a Visual Analogue Scale (VAS), in which the patient simply marks a point on a line, 
which is then measured by the evaluator and numbers assigned. Using this system, the 
patient can clearly indicate whether the pain is exactly the same as it was previously, 
without having to remember a point on a line. Generally these lines are only lOcm, 
however Jensen and Karoly (1992) recommend that the more points available, the greater 
the discrimination in pain hence a 50 point numeric rating scale is used to pick up subtle 
changes in pain. In Leavitt (1985), a 100 point numeric rating was used, however as 
Jensen and Karoly (1992) indicate, patients often tend to use blocks of 10 rather than 
utilise the discriminative potential of the scale. A compromise was the use of a 50 point 
scale. The decision to use a pain measure for 5 days prior to the assessment was due to 
the research by Linton and Melin (as cited in Chapman & Brena, 1995). They found that 
• 
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there were significant discrepancies in subjective pain when measured daily compared to 
remembered pain after a delay from 3 to 11 weeks. It was concluded that retrospective 
self-report data is very unreliable. 
Appropriateness of the Barkemeyer-Callon-Jones Malingering Detection Scale in 
emluating pain 
The application of the Barkemeyer-Callon-Jones Malingering Detection Scale (1989) is 
useful in pain settings due to its reliance on verbal behaviour which Reading, Everitt and 
Sledmere ( 1982) suggests is the most common method in clinical settings of assessing 
pain. The use of a verbal assessment tool for malingering appears to be supported by 
Lees-Haley (1986) who suggests that often malingerers will begin to contradict 
themselves in long interviews, they will tend to be obtrusive with their symptoms through 
wanting attention and they use language differently from the genuinely ill. In short the 
"malingerer's mind is on how to convince you. The genuinely disabled person's 
attention is on grieving the loss, denying it and looking for a way out."(Less-Haley, 1986, 
II 0). Certainly Cunni en (1997) and Barkemeyer (1998) indicate this tool is applicable 
when assessing for malingering of neurological disorders however it is Hall and Pritchard 
(1996) that suggest it is applicable within pain settings. 
Conclusion 
On the basis of the current research it appears that the MDS is an appropriate tool, to 
utilise within pain setting. In addition, the measurement of the intensity of chronic low 
back pain by the NRS has considerable support in both research and clinical settings. By 
using just male, chronic low back pain participants, many of the issues of sex differences 
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and pain syndrome type can be avoided. As a result this research would have to be 
extended before it would apply to other groups. 
Conceptual Issues in Malingering 
The term malingering has a very specific definition, and the ramifications of this are 
important to understand within the context of pain. This section focuses on the issues in 
the definition of malingering, the different types of malingering, the construct of 
malingering, the use of the term malingering in legislation, and the role of forensic 
psychologists in assessing for malingering .. 
Definition of malingering 
Crucial to the current study is an understanding of what malingering represents. The 
definition used by DSM IV is "the intentional production of false or grossly exaggerated 
physical or psychological symptoms, motivated by external incentives such as avoiding 
military duty, avoiding work, obtaining financial compensation, evading criminal 
prosecution or obtaining drugs"(DSM IV, 1994, 296). Another definition is from 
Mendelson (1988) who suggests that malingering can be defined as "the willful, 
deliberate and fraudulent feigning or exaggeration of symptoms of illness, done for the 
purpose of a consciously desired illness" (p. 196). It is specified that malingering differs 
from factitious disorder as it has distinct external incentives for the symptom production 
whereas the incentive in factitious disorder is just to take on the sick role (DSM IV, 
1994). Evidence of an intrapsychic need as opposed to external need is required for a 
diagnosis of factitious disorder. Conversion disorder and other somatoform disorders are 
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distinguished from malingering as there are no external incentives in the former and 
symptom rei ief is not obtained by suggestion or hypnosis. An aspect of this definition 
important in the current study is that, contrary to popular thought that malingering is the 
complete falsification of symptoms, malingering is more likely to be an exaggeration of 
symptoms. Overall, the external goal that is often claimed is compensation from a 
workers' compensation system and/or claims for damages in civil litigation (Mendelson 
& Mendelson, 1996). 
Malingering as a legal construe/ 
Despite the use of malingering as a term available to psychologists and psychiatrists, the 
legal profession technically drew it from military law, making it an 'all or nothing' legal 
construct. The result of this, as Mendelson and Mendelson (1993) conclude is that 
while the psychiatric expert witness may draw attention to inconsistencies in the 
history obtained and on examination in the mental status, poor treatment 
compliance, lack of motivation during treatment or rehabilitation program, the 
presence or extent of any psychiatric impairment if applicable and the nature of 
or absence of a diagnosable psychiatric disorder using a specified system of 
diagnostic criteria and classification, the ultimate question of the veracity of the 
claimant is for the court to decide (p. 31). 
Main and Spanswick (1995) also support this point noting "it is appropriate for the expert 
to highlight the inconsistencies in the client's presentation of symptoms and perhaps 
response to treatment but the interpretation of such findings is a matter for adjudication" 
(p. 749). Despite this Mendelson and Mendelson comments that "there is no evidence of 
sophisticated understanding (of malingering) by the legal profession" (1996, p. 26) so 
psychologists or psychiatrists are often used as experts. However, the psychiatric expert 
is not required to 'prove' that the plantiffis a liar or indeed confirm the validity of the 
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plantiff's entitlement in a compensation claim as this is the function of the court rather it 
is to provide commentary on the "nature, or absence, of a diagnosable psychiatric 
disorder using a specified set of criteria and classification" (Mendelson & Mendelson, 
1996, p. 26). 
It is vital to recognise that malingering is not a diagnosis, but in both DSM IV and the 
ICD-10 (1992)(International Classification of Diseases 10111 Edition) it is considered an 
additional condition which may be the focus of future clinical attention or a category for 
general record keeping purposes. Despite this, Erikson (1990 as cited in Mendelson, 
1995) has found through examining medical literature and law reports that many doctors 
consider the "detection of malingering as integral to the medical enterprise"(p. 428). 
Regardless of the veracity of the diagnosis, Mendelson (1995) notes that as soon as a 
medical practitioner uses this term in an evaluation the other will probably attempt to 
seek some form of legal remedy therefore, as previously mentioned, it has more relevance 
as a legal term. So in legal terms a definition of malingering Mendelson (1995) gives is 
"obtaining pecuniary or other gain by falsely pretending to suffer from an illness, disease 
or disability may also constitute an offence of fraud, and depending on the context of the 
litigation, the simulator may also be liable for the tort of deceit and the offence of 
perjury"(p. 429). The fact therefore remains that while the definition may 
'psychological' it is a term that is generally used only in a legal context. Currently there 
is no common law definition, and therefore the psychological definition of faking for 
external gain will be used for the purposes of this paper. 
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Mention of malingering in Australian Statute.\~ in which it could become the basis for a 
criminal charge 
Malingering is considered a specific statutory offence under some Australian statutes 
such as the Workers' Compensation Acts. For example, section 188 of the Workers' 
Compensation and Rehabilitation Act (1981) in Western Australia specifies: 
A person who fraudulently obtains or fraudulently attempts to obtain any benefit 
under this Act, by malingering or by making any false claim or statement, and 
any person who, by a false statement or other means, aids or abets a person in so 
obtaining or attempting to obtain, commits an offence. 
A medical practitioner who is viewed as aiding the individual in this enterprise places 
him/herself at risk of prosecution too. To an extent, this would make health practitioners 
more likely to state that a person is malingering than to try to 'fight' for a diagnosis such 
as chronic pain, which is does not often have many objective measures and risk possible 
prosecution. 
In Queensland, under section I J .2 of the Workers' Compensation Act (1990) it is offence 
to obtain compensation by fraudulent means or by malingering while claiming an injury. 
Under other compensation systems the term malingering does not appear, but it is clearly 
stated that is illegal to fraudulently gain benefits under a compensation system. Further 
to this, the provisions for fraud while differing within the different legislation of the states 
of Australia, would probably cover this situation. Still as previously mentioned the strict 
psychological definition would be utilised, it is assumed. 
Validation of the MDS 21 
Types of" malingerers 
An alternative definition is offered by Travin and Protter (1984) where malingering is 
viewed as a "social psychological process which is influenced by both external and 
internal factors interacting with each other and serving an adaptive function" (p. 189). 
External factors are the consensually perceived context and goals which make for a high 
index of suspicion for diagnosing a malingering. Internal factors are the intrapsychic 
state of the malingerer. Travis and Protter (1984) conceptualise this state as a continuum 
ranging from malingering to malingering-like behaviour; that is; from full conscious 
awareness of the behaviour to much less awareness (unconscious) of the source of the 
symptoms. In this sense, the distinction can be made in terms of the conscious awareness 
of the source of the symptoms, as opposed showing no understanding why the symptoms 
are being produced. 
Travis and Protter (1984) suggest that along the continuum there are three types of 
malingerers which are differentiated by their level of awareness of the reasons for the 
production of symptoms and their control over the symptoms. The first type of 
malingerer is the form that the DSM IV and virtually all other definitions of malingering 
use, where the patient is fully aware and control of their presentation of feigned 
symptoms, that is, they are consciously producing the symptoms for a specified goal. 
The second is the mid-range of category of symptoms where the patient is a malingering-
like mixed deceiver, that is, the patient is aware that he/she is feigning the presented 
symptom but is not aware that other aspects of the presented symptom are beyond his/her 
r 
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control (unconscious). The third category is the end-range malingering self-deceivers 
where the patient has completely deceived him/herself into realising the reality of the 
presented symptoms, believing instead that it is completely feigned. Unfortunately this 
topic is rarely covered in the literature, with most studies viewing malingering as a 
conscious act, however, Hall and Pritchard (1996) discussed the importance of analysing 
both conscious and unconscious malingering. The current study does not seek to analyse 
this, and actively indicates to participants the 'conscious' state they should be in for the 
assessment. 
The premise that Travin and Protter (1984) follow was suggested by Fingarette (as cited 
in Travin & Protter, 1984) when he said that "rather than taking explicit consciousness 
for granted, we must come to take its absence for granted" (p. 190). According to 
Fingarette, to be considered consciously aware an individual must explicitly state his 
means of engaging the world in a clear and elaborate way (Travin & Protter, 1984). This 
appears contradictory to the very concept of deception, for it is not possible to assess the 
internal dialogue of an individual, and he/she is certainly not going to inform the assessor 
of his/her proposed method of dealing with the world. Another problem with this type of 
research is the use of case histories to support the continuum hypothesis, as all involved 
psychological disorders and four of the five also involved criminal law matters. This 
represents a potentially biased population of 'malingerers' from which certain judgments 
have been made. Quite simply the capacity for self-delusion (or self-deception) is 
naturally going to be higher for the psychologically ill, as a facet of their disorder. Travin 
and Protter (1984) do make the point, that everyone is capable of malingering, as an ego 
r 
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defence. This is fraught with operational and conceptual problems and is not a topic that 
will be explored. Basically the type of malingering the current study is interested in 
involves primarily external gain. It is interesting to note that given the age of the Traven 
and Protter's study its concepts may well have now been introduced in mainstream 
diagnosis under the names of factitious disorder, somatoform disorders, and 
hypochondrasis. This effectively changes the definition of malingering to one for 
external gain, as the DSM IV and Mendelson's (1988) definition indicates. 
Conclusion 
Research into malingering is a difficult and complex process in which the definition must 
be constantly restated, or else the goals can be distorted. Specifically, intent must be 
shown in the attempt to exaggerate or completely feign symptoms. The use of 
malingering as a form of diagnosis is clearly inaccurate and when assessing for 
malingering the forensic psychologist must remember that the decision of malingering or 
'fraud' is for the court. The expert can only comment on the consistency of symptoms 
with the claimed disorder, not to comment on what the intent of any deviation from this 
set of symptoms. 
Methods of Detecting Malingering and Deception 
This section of the introduction seeks to bring together some of the general research on 
deception, malingering for pain and the resulting assessment issues. Firstly, this section 
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will address the ability of professionals, particularly psychologists/psychiatrists, to be 
able to accurately assess those who are malingering and why this might be the case. 
Secondly, a variety of different psychological techniques or indicators for assessing for 
malingering will be presented. Thirdly, a physiological method of assessing for 
malingering for pain will be presented. Fourthly, a range of different methods that have 
been developed to assess for chronic low back pain will be presented. Fifth, an 
examination of the different methods of research into this area will be made. Finally, 
some comment will be made in regard to the application of malingering scales, and the 
importance of other factors. These points will then be explained in terms of the current 
study. 
Recent interest in malingering as part of the deception literature 
There has been increased interest in malingering, however despite its importance to 
clinical and forensic practice, it remains relatively unresearched. Malingering appears to 
be largely viewed as deception in the medical and/or psychological context, and most 
texts on deception (Rogers, 1988; 1997; Hall & Pritchard, 1996) give the topic 
consideration. The 'science' of detecting deception has undergone considerable change 
largely due to work reported in the book Clinical Assessment of Malingering and 
Deception ( C' and 2"d Editions) edited by Richard Rogers (1988; 1997). This appeared to 
stimulate considerable comment and research into the field. Two significant areas were 
noted where a professional shift appeared to occur. First, the professions had to accept 
that there was a relatively poor ability exhibited by staff to successfully detect deception 
and second, that deception, and especially malingering is very difficult to detect. Indeed 
r 
Validation of the MDS 25 
recent research has suggested that the level of malingering in forensic evaluations may be 
as high as one sixth of all evaluations (Rogers, Salekin, Sewell & Goldstein as cited in 
Rogers & Cruise, 1998) the need for increasing knowledge in this area is clear. While on 
first impressions this figure is questionable give Cornell and Hawk's (1989) finding that 
in 314 psychiatric/legal evaluations approximately 8% of individuals presenting were 
'diagnosed' as malingering, when the standard deviations in Rogers Salekin, Sewell and 
Goldstein are examined it is clear that both estimations fall within the same range. 
Psyc!wlogists sometimes cannot disti11guish .between those clients/participants faking and 
genuine clients/participants 
Increased focus has been placed on the ability of health professionals to detect deception. 
Since Rosenhan's (1973) classic study in which pseudopaticnts were admitted to a mental 
institution and diagnosed as having major psychiatric disorders, the medical and 
psychological professions have been forced to admit that occasionally they are fooled. 
Heaton, Smith and Lehman (as cited in Faust, 1995) found that neuropsychologists 
performed at only up to 20% better than chance when they attempted to differentiate 
between faking litigating individuals and genuine non-litigating participants. Faust, 
having reviewed limitations of malingering research, concluded that "clinicians' capacity 
to detect feigned emotional or cognitive disturbance is in doubt .... contrary claims for 
proficiency at the task lack adequate scientific support" (1995, p. 57). 
Evidence differs as to the ability of psychologists and other health professionals to 
successfully gauge whether an individual is malingering. Ekman and O'Sullivan (1991) 
indicate that, in general, health and legal professionals are not good at detecting faking 
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and due to the strength of the inverse relationship between the confidence of the 
professional and accuracy in detecting faking, this situation does not appear likely to 
change. Weintraub (1995) suggested that it is relatively easy to fool psychologists and 
pain experts (Faust, Hart, Guilmette & Arkes; and Faust, Hart & Guilmette, as cited in 
Weintraub, 1995). In contrast, Cornell and Hawk (1989) found a relatively high 
reliability between forensic psychologists, regarding the accuracy of diagnosis of 
psychiatric patients regarding malingering (35 malingerers and 25 genuine patients), 
suggesting that when a formalised series of symptoms are addressed the accuracy level 
rises. While this is useful in psychiatric settings it should be noted that research has 
already indicated that it is not difficult to deliberately score poorly on pain evaluation 
tools (Frazen, Iverson & McCracken as cited in Weintraub, 1995). 
Why clinicians do not appear to be able to accurately detect an individual attempting to 
malinger 
Faust ( 1995) has suggested that certain distinct factors underlie the research findings into 
why practitioners sometimes do incorrectly assess a person as not being deceptive. These 
reasons are clinical orientation, dependence on soft methods and evidence and finally the 
tendency of practitioners to underestimate the skills of their 'patients'. Simultaneously 
practitioners are overconfident in their ability to assess malingering. The orientation of 
clinicians is traditionally to assume dysfunction and sympathise with their patients. 
Indeed the training health care professionals receive is "based on an orientation 
emphasizing supportive, empathic and healing forms of rapport building, rather than 
attempts to penetrate deception"( Lees-Haley, 1986, 110). Further to this Faust (1995) 
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notes that when the physician's primary obligation shifts from the patient to uncovering 
the truth, he/she may now be an adversary rather than a support. As Chapman and Brena 
( 1995) indicate there is a dependence in many conditions on the report of the patient for 
such information as history and symptomatic complaints. 
Faust (1995) indicates that when plantiffs withhold or distort information about important 
issues that may account for symptoms, such as pre-injury condition or substance abuse, 
limitations in methodology and knowledge makes it difficult to determine whether his/her 
presentation makes sense medically. Finally, often patients are underestimated by the 
evaluator, in their knowledge, preparation and skills. Indeed some malingerers gain 
access to the literature on malingering assessment instruments, to help them avoid 
detection. This issue will be addressed later. Faust (1995) indicated that as the 
confidence of the practitioner increased their ability to detect malingerers was reduced. 
So when practitioners don't complete external checks on subjective information and 
instead follow clinical lore, which has not been properly validated, then they may be 
deceived (Faust, 1995). 
A variety ofpsychological approaches have been suggested to detect malingering 
The American Psychological Association (A.P.A), through the DSM IV (1994), 
acknowledge that malingering may be very functional. An example might be feigning 
sickness as a prisoner of war. In addition they suggest that beyond functionality, 
malingering should be "strongly suspected" when any combination of the following is 
noted: "medicolegal context of presentation, marked discrepancy between the person's 
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claimed stress or disability and the objective findings, lack of cooperation during the 
diagnostic evaluation and in complying with the prescribed treatment regimen, and the 
presence of Antisocial Personality Disorder"(p. 297). 
Hall and Pritchard (1996; Paulsen & Hall, 1991) advocate that a framework be used when 
assessing deception rather than just relying on intuition. Paulsen and Hall (1991) have 
suggested that any assessment of malingering be broken into three areas: before, during 
and after the evaluation. Prior to the interview, Paulsen et al. (1991) suggest that the 
evaluator must gather source material, maintain independence from the referral party, 
assess examiner distortions and remain vigilant to the possibility to distortion. During 
the evaluation it is suggested that the interview is recorded, that questions are open-
ended, focus is given to critical distortion issues, multiple assessment measures are used 
and the assessee is confronted with suggestions of distortion. After the evaluation 
Paulsen et al. (1991) recommend that the interviewer assess nondeliberate distortion of 
the assessee, differentiate between incident and evaluation distortion, report incomplete 
or invalid data and identify a feedback mechanism. The MDS can clearly fit into this 
model, however this model while providing suggestion does not specifically give a 
decision making framework for deciding whether an individual is malingering or not. 
Hence, the MDS and other deception detection tools, such as the SIRS, are still required 
to be part of any test assessment battery. 
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According to Faust (1995) there are currently three methods of detection: responses to the 
Minnesota Multiphasic Personality Inventory (MMPI) I and 2, symptom validity testing 
and atypical performance patterns in specialist assessment tasks. Mossman and Hart 
(1996) have suggested that clinical methods, malinger profiles and external information 
be used to make decisions about malingering. It should be noted however that Rogers 
and Salekin (1998) have noted significant problems with many of the approaches that 
Mossman and Hart (1996) advocated. These are too numerous for this paper to address. 
The MMPI has long been used as a malingering assessment instrument, as it assesses 
certain personality correlates. The F score and obvious items are often elevated for 
malingerers. The subtle items generally have a normal response rate as malingerers 
cannot distinguish which direction indicates abnormality. There is still some debate over 
the efficacy of the MMP1 (J or 2) at assessing malingering. Various meta-analyses have 
suggested that MMPI I (Berry, Baer & Harris, 1991) and 2 (Rogers, Sewell & Salekin, 
1994) have found different validity scales are able to distinguish between the malingering 
or defensive group and the group taking the test honestly. In terms of external validity 
Greene ( 1997) points out that research has found that MMPll and 2 has greater difficulty 
in distinguishing between the group instructed to malinger and actual patients than 
between simulators and normal individuals. Greene (1997) reported that the malingering 
a wide range of different disorders on the MMPI 1 and 2 have found that the malingering 
group could be distinguished, however the more severe psychopathology, the easier it 
was to detect malinger. A sobering point made by Berry, Lamb, Wetter, Baer and 
Widiger (1994) is that due to such widespread research and use the MMPI-2 has lost 
some of its integrity. Indeed Berry et al. (1994) suggest that the widespread publishing of 
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information about the MMPI-2 has reduced its effectiveness as a psychological 
assessment tool. 
Symptom validity testing, which often involves a forced choice format, has been used in 
an attempt to make the malingerer overplay his 'sick' role and perform at a level lower 
than chance. In time this can produce evidence of systematically produced incorrect 
results. The major problem with this format it that it has limited sensitivity and if the 
feigned deficits are not gross, then the malingerer will not be detected (Faust, 1995). If 
these can be refined, it may represent an excellent method. Both the SIRS and the MDS 
utilise this format by suggesting improbable symptoms of a disorder for which there is no 
medical evidence. This is known as a false choice format but represents the overt 
agreement with any indication of disorder. This is, to an extent, utilised by the MDS. 
Faust (1995) suggests that in time other approaches will be developed to detect 
malingerers such as reaction time and atypical patterns on cognitive tests. Mossman and 
Hart (1996) support such an approach with a distribution of scores on malingering 
assessment tools indicating probability of malingering rather than arbitrary cut off scores. 
This, it was suggested, is especially useful when presenting evidence of malingering to 
the court, however this will be commented upon later. Overall these approaches are still 
in the experimental stage and similar to symptom validity testing require significant 
levels of research before probability tables and profiles (typical versus atypical, age 
appropriate, gender based) can be generated which would allow this format to be used on 
a wide scale. 
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Main and Spanswick ( 1995) have suggested certain features which "should alert the 
assessor to the possibility of simulated incapacity" (p. 748) in which some are primarily 
suggestive of malingering and some are not. These features appear to be relatively 
similar to those described by the DSM IV. Features they suggest are primarily suggestive 
of malingering are: failure to comply with reasonable treatment, report of severe pain 
with no associated psychological effects, marked inconsistency in effects of pain on 
general activities, poor work record, history of persistent appeals against awards and 
previous litigation. Features that are not considered primarily suggestive of malingering 
are: mismatch between physical findings and reported symptoms, anger, report of severe 
or continuous pain, poor response to treatment and behavioural signs/symptoms. This, 
rather than being overly inclusive, gives some indication of areas in which malingering 
can be differentiated from associated pain disorders. While not in complete agreement it 
is interesting to note that Leavitt (1985) found that simulating malingerers reported 21% 
more clinical pain than actual patients and further focus on this result will be made. 
Chapman and Brena (1995) has proposed that due to problems with self-report in pain 
assessment a label of malingering should only be diagnosed from a consistent pattern 
among multiple indicators. In their evaluation 175 low back pain patients were used, for 
reasons similar to the current study; the literature suggests that back pain is both common 
and often considered suspect. The method of assessment utilised client self report, 
physician assessment and three independent raters. The physician assessed all the 
patients involved in the study on a number of different measures. During the verbal pain 
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reports the level of dramatization was assessed. A rating was given on the severity of 
medical findings involving muscle strength, joint mobility, trigger points, sensory and 
motor losses, and results from radiological and other studies of severity. An assignment 
was made to one of the four categories in the Emory Pain Estimate Model. This model is 
based on medical findings, MMPI scales, drug intake and indices of pain behaviour. The 
patient's response to lumbar sympathetic two injections of saline and at least two 
injections of .25% bupivacaine was recorded. A rating of drug use during the week prior 
to treatment and the last week of treatment was made. This was based on subject's 
records of medication and was divided into classes of drug type: narcotics, 
sedatives/hypnotics, minor tranquillisers, phenothiazines, antidepressants, nonnarcotic 
pain medication and other drugs for pain. Each class was given a label of "no use" 
(averaging less than three tablets per week) or "use" (over three or more tablets per 
week). Finally a rating of physical impairment, in accordance with the AMA Guides for 
Evaluation of Permanent Impairment was given. 
A physical therapist and psychologist, both gave independent ratings at the end of 
treatment relating to the patient's overall "attention and interest" in treatment, and "focus 
on pain". The physical therapist also gave ratings on each patient's "compliance with 
recommended exercises". All of these ratings were based on five categories ranging from 
very low to very high. Some patients were referred for an EMG examination where the 
consultant running the procedure was asked to rate whether he observed inconsistent 
tensing of a muscle that suggests that this patient was showing "submaximum effort" to 
fully contract the muscles during the examination. 
Validation of the MDS 33 
The self-report data that was administered involved five paper and pencil measures. An 
MMPI was given at the start of treatment. An Activity Diary listing activities involving 
movement on one's feet was kept and a score indicating the mean daily total of minutes 
spent moving on one's feet was calculated for one week prior to treatment and the last 
week of treatment. Subjective pain intensity was assessed using a 0 - 100 visual 
analogue scale with end points labelled "no pain" and "pain as bad as it could be" was 
used to measure pain at the beginning and end of treatment. All the treatments offered 
were rated by patients as being "very helpful", "somewhat helpful", "not helpful" or 
"harmful". Finally the Multidimensional Health Locus of Control questionnaire was 
given halfway through the treatment to assess the extent to which patients saw their 
health as being dependent on their own actions. 
Of 143 participants in Chapman and Erena's (1995) study, 17 inconsistent participants 
were unanimously rated by all three evaluators as showing at least one inconsistency. 
The behaviours judged as inconsistent covered a very wide range. First, contradictory 
statements to different staff members regarding pain, medication or compliance were 
made. Second, exhibiting behaviour which they have either claimed they could not do or 
they claimed to have clone exercises but had not actually done them. Inconsistent patients 
were generally younger; all were inpatients, whO have pending litigation or current 
disability status. These patients exhibited a higher focus on pain and clramatised 
complaints, however all had a low level of medical evidence to support their claims. Not 
surprisingly these patients had a low level of interest in treatment, show a poor 
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compliance to treatment and low level of physical activity. The flaw in this study which 
relates to the concept of an intent that the current study hopes to redress is that all the 
inconsistent patients were inpatients which suggests the possibility of institutionalization 
or at least some abnormal illness behaviour due to the environment. Chapman and Brena 
(1995) note that it is difficult to assess whether inconsistency was conscious or not, and 
issues such as institutionalisation take the conscious element out of the inconsistency. If 
this intent cannot be assessed then the issue may now not be malingering but rather 
factitious disorder or conversion disorder. 
The difficulties of the differential diagnosis of malingering and factitious disorder with 
physical symptoms have been canvassed by Overholser (1990). He highlights important 
issues such as the strong similarity between malingering and many other pain or illness 
'disorders'. Overholser (1990) has indicated that there are 4 domains in which 
differential diagnosis can be made: observed symptomology, course over time, response 
to treatment for somatic conditions and proposed etiology. Observed symtomology 
includes somatic symptoms, actual tissue damage, behaviour during interview and the 
typical setting in which each is encountered. The course over time looks specifically at 
onset of somatic symptoms, duration of episodes, discharge status, stability of problems 
and recurrent episodes. The patient/client's response to treatment for the somatic 
symptoms includes the nature of treatment provided, somatic response to this treatment, 
emotional response and behavioural response. Finally, the proposed etiology looks at the 
production of symptoms, control over symptoms, primary sources of motivation, external 
motivation, internal motivation and presumed personality. When this set of criteria is 
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used to actually differentiate malingerers and those with factitious disorder with physical 
symptoms, it appears the major differences occur in the proposed etiology through 
internal (factitious disorder) and external (malingering) goals, probable type of treatment, 
behavioural and emotional response to treatment, whether discharged by doctor or self, 
whether actual tissue damage has occurred and whether an outpatient or inpatient. 
Overall, Overholser (1990) acknowledges that this set of criteria has not been validated, 
and he is relying on clinical observations for his evidence in malingering. What this does 
demonstrate is the heavy reliance on assessing motivation (internal or external), even 
when conscious production of symptoms can be proven, in order to 'prove' malingering. 
Hall and Pritchard (1996), presumably from clinical experience, have suggested that as 
malingerers would wish to avoid evaluators and treatment personnel, certain behaviours 
related to evaluation may be indicative of malingering. Behaviours such as the number of 
hospital admissions, length of stay in hospital, number of diagnostic procedures in 
hospital, help-seeking in regard to rehabilitation centres, days lost from work and number 
of patient-physician contact or specialists consulted constituted malingering. Hall and 
Pritchard (1996) have suggest a number of detection strategies; anatomical 
inconsistencies, drug responses discrepancies, clinical interview behaviour, presence of 
psychometric, inconsistency in community versus evaluation behaviour and lack of 
response to common interventions, Pritchard anti Hall (1996) have noted that all chronic 
pain and sensation-loss syndromes can be targeted for deception. They did make the 
point however that evaluators should not confuse complainers with fakers. Matheson (as 
cited in Waikar eta!., 1991) introduced the term symptom magnification syndrome as an 
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alternative to malingering in which the behaviour has an imputed motivation. Symptom 
magnification syndrome separates that behaviour from the motivation (Waiker et al., 
1991), but Bourg, Connor and Landis (1995) argue that it is the circumstances that are 
crucial to the reason for the assessment, and therefore the assessment cannot be done in a 
vacuum. 
A purely physiological me/hod (~f" assessing malingering in chronic low back pain 
populations 
A physiological method of screening for malingerers using chronic low back pain was 
developed by Waikar et al. (1991) following work by Daniel ( as cited by Waikar et al., 
1991) and Kroemer and Marras (as cited in Waikar et al. 1991). Waikar et al. (1991) 
researched this area with three groups. The first group were healthy and were told to 
exert maximum lifting strength. The second group were also healthy but were told to 
only use half their effort. The final group were chronic low back pain sufferers who were 
told to exert their maximum safe strength without incurring pain or discomfort. The 
static strength measures were conducted in both the "squat" and "stoop" position that 
Chaffin (as cited in Waikar et al., 1991) suggested in accordance with the standardisd 
procedure proposed by Caldwell, Chaffin, Dukes-Dobos, Kraemer, Laubach, Snook & 
Wasserman as cited in Waikar et al., 1991 ). A single maximal voluntary contraction has 
a force output based on time for a sustained 5 second period. The strength score was 
taken as the mean value recorded in the middle three seconds of the exertion. A slope 
score is generated by the amount of weight lifted per second. 
The finding of Waikar et al. 's ( 1991) study was that the average amount of force 
produced by the healthy subjects only trying with 50% exertion was only 38% when 
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compared to the maximum exertion of both the healthy subjects and the chronic low back 
pain patients. Across all three groups the average lifting strength was greater in the squat 
position than in the stoop position. Interestingly, the average strength scores for both the 
healthy subjects using their full exertion and the chronic low back pain patients were 
almost identical in each lifting condition. As no significant differences were found 
Waikar et al. (1991) suggested that this measure was inappropriate in distinguishing 
between chronic low back pain patients and healthy patients not exerting maximum 
effort. Using discriminant analysis based on seven variables from the strength testing 
yielded an accuracy rate of 91% but tended to misclassify more low back pain patients. 
The strength testing variables used were: mean strength for ten trials, strength standard 
deviation, mean slope for 10 trials, mean range for lO trials, mean range/score ratio, ratio 
standard deviation and ratio coefficient of variation. 
To use this method, Waikar et al. ( 1991) suggest that a participant be asked to exert his or 
her safe maximal strength each time in I 0 trials following the protocols outlined. After 
calculating the values of these strength measures they could be inputed into the developed 
discriminant model, which would classify this person as either healthy and giving 
maximum effort, healthy but giving submaximal effort or having back injury and giving 
safe maximal effort. Clearly if the individual is classified as giving submaximal effort 
then it possible that they are malingering or symptom magnifying according to Waikar et 
al. (1991). Finally, it is recognised that this represents only an additional diagnostic tool 
for chronic low back pain and should be used in conjunction with other measures. Faust 
(1995) has indicated the problem with many of these physiological assessment 
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instruments, is that they must assume motivation to produce maximum effort; and it is 
there that the deception lies. The MDS does attempt to assess motivation, albeit in a very 
blunt manner, through the questions found in Part 2. The effectiveness of establishing 
motive does appear to be an field that is profoundly under-researched and given the 
definition of malingering, one that will need increased attention. 
Malingering screening tools specifically designed for chronic low back pain 
Screening tools for malingering, such as those used by John Hopkins Chronic Pain Centre 
(See Appendix 2) (Long, 1986), have been developed for specific reasons but generally 
they are not based on research. They tend to reflect an in-house approach to assessment. 
There are even malingering screening measures for back pain available on the Internet 
through the Mensana Pain Clinic (Mensana Pain Clinic, 1997) (Appendix 3). What is 
clear with both these instruments is that they rely heavily on examining the economic and 
social circumstances of the individual with back pain. This essentially is an examination 
of the conditions for which a person may have reason to malinger, that is, financial 
difficulties or attitudes to work. As with litigation, while the circumstances may be 
conducive to malingering, this is not evidence of the act. Put simply it is the difference 
between a motive and intent- with intent being the crucial factor in the definition of 
malingering. 
A study by Leavitt (1991) using a low back pain simulation scale to predict disability 
time, evaluated the endorsement of different 103 pain words by 1679 individuals injured 
at work. This was developed following Leavitt's (1985) early work with simulating 
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malingering for low back pain when compared to genuine pain patients in which the 
results suggested that people who simulate back pain employ different pain language than 
those with clinical pain. Leavitt (1991) suggests that the low back pain simulation scale 
utilises 45 words that can differentiate those simulating from those with genuine pain. 
After administering this scale it was suggested 10.4% were in the simulating range, with 
this sample indicating that they felt more intense pain and would be disabled longer. A 
known groups design was utilised in which, the participants identified as simulating 
(10.4%) had generally previously been labelled as possible malingerers. The problems 
with this sort of design will be examined later. Overall this group had indicated that they 
experienced 21% more pain than those found not to be simulating. This is not surprising 
if the pain words identified as indicative of conscious exaggeration are more extreme in 
their intensity than the 'normal' pain language. In addition, the individuals who had been 
off work for over a year accounted for 33.9% of the high simulation group and 19.3% of 
the low simulation group. Leavitt (1991) suggests that, even when 25 participants from 
the high simulation range and 25 from the low simulation range and then rated by 
physicians for organic pathology and confidence that the individual is malingering there 
is a significant level of discriminative ability for those labelled as high simulators. In 
short, those with less tissue pathology report more pain and record the longest time for 
disability. 
When validating or developing measures to assess malingering several problems emerge. 
Chapman and Brena (1995) note that it is virtually impossible to gain access to a 
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population of known malingerers, as by definition, these people make sure that they arc 
not identified. This leads to two possibilities, the first being identifying participants who 
were inconsistent in their responses and therefore are probably malingerers or 
alternatively using a simulation design in which participants are asked to simulate 
malingering. 
Several studies have used simulation designs for back pain (Leavitt, 1985; Clayer, 
Bookless & Ross, 1984) in which participants without back pain were asked to simulate 
low back pain when completing certain written evaluation tasks. These responses were 
then compared to the responses of authentic low back pain patients; and in both cases the 
evaluation tool showed differences between the two groups in the endorsement of pain 
words and cognitions relating to illness behaviour. 
A major study, which from the results and methodology, was a significant basis for the 
current study is Leavitt (I 985). Following from work on pain descriptors by Melzack 
( 1975), Leavitt ( 1985) sought to use pain word descriptions as a means of differentiating 
between clinical and simulated low back pain. Basically he used 103 pain terms which 
covered the range of sensory and affective sensations typically reported by patients with 
low back pain. Eighty seven items were drawn from the Low Back Pain Scale (Leavitt, 
Garron, Whisler & Shenkop as cited in Leavitt, 1985). The remainder came from a 
general review of the clinical work on low back pain completed as part of the 
development of the final scale. There were two groups of participants: 553 patients with 
low back pain and 347 participants, obtained from the Chicago directory, who were asked 
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to "play the role of a person who is trying to convince a doctor that their back pain is 
severe enough to stop them from working at their regular job" (p. 497). This instruction, 
arguably then limits the type of low back pain, to being mechanical in origin rather than 
pathological or traumatic which Giles and Crawford (1997) have suggested are 
physiologically different. However for the purposes of this study, traumatic pain, is of 
greater interest, making this set of instructions slightly inaccurate. 
A predecessor of the Barkemeyer-Callon-Jones Malingering Detection Scale was the 
Conscious Exaggeration scale (Clayer et al.,-1984) based on the Illness Behaviour 
Questionnaire (IBQ) (Pillowsky & Spence, 1983). The IBQ was designed to assess 
abnormal illness behaviour whereas the conscious exaggeration scale was designed to 
differentiate between control participants, conscious exaggerators and those with neurotic 
pain. Pilowsky (1994) indicated that he did not consider that abnormal illness behaviour 
was the same as malingering. This will be discussed later. While not the same as 
abnormal illness behaviour there are similarities between this diagnosis and factitious 
disorder with physical symptoms, and given Overholser's (1990) highlighting of the 
similarity between factitious disorder with physical symptoms and malingering 
Pilowsky's ( 1994) comment clearly needs to be clarified. The study used a simulation 
design, similar to the one employed by the current study. Results showed that a 
conscious exaggeration scale could differentiate~ at a significant level, between 
malingerers and those with neurotic pain, and between people with neurotic pain and 
controls. 
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In Clayer et al.'s (1984) study the items that differentiated the three groups most 
dramatically, as they were endorsed by the participants asked to exaggerate, fell into a 
wide range of cognitions. The most common (endorsed by over 75% of participants 
asked to malinger) groupings of items were: the participant thought there was something 
seriously wrong with his/her body, that other people did not recognise the seriousness of 
the problem and issues of depression. These clearly are not sufficient to objectively 
differentiate between malingerers and those with chronic pain, from a diagnostic 
perspective, and only suggest a general sense of catastrophising the level of impairment 
resulting from the pain, something that genuine patients do not to tend to do due to 
experience. Mendelson (1987) completed a study in which the conscious exaggeration 
scale (from the IBQ), a visual analngue scale and a list of pain related adjectives from the 
McGill Pain Questionnaire were given to chronic pain patients some of whom were 
litigating and others were not. It was found that conscious exaggeration scale could not 
distinguish between those litigating and those not. Mendelson (1987) ultimately suggests 
that there is "a high correlation between scores on the Conscious Exaggeration scale and 
personality factors, especially anxiety proneness, state anxiety, depression and hostility" 
(p. 709). The impact of this will be discussed later. 
The current study seeks to use a simulation design, the difference being that all the 
participants are pain patients half of whom will "be asked to consciously exaggerate their 
pain. When Clayer et al. (1984) conducted their research chronic pain was considered a 
neurotic condition hence the inclusion of neurotics as participants; this is no longer the 
case (Turk & Melzack, 1992). The flaw in this study that the current study seeks to 
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redress is that conscious exaggeration, can, by definition, only occur when some form of 
pain is felt, that is, something exists which can be exaggerated. 
Currently no study has attempted to validate the Barkcmeyer-Callon-Jones Malingering 
Detection Scale (1989) which, at this stage, seems to be the only malingering scale based 
upon research that purports to be applicable in pain settings. The Barkemeyer-Callon-
Jones Malingering Detection Scale has only been cited on four occasions: Dannebaum 
and Lanyon (1992), Hall and Pritchard (1996) and recently Cunnien (1997) and Smith 
( 1997). Donnebaum and Lanyon ( 1992) cited it as an example of subtle items in the 
detection of deception. Hall and Pritchard (1996) cited and reproduced the scale, in their 
book, as an example of an assessment tool for malingering for pain or Joss of sensation. 
Similarly, Cunnien (1997) describes the scale but does not cite any validation procedure 
completed on the MDS by an independent body. Smith (1997) comments in the most 
detail on the MDS, and this will be discussed later. 
Even when malingering assessment tools are developed certain procedures, if followed, 
give the assessment consideral7/y more validity 
Even when clinical tools are available for malingering Faust (1995) suggests several 
guides for the clinician, which will, he claims strengthen the health professional's 
position in the courtroom. First, it is important not let subjective confidence be the guide 
for whether an individual is malingering. A study has shown that clinicians who 
indicated that they were confident or very confident in their diagnoses had an error rate of 
LOO% (Faust, Hart & Guilmette as cited in Faust, 1995). This may be due to the 
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relationship between overconfidence, premature conclusions, insufficient data collection, 
failure to use useful diagnostic procedures and decision rules (Kahn em an, Slavic, 
Tversky as cited in Faust, 1995). Second, consider the degree to which the examinee has 
a motive to deceive, which cao be extremely difficult to ascertain in legal proceedings, 
where there may be strong incentives to deceive. Faust ( 1995) suggests that "under such 
circumstances, the base rates for malingering is higher, and thus the index of suspicion 
needs to be greater, diagnostic thresholds need to be adjusted and more thorough and 
systematic assessment is indicated" (p. 261 ). It is interesting that no papers are cited to 
support this contention, and similar to Leavitt and Sweet's (1986) finding, it appears to be 
part of clinical folklore. The current study seeks to assess this link between the court 
process and malingering. 
Conclusion 
The literature on detecting malingering clearly gives disparate results. Certainly the 
ability of clinicians to detect malingering appears to be in doubt however the ability of 
standardised testing appears to be proven yet. Clearly, one cannot rely on one method to 
substantiate the other, which is what effectively occurred in the original validation of the 
MOS. Specifically, the detection of the malingering of pain has been approached through 
both physical and psychological methods. Neither has been proven conclusively and 
generally the methodology used to 'prove' the capacity of a malingering assessment has 
been controversial. While certain factors such as extreme responses on pain intensity and 
attitude to treatment, when compared to genuine patients, are suggested by the research, 
no conclusive technique has been found to address the element of why a pain patient is 
Validation of the MDS 45 
attempting to malinger. This is crucial, given the criteria for malingering. What is 
perhaps more difficult to operationalise is the distinction between simulators being given 
a motivation and a 'real' malingerer, where there are perhaps multiple motivations and 
rationalisations within them. 
Chronic Pain and Litigation 
The relationship between litigation and chronic pain is well established, however 
it appears to lead to certain assumptions being made about those in litigation with chronic 
pain. Litigation, whether through a no fault system or a common law remedy, relies 
heavily on pain and suffering for the final level of compensation and this must prove 
tempting for those willing to manipulate the system. Several studies have indicated that a 
high degree of suspicion exists towards particularly low back chronic pain patients who 
are attempting some form of litigation. Interestingly while research suggests that there is 
little relationship between litigation and malingering, the stereotype still appears to be 
prevalent. 
Pain is often central in litigation 
A survey of only six plantiff attorneys indicat~d that in 1989 they handled a total of 69 
cases involving back injuries for settlements totalling approximately 7 million dollars 
(Aghazadeh as cited in Waikar et al., 1991). With this in mind, Weintraub (1995) notes 
that people are compensated for "subjective and intangible pain and suffering, loss of 
consortium, and loss of life's pleasures ... despite the fact that these losses cannot be 
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quantified, they are responsible for 80% of the reward" (p. 341). This system must prove 
tempting for some individuals to attempt to manipulate for personal gain, especially given 
the level of awards involved 
Involvement as a litigant, whether prior or current, appears to be cause for suspicion of 
possible malingering 
The comments by Faust (1995) and the DSM IV (1994) suggesting that litigation is an 
excellent indicator of the possibility of malingering are by no means unusual. Leavitt and 
Sweet's (1986) study, using a sample of 113 orthopedic surgeons, found that 50% of this 
group considered that when a back patient indicated that they were involved in some 
form of litigation or were considering becoming involved, could be considered a sign 
that this patient may be malingering. In support of this Chapman and Brena (1995) found 
that inconsistent participants (suspected of malingering) in their study were likely to have 
pending litigation or to be receiving current disability income and report a higher degree 
of pain. Main and Spanswick ( 1995) suggest that previous litigation is a strong indicator 
of the possibility of malingering. As malingering is strictly a legal term although a 
psychological definition is utilised, this may be acceptable, however the interest for this 
study is whether this assumption is correct. Travin and Protter (1984) lend some support 
to the study's approach when they state 
"malingering-like phenomenon ..... are utilised in a wide range of perceived 
adaptive circumstances; and just as lying behaviour can blur and merge into 
subtle forms of self-deception it is only within the forensic context that with its 
sociopsychiatric and medico-legal overtones that one scrutinises the obvious 
motivations for the act" (p. 198). 
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Need to factor in legal system for any malingering validation especially one in which 
personal injwy litigation is i111Jolved 
As part of the validation of the MDS there needs to be a validation with those individuals 
who are aware of the rewards associated with malingering due to the sort of system that 
they have been operating in. The validation of the Structured Interview for Reported 
Symptoms (SIRS) (Rogers, 1988) is an excellent example of such a validation process. 
The SIRS is used in psychiatric settings to assess malingering, and, as with malingering 
measures, it primarily relies on assessing inconsistency in responses. The validation 
process the SIRS has undergone shows the value of simulation designs to assess the 
potential problems that a malingering population may present to a new scale such as 
discriminant and concurrent validity (Rogers, Gillis, Dickens & Bagby, 1991). In 
particular their ability to assess faking in a number of specific disorders (Rogers et al., 
1992) and the effect on coaching on the discriminative ability of the scale (Rogers, Gillis, 
Bagby & Monteiro, 1991). For a complete validation the Barkemeyer-Callon-Jones 
Malingering Scale will have to show similar discriminative levels under similar 
conditions. It is for this reason and the influence of Leavitt and Sweet's (1986) findings 
that the responses of pain patients who have been involved in workers' compensation 
systems and/or legal system will be compared to the responses of pain patients who have 
not had contact with any adversarial system. 
Research in this area is difficult because, it is difficult to know the level of pain prior to 
the injury, and then the effect of anxiety regarding financial concerns for the future. So 
studies that have indicated that perceived pain levels dropped after the litigation was 
completed (Mendelson, 1992) may be indicative of stress relief rather than malingering. 
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Certainly research by Guest and Drummond (1992) does suggest that no significant 
difference exists between litigants and non-litigants after the court process, and that 
emotional distress was not necessarily lessened after the court case. This research was 
slightly different to the current research as it utilised chronic low back pain sufferers who 
went to court and compared them to those who settled their claim prior to court. In the 
current research both groups would all be in the litigating group. Weintraub (1988) stated 
that chronic pain is generally regional, involving the back, neck, limbs or head however 
during litigation the locations of the symptoms are not random. Instead they seem to be 
concentrated in the functional domain of the sensory and motor systems of the injured 
area. This can be interpreted in a number of ways: malingering, compensation 
neurosis/accident neurosis or abnormal illness behaviour. Interestingly, Clayer et al. 
(1984) proposes that Pilowsky (as cited in Clayer et al., 1984) clearly includes 
compensation neurosis within his conception of abnormal illness behaviour, which would 
appear to negate a label of malingering under the current definition, requiring specific 
intent. 
Compensation neurosis 
Compensation neurosis has been termed by Foster Kennedy (as cited in Mendelson, 
1992) as "a state of mind, born out of fear, kept alive by avarice, stimulated by lawyers 
and cured by a verdict' (p. 121). It has been suggested by Miller (as cited in Clayer, 
Bookess-Pratz & Ross, 1986) that there is substantial difficulty in distinguishing between 
compensation neurosis and malingering. Further to this Miller, in the same article, made 
the important point that such a term automatically prejudices an individual's case as it is 
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in effect an accusation, which presumes to understand the motivation of the patient 
(Voiss, 1995). Specifically the difference, it has been suggested, lies in the concept of 
conscious and unconscious motivation. Miller states that 
whether such exaggeration is conscious or unconscious is a question often by 
debated by lawyers and psychiatrists in court. To many psychiatrists it represents 
no problems, and they authenticate the complainant's unawareness of motivation 
with confidence that seems impressive- until one reflects that the differentiation 
between conscious and unconscious purpose is quite imperceptible to any 
scientific inquiry and that it depends on nothing more fallible than one man's 
assessment of what is probably going on in another man's mind (p. 296). 
Hall & Pritchard (1996) express similar sentiments regarding the ability of an assessment 
to discern conscious deception from unconscious deception. This has probably lead to 
more accurate but no less difficult terms such as 'patterns of conscious failure to provide 
accurate self-report data' (Main & Spanswick, 1995) which has been used, perhaps to 
avoid the decision between conscious and unconscious exaggeration. 
Studies specifically addressing the c[f"cct of litigation on chronic pain 
All of the few studies that have looked at chronic pain in litigation, support Mendelson's 
(1982) contention that patients arc not 'cured by a verdict'. Peck, Fordyce and Black 
( 1978) studied the different response styles to chronic pain by claim tort litigants 
compared to non-litigants. Whilst acknowledging that there were very few differences 
between the two groups they did find that two pain behaviours identified the litigants. 
The litigants consulted fewer doctors and used-more supportive devices such as crutches 
and prosthetics that cost more than $200. Non-litigants used more prescribed pain 
relieving medication than the litigants in the first month after injury however, by the sixth 
month, drug ingestion was significantly reduced for both groups. 
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There does not appear to be a significant difference between litigants and non-litigants in 
the self report of pain intensity. Mendelson (1984a) compared 47 chronic low back pain 
patients with 33 chronic low back pain patients not seeking compensation and found 
using a visual analogue scale, that there was no difference between the two groups in the 
level of reported pain intensity. This study was conducted close to or after litigation was 
completed which does not necessarily capture the levels of pain during the litigation 
process. Suter ( 1998) found that when litigants and non-litigants were compared on 
levels of pain and anxiety before, during and after litigation, there was a definite increase 
during litigation which returned to normal levels later. However the confounding 
relationship between pain and anxiety can be used to explain this result (Hawkins & 
Price, 1992; Guest & Drummond, 1992). 
There is I ittle doubt that there is substantial anxiety for litigants in the court process 
which the rise of therapeutic jurisprudence movement has shown (Wexler & Winnick, 
1996). Leavitt's ( 1990) study into emotional distress among patients with chronic pain 
showed that patients with such an issue, were more likely to have a longer period of 
disability irrespective of whether they were in receipt of compensation payments. This 
interaction between response to litigation and injury has been addressed in a number of 
studies 
An interesting analysis, completed by Binder, Trimble and McNeil (1991) showed that 
the relationship between financial compensation and outcome was reliant on several 
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different factors. The methodology utilised 18 participants who had complained of 
psychiatric symptoms during the litigation process and were recruited from a 
psychiatrist's files. Through reviewing the court documents and interviews with the 
participants, Binder et al. (1991) developed case examples which appeared to 
demonstrate complicated relationships between monetary compensation and outcome. 
Certainly some of the participants reported that they had improved after they had received 
compensation, however this appeared to be related to issues besides the money. Reasons 
such as feelings about impairment, family support, the loss or gain of a relationship, 
personality characteristics, personality characteristics and ability to work were all cited as 
issues that contributed the improvement. Clearly there are some qualitative issues with 
this methodology, specifically the lack of a non-litigating group, which limit the 
conclusions that can be drawn from the study. It does appear that a range of issues are 
related to any improvement and that the monetary factor is only one element that may or 
may not contribute to the secondary gain of the litigation. 
Several researchers have suggested that while presentation at litigation is slightly more 
than pre-litigation gradually litigants returned to the same behaviours as non-litigants. 
Indeed Mendelson (1987) suggests that "the view that the prospect of financial gain is the 
sole, or even the predominant factor that maintains chronic pain and disability is not 
supported" (p. 710). When this was tested Mendelson (1984b) found that between 35%-
75% of litigants continue to attend for medical treatment and remain disabled when 
interviewed 2-3 years after the litigation has concluded. The current research also seeks 
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to find different responses from former litigants to those without litigation experience to 
assess whether the litigation experience has an impact on malingering. 
The existence of any change in pre and post litigation injury levels has been described 
(rather than explained) through the use of such terms as functional overlay, litigation 
response syndrome and compensation neurosis (Mendelson, 1992; Main & Spanswick, 
1995; Lees-Haley, 1988). While debate rages over the empirical validity of this 
'diagnosis' within Australian courts this has been accepted as a legitimate concept (i.e 
Kilpatrick v The Commonwealth Bank of Australia (1988) N82/156 Administrative 
Appeals Tribunal). With regards to litigation response syndrome Lee-Haley (1988) 
indicates that a series of symptoms such as depression and anxiety arise from the process 
of being personally involved in litigation that may hinder either defendants or plantiffs in 
their ability to protect their interests. One of these responses Lees-Haley (1988) suggests 
from his clinical experience is hysterical and hypochondrical responses in which 
symptoms may be exaggerated in number or degree. He does suggest that this 
exaggeration should pass at the conclusion of the litigation suggesting that the effect of 
litigation on chronic pain, is at best temporary. 
7he ef("ect of" litigation on the level of exaggeration of chronic pain patients 
While treatment outcome does not appear to be affected by I itigation, the mere 
involvement with the legal system appears to suggest that litigants are 'tainted' as they 
are more prone to exaggeration of their complaints for external gain. As was mentioned 
earlier, Mendelson (1987) assessed chronic pain patients of which 157 were receiving 
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compensation or had been involved in litigation and 106 had no entitlement to 
compensation. It was found that there was no significant difference between litigants and 
non-litigants on the Conscious Exaggeration Scale (as Clayer et al., 1984 used). This 
suggests, that litigants as opposed to non-litigants, are no more likely to be exaggerating. 
This appears contrary to some of the suspicions in relation to the assessment of pain 
(DSM IV, J 994; Faust, 1995). 
Conclusion 
Clearly the effect of litigation on both reported pain and malingering has been either 
explicitly or implicitly addressed both in assumptions made in assessment and in 
research. It has to be said, that currently there does not appear to be an effect on either 
the ability to malinger or on the level of reported pain according to the research however 
clinicians continue to believe otherwise. Whilst most assessment tools state that litigation 
is a crucial element in malingering, it could be said that its presence does not increase the 
likelihood, only that the reasons for external gain, are more clearly defined. Regardless 
of this, when a change in pain levels does occur, it could be due to stress in the litigating 
process rather than malingering, when no statement of intent exists. As this element of 
the study is yet to gain clear direction, the resulting hypothesis will be positive rather than 
negative, to assess whether a relationship exists at all. 
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Validation of Malingering Detection Scale by the author 
Methodological Issues in Research 
In this section the issues arising from the development and validation of the Barkemeyer 
Calion Jones Malingering Detection Scale are discussed with reference to the major 
issues in malingering research. Specifically the lack of internal validity in the 
development of the MDS is discussed and the attempt by the current research to redress 
this imbalance by using a combination of a known groups and simulation design is 
detailed. The issues arising from this approach are then discussed. 
111e development of the Barkemeyer Callon Jones Malingering Detection Scale 
The Barkemeyer Calion Jones Malingering Detection Scale (MDS) is based on 26 
malingering behaviours (Sec Appendix 1) that the authors have identified (Barkemeyer, 
personal communication) (Appendix 4). Their method of identifying specific 
malingering behaviour appears to come from clinical experience as no studies or pilot 
testing are discussed in either the paper by Calion, Jones, Barkemeyer & Brantley (1989) 
or in the manual for the MDS. Such experience may have come from Barkemeyer and 
Calion as they have extensive experience in neurology and behavioural neurology 
respectively. These 26 malingering behaviours represent 26 items in the scale while the 
remaining 3 examine the goals of such behaviour. Hence the MDS has a total of 29 
items, an interviewee is given one point, for each behaviour or goal that they exhibits 
during the interview. 
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Original validation study 
In the original validation study (Barkemeyer et al., 1989) a known groups design was 
employed in which external methods were utilised to define who was a malingerer and 
then the MDS was used to test whether the same individuals were identified. In this case 
it was one neurologist who made his/her judgements using an unstated criterion. Using 
this approach it was stated that the MDS was developed to "differentiate between patients 
who are malingering and those who have a recognisable organic disease" (Calion et al., 
1989, p. 3). Furthermore the MDS attempts to provide a clinician with "positive 
inclusive evidence" (p. 3) that a patient is malingering whereas a conclusion that a patient 
is malingering is reached more frequently on the basis of exclusion evidence rather than 
direct evidence. The purpose of the original validation study (Calion et al., 1989) was to 
test the hypothesis that the test differentiates between "patients whose medical complaints 
were associated with physical evidence and those who were determined to be 
malingering"(p. 4). As Smith ( !997) notes no demographic data was provided on the 
participants, which makes the effectiveness of the scale difficult to judge, as other 
features may be responsible for certain individuals being selected, and not just their 
behaviour that indicated malingering. 
Research by Barkemeyer et al. (1989) indicated that the scale had high internal 
consistency (alpha coefficient of .93) and inter:rater reliability (r = .94). Predictive 
validity (r=.86), which is what the current study is primarily concerned with, was 
assessed by a criterion measure. This measure according to Call on et al. (1989) was 
designed to reflect a lack of cohesiveness in the patient's responses and the absence of 
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objective findings supporting the complaints. Specifically, the criterion score was 
derived from three items: the presenting complaints were not consistent with a defined 
symptom complex, the neurological examination failed to support the patient's 
complaints and laboratory test results were equivocal or did not support the patient's 
behaviour. 
A hoard certified neurologist was used by Barkemeycr ct al. (1989) to examine 122 adult 
neurology clinic patients, and to give a criterion score out of three using the criterion 
approach previously outlined. If the criterion was either two or three, the patient was 
considered to be malingering. Under this system 30 of the neurology patients were 
considered to be malingering while the remaining 92 were considered to be non-
malingerers. When the MDS scale was applied it was found that the mean score for non-
malingerers was only 1.3 out of 29 compared to the mean for the malingerers (13.87). 
This, Calion et al. (1989) suggests, is due to "the suspect behaviours tend(ing) to 
characterise the presentation of the malingerers" (p. 5). A discriminant function analysis 
indicated that a score of 7.6 differentiated between malingerers and non-malingerers. 
Finally a cross classification procedure was completed which showed that the MDS 
correctly identified 95% of patients as being in the same group that the criterion measure 
did. 
Cross validation study 
A cross validation study, discussed by Calion et al. (1989), was completed later using a 
completely different sample group of 66 neurology clinic patients and a non-neurologist. 
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The evaluator, who had some knowledge of neurology was either a medical resident on 
neurology rotation or was an experienced neurology nurse. An MDS was completed by 
the evaluator. A neurologist, blind to the evaluator's ratings, classified each of the 
patients as either malingering or not malingering. Barkemeyer et al. (1989) research 
indicated that an MDS score of 7-8 to differentiate between malingering and non-
malingering was use in this study. A person who scored 7 or less was judged to be not 
malingering however a person who scored 8 or over was judged to be malingering. 
When the results were compared to the neurologist's assessment it was found that of the 
patients who scored 7 or less, 100% had been judged as not malingering. Of those who 
scored 8 or over, 94% had been judged by the neurologist as malingering. One person 
whose MDS score was below 7 was judged by the neurologist to be malingering. 
Smith (1997) is only authority other than the authors to provide a substantial critique of 
the MDS but he tends to only note the similarity or originality of the different sections of 
the MDS rather than directly assessing its validity. Four points were made by Smith 
(J 997). First, the development of the scale, specifically the basis of the items, was not 
clear. Second, the validation studies conducted by the authors of the scale did not supply 
any demographic information, which makes it difficult to directly assume that it was not 
features other than malingering, which caused this result. Third, the validity procedure 
was flawed as there was enormous potential for contamination of results, between 
predictors and criteria. Finally, Smith ( 1997) notes that research with additional 
populations is needed to determine the scales generalizability. Clearly the present study 
is part of this process as no validity study has been completed for the MDS and chronic 
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pain, despite Hall and Pritchard's (1996) assertion that the tool was to be used for 
assessing malingering in pain populations. 
Reliance on expert's opinion 
The issue that Smith (1997) highlights is the reliance on an expert's opinion. Further to 
this Clayer, Bookless-Pratz and Ross (1986) in exploring this problem with pain found 
that when two assessors (experienced psychiatrists) were asked to give a judgment of 
malingering they gained an overall correlation of .64 with the conscious exaggeration 
scale; developed in an earlier study (Ciayer.et al., 1985). This may suggest that the 
correlations between experts may be improved, but only when an instrument is employed. 
However in the validation of the instrument, it may be more beneficial to have a 
simulation design once a knuwn groups design has been completed. Probably the worst 
example of this bias in malingering research is from Leavitt's (1991) research in which 
he validated his low back pain simulation scale by assessing a group of pain patients and 
then indicating that the scale had identified the same individuals that he had, who were 
suspected of malingering. The problem in this case being, that both the scale and Leavitt 
(1991) could be assessing something completely different to malingering. Calion et al. 
( 1989) at least utilised another neurologist to indicate those he considered likely to be 
malingering making the MDS at least valid against the opinion of another professional in 
the field. However if the prior findings of clinicians' dnbious ability to assess 
malingering are taken into account then it is inappropriate that an instrument is assessed 
against a clinician as opposed to another instrument known to be effective. The difficulty 
being that no such instrument exists for chronic pain yet due to the reliance on patients' 
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self report. What is certain is that the clinician used to denote malingering should not be 
a senior author of the assessment tool, which is what Smith (1997) claims occurs in the 
validation procedure. 
Jutemal validity versus extemal Falidity 
The current validation process will see the suggestion by Rogers (1997) that the measures 
of malingering should be validated with a combination of simulation design and known 
groups design being implemented. It is suggested in Rogers and Cruise (1998) that it is 
the convergence of the two methods that "offers the strongest evidence of accurate 
determinations because of their respective strengths: simulation design (internal validity) 
and known groups comparison (external validity)" (p. 281). Through having all 
participants with chronic low back pain, both of these elements are addressed because the 
only difference between a known group and simulation when all the participants have the 
same condition is the intent. In this case, this intent (workers' compensation lump sum) 
is not only given to participants but any prior experience participants may have had just is 
to an extent controlled by the usage of both litigants and non-litigants. So prior 
experience of compensation may make a participant more aware or more cynical of the 
potential for gain in such a system, which in turn, may regulate the strength of their 
intent. 
Interestingly, the Barkemeyer Calion Jones Malingering Detection Scale was developed 
from clinical observations and essentially evaluated in the same manner, thereby losing 
internal validity. In contrast, Rogers (1997) states that any measures developed from 
Validation of the MDS 60 
analogue research should then be cross validated with actual malingerers to gain external 
validity. As Brena and Chapman (1995) noted, malingerers by definition do not identify 
themselves, making a known group not feasible. The only possible group, would he 
malingerers who admit, without duress, that they were attempting to fake or exaggerate 
their symptoms, after the assessment procedure, thereby allowing the assessor to be 
completely blind to the deception. This would be an interesting follow up for the current 
research. Even malingerers who are 'caught', especially those with pain, have a myriad 
of 'disorders' they can be diagnosed with, if it cannot be shown whether the deception 
was conscious or unconscious. The decision in Boyd v General Industries (1987 as cited 
in Hall & Pritchard, 1996) in which an employee was found to be malingering back pain 
in a compensation claim, and the court ruled that the company pay for the treatment of 
the issues that lead to her malingering, indicates that possibly American courts advocate 
such an approach. 
ls it malingering? 
The difficulty with malingering research, as other studies such as Chapman and Brena 
(1995) indicated, is that despite a wide range of possible criteria, it is still impossible to 
conclusively separate individuals malingering from those showing abnormal illness 
behaviour. Pillowsky (1994), the major writer in the abnormal illness behaviour field, 
indicated he does not consider these two areas s'imilar at all, and was very angry that 
elements of the instrument he developed, the Illness Behaviour Questionnaire, were used 
by Clayer et al. (1984) to distinguish simulating malingerers from control pain patients. 
Given this, it appears virtually impossible to define criteria for deciding who is a 'known' 
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malingerer, for those with chronic low back pain without a very specific statement of 
intent. It does appear possible to have a known groups design when validating instrument 
such as the SIRS (Structured Interview of Reported Symptoms) (Rogers, Gillis, Dickens 
& Bagby, 1991) because they are designed specifically to address discrete variables 
within psychiatric disorders. Pain is so multidimensional that currently this level of 
discrimination does not appear possible. 
Simulation designs 
There are several issues with simulation designs which make them much easier to 
experiment with, but most have problems with external validity. Rogers and Cavanaugh 
(1983) have indicated that the responses used in such validation studies are obtained by 
asking participants to simulate malingering in order to study 'true' malingerers. This, 
they suggest represents a paradox in asking participants to comply to instructions to fake 
in order to study participants who fake when asked to comply. Similar to this point 
Rogers, Cruise and Sewell (as cited in Rogers, 1997) noted the importance of very 
specific instructions to fake in which a stated goal must be made, rather than simply to 
'try to fake'. Indeed Leavitt's ( 1985) instruction to try to play the role of a person trying 
to convince their doctor that they have severe back pain, is clearly not enough 
information. Rogers et al. (as cited in Rogers, 1997) suggest 6 elements be present in 
any instruction to malinger: comprehensibility, specificity, contextuality, relevance, 
motivation and believability. These have been incorporated into instructions to 
participants for the current research as much as possible. 
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Conclusion 
The original development and validation of the Barkemeyer Call on Jones Malingering 
Detection Scale was lacking in internal validity, and so it is appropriate to complete a 
well controlled simulation design on this scale. This will strictly control the concept of 
intent, so the techniques used to simulate malingering will represent, to some degree, a 
known groups design. Specifically, a person already suffering chronic low back pain 
rather than someone with no experience of the problem is asked to exaggerate. 
Pm·pose of the study 
Call on et al. (1989) suggests that the Barkemeyer Calion Jones Malingering Detection 
Scale represents "a standardised means for organising one's observations of patient 
behaviour. .it provides a systematic aid to decision (making)"(p. 6). This study seeks to 
verify that the MDS can distinguish between people with chronic low back pain who are 
exaggerating their symptoms and those who are being as honest as possible. In addition, 
this study seeks to assess whether, as some clinicians appear to believe, litigation is a 
fundamental basis for suspecting malingering in a chronic low back pain patient (Long, 
1986; Mensana Pain Clinic, 1997; Leavitt & Sweet, 1986). 
Limitations 
This study has several limitations both general to malingering research and specific to 
this study. Faust (1995) outlines several limitations in most malingering research. These 
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are a restriction of information to clinicians and a failure to warn clinicians about the 
possibility of malingering. The current research addresses this by conducting an 
interview, in which questions can be actively asked by the clinician and the purpose of 
the interview is for a pain evaluation which directly impacts on an external system. 
Therefore, the possibility of malingering should also be assessed, albeit briefly, by an 
evaluator hence the purpose of the study. Hall and Pritchard (1996) suggest that 
involuntary malingering makes simulation designs obsolete, as this form of design 
presumes intent, as does the legal definition of malingering. However the present study 
seeks to closely focus on the scenario invalving external rewards which Rogers et al. (as 
cited in Rogers, 1997) suggested, thereby focusing on conscious malingering. In this 
sense the study rejects the construct of unconscious or involuntary malingering, as a 
specific goal behaviour or intent must be expressed in some form, by definition, for 
malingering to occur. 
Along a similar vein, recent research by Rogers and Cruise (1998) has found that when 
external incentives are provided for successful malingering and punishments for 
unsuccessful malingering are also included, the quality of malingering rises. This study 
does not provide incentives for either a negative or positive nature. In addition while 
positive incentives are relatively clear it must be questioned what form the negative 
incentives might take (perhaps fraud) given the liberal use of terms such as functional 
overlay and compensation neurosis which are still so commonly applied (Mendelson, 
1992; Main & Spanswick, 1995). In Rogers and Cruise's (1998) research participants 
(students) were asked to asked to malinger a major depression for positive incentives 
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(class credit and possible financial reward) or negative incentives (loss of class credit and 
public posting of unsatisfactory performance). The results indicated that participants 
with negative consequences were more focused in their feigning than those with positive 
incentives and produced fewer symptoms unrelated to depression. The implications that 
Rogers and Cruise (1998) posit that came from this study (simulation design) was that 
incentives should are offered for both successful and unsuccessful malingering, both 
negative and positive incentives should be offered, the contexts used are relevant to the 
participants and germane to the psycholegal issue, and the groups assessed should be 
representative of the population to which such a forensic evaluation would be applied. 
The final issue with this research is the lack of generalisability and lack of control over 
the condition of the participants. This study is really only generalisable to men who are 
claiming to suffer from chronic low back pain. Furthermore while this study went to 
some effort to only have participants with chronic low back pain, the respective condition 
of that patient was not controlled for. This was on two levels: level of injury/loss of 
function and medication. No attempt was made to ask the level of injury to the back prior 
to participating in the study. Second, no record of substance use when completing pain 
evaluation tasks was made. The effect that this would have on this study is unknown. 
This does reflect Smith's (1997) call for more studies validating the MDS with different 
populations. In this case the population is very specific but given the use of men aged 
from early to middle adulthood (Greene, 1997) with chronic low back pain (Long, 1986), 
represent two groups upon which considerable suspicion is placed on regarding 
malingering. 
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Design of the current study 
The validation work by Barkemeyer et al. (1989) using a known groups design parallels 
the work by Chapman and Brena ( 1995) in which an expert's opinion is used to denote 
who is malingering and. This, in a sense, is circular because the tool is designed to be 
independent of the expert, and should be validated against another criteria with more 
objective evidence. Even the use of private investigators would be difficult given the 
discussion by Waddell and Turk (1992) on-chronic low back pain which suggests that the 
loss of function can alter over time, and that some behaviours while not possible some 
days are possible on others. Similarly, functional testing, as was suggested by Waikar et 
al. (1991), may also have similar difficulties as the level of pain may bave little to do 
with the functional capacity and as Bigler (as cited in Bourg, Connor & Landis, 1995) 
has mentioned the test for malingering should involve motivation rather than physical 
ability. The Barkemeyer-Callon-Jones Malingering Detection Scale does appear to assess 
this at some level. 
Hypotheses 
On the basis of the literature, six hypotheses have been generated to accurately determine 
whether the Barkemeyer Calion Jones Malingering Detection Scale is capable of 
differentiating between participants, all of whom suffer from chronic low back pain, half 
of whom are asked to malinger while the other half are asked to be honest. How and 
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where the scale is most successful will be examined, as will potential correlates such as 
previous experience with litigation and level of reported pain. 
I. The scores on the Barkemeyer-Callon-Jones Malingering Detection Scale will be 
significantly higher for those asked to malinger than those asked not to malinger. 
2. The criterion of a score of 7.6 on the Barkemeyer Calion Jones Malingering Detection 
Scale will differentiate, to a significant level, those participants asked to malinger, 
from those not asked to malinger. 
3. The items on the Barkemeyer Calion Jones Malingering Detection Scale that will 
differentiate those asked to malinger from those asked not to, will be items 4 and 5 
which focus on severity of the problem rather than description and part two of the 
scale in which the potential gains or benefits derived from the pain are examined. 
4. There will be a significant relationship between scores on the MDS and reported level 
of pain. 
5. Participants who are former litigants will have significantly higher scores on the 
Barkemeyer Calion Jones Malingering Detection Scale than those with no prior 
litigation experience regardless of whether they are asked to malinger or not. 
6. Participants with previous experience in litigation will have significantly higher levels 
of reported pain than those with no prior litigation experience regardless of whether 
or not they were asked to malinger or not. 
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Method 
Participants 
There were 32 participants in this study, all of whom were men who had suffered chronic 
low back pain (3 months or longer). This criteria was made on the basis of the Western 
Australian Work Cover Authority's demarcation of 3 months after the injury, as most low 
back injuries heal within this time. Most participants were well within the standard 
criteria of 6 months suggested by the DSM IV (1994) and Turk and Melzack (1992). The 
average length of time that back pain was suffered was in fact 124 months with only two 
participants having pain for less than 6 months. 
Although all participants were male chronic low back pain sufferers, the sample was 
drawn from a number of different sources but overall could be characterised as a 
convenience sample. Specifically, it included 13 serving officers from the Western 
Australia Police Service, 14 members of the community and 5 former clients of a pain 
centre in Perth. Initially, it was thought that all the participants could be recruited from 
the pain clinic, however there were not the number of willing participants available. This 
was primarily due to the specific focus on both gender and type of chronic pain (i.e. male 
and chronic low back pain). The aetiologies of the back pain were not controlled for and 
involved pathological, mechanical and traumatic diagnoses. All the participants had been 
involved in contact sports at some time which satisfied the issue of background of the 
pain sufferer (Hargraves, 1996; Ryan & Kovack, I966). The age range of the participants 
was 19 to 57 years of age with a mean of 40.5 (SD = 10.15). 
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Of the 32 participants, I 6 were chosen as having been involved in litigation as a result of 
their pain while the other I 6 had not. The method used to differentiate litigation from not 
litigation followed a method similar to Mendelson's (1987) research. This involvement 
in the legal system may have been only transitory, as often occurs in the workers' 
compensation system, or it may have involved complex common law litigation 
proceedings spanning years. Primarily this litigation group comprised individuals, who 
received workers' compensation for their injury or compensation for motor vehicle 
accidents. It is unknown whether the claim was made under common law, prior to no-
fault schemes being introduced, or was unrelated to either workers' compensation or 
vehicle accident. The type of compensation procedure varied with the type of 
employment. Some had involved lawyers directly while others had not. 
The non litigation group comprised 16 participants suffering from chronic low back pain, 
who by their own report had no contact with the legal system with reference to their pain. 
The reasons why they did not enter into litigation varied, and were not explored by the 
researcher. Within this group, it was deemed acceptable if they had contact with the legal 
system for criminal matters, provided there was not an issue where feigning illness or 
disability would have lead to a reduction in the charge. 
Tools 
Two scales were used, the Barkemeyer Calion Jones Malingering Detection Scale (See 
Appendix 1) and a 50 point Numeric Rating Scale for pain intensity (See Appendix 5). In 
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addition, participants were given directions to 'malinger' (See Appendix 6) or 'not 
malinger' (See Appendix 7). 
Barkemeyer Callon.Tones Malingering Detection Scale. 
The Barkemeyer Calion Jones Detection Scale (MDS) (Barkemeyer eta!., 1989) 
consisted of 29 items designed to assess malingering in neurology patients. It has been 
suggested b'y Barkemeyer et al. ( 1989), Cunni en (1997) and Hall and Pritchard (1996) as 
a useful assessment tool for assessing malingering in medical settings. lt is basically a 
series of behaviours that an assessor should look for during the course of a routine 
examination. Until now it has not been systematically evaluated by any group except the 
authors. 
The scale is in two parts. The first part examines specific behaviour or responses of the 
interviewee during the interview while the second part examines the goals of the 
interviewee. Within the first part there are six phases: the introductory phase, history 
taking phase (Characteristics of the Patient's presentation), history taking phase 
(Manipulation attempts), patient's response to questions, examination phase and patient's 
response to disagreement. These phases will be described in more detail later. The 
second part does not have these phases and requires the examiner to specifically ask three 
. 
questions which assess what the goals for the patient's behaviour are. 
The 'Introductory Phase' has three items listed, which are to be judged from the 
spontaneous comments by the patient. These involve expressions of exaggerated 
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confidence in the examiner's ability, statements designed to enhance his/her position in 
society and statements denigrating those in the immediate community. The first 'History 
Taking Phase' has 9 items which the interviewer uses to assess the patient's; focus on the 
severity of the problem, focus on the impairment from the pain, exploration of alternative 
aetiologies, use of non-causally based associations, unusual responses to treatment 
(became worse or showed no improvement at all), denial of responsibility for clearly 
voluntary acts and his/her presentation included a constellation of inconstant complaints. 
In addition if the patient's disability was emphasised during the examination to the 
exclusion of any consideration of his/her abilities, where the interviewee makes no 
attempt to describe his/her strengths; only the impairment from the injury. 
The second 'History Taking Phase' looks at attempts of manipulation by the patient, and 
covers five items, although these items actually assess seven behaviours. These 
behaviours involve citing another professional who agreed there was problem, describing 
the prestige of others who allegedly found a pathological process, quoting an authority on 
the suspected pathological process, using an irrational analogy to justify a claim of 
physical pathology, threatening to harm self or others if relief is not found, overstating 
the examiner's authority for intervening on the patient's behalf and making an 
implication that there might he legal retaliation for missed diagnosis or improper care. 
The 'Patient's Response to Questions' is examined for two behaviours. The first is 
whether or not the patient questions the competence of the examiner to avoid answering 
questions as he/she is unsure of the answer. The second is whether or not the patient 
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gives an affirmative response to an inappropriate leading question, due to a lack of insight 
into the alleged illness or impairment. 
The 'Examination Phase' is the only area in the MDS where some physiological 
knowledge is necessary. Two behaviours are looked for. The first is whether any 
physical effort whatsoever resulted in an enhancement of the patient's presentation of 
symptoms. The second is whether or not the patient's responses during the examination 
supported a physiological explanation. 
Finally, the 'Patient's Response to Disagreement' is assessed by looking for the presence 
of three behaviours. The first behaviour is when the patient's response to the examiner's 
explanation suggests a distorted meaning of the examiner's statement. This is often used 
as a mechanism to avoid the acceptance of the examiner's explanation. The second 
behaviour occurs when a patient demands a prognosis based on inadequate data, knowing 
that level of information is insufficient to give an explanation. An examiner who obliges 
this request places him/herself in an unjustifiable position. The final behaviour is 
whether the patient questions the examiner's motives. Again this is sometimes used to 
avoid acceptance of the examiner's impression. 
The second part of the MDS assesses the apparent goals for the patient's behaviour. This 
involves three elements. These clements assess whether the patient's complaints lead to; 
the avoidance of a normal responsibility or noxious activity, the gain of either a concrete 
entity or abstract quality and the retention of either a concrete entity or abstract quality. 
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The MDS was then placed in an interview format (Appendix 8) which involved phrasing 
appropriate questions to ask the participant. This was done for consistency in approach 
between participants. The process that saw the scale placed into an interview format 
involved writing item specific questions, drawing from the description and intention of 
each item, as stated in the MDS manual. These items were then piloted with on a male 
chronic low back pain sufferer, who is also a graduate level psychology student. Items 
that were confusing, or inappropriate were altered. This individual was not a participant 
in the experiment. The only issue being that questions were asked rather than comments 
(i.e manipulation attempts) volunteered or attempted by participants as opposed to a 
genuine physical assessment. 
50 point Numeric Rating Scale of Pain Intensity. 
The second scale used is a numeric rating scale for pain (NRS) similar to the one outlined 
in Leavitt (1985) and Turk and Melzack (1992). This scale lists numbers in 
chronological order from 0 to 50. Pain description statements suggests, that 0 represents 
"No Pain" while 50 represents "Pain is Unbearable". 
Direction to 'Malinger' or 'Not Malinger'. 
The direction to malinger was problematic as it had to be very specific. Having 
considered the instructions given by Clayer et al. (1984) and Leavitt (1985) it was 
decided that both were inappropriate as they were designed for controls not people in 
pain. An alternative direction was written with the help of the clinical psychologist (See 
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Appendix 6, 7). This approach also satisfied all of the criteria specified by Rogers, Cruise 
and Sewell (as cited in Rogers, 1997) of comprehensibility, specificity, contextuality, 
relevance, motivation and believability. 
The directions to malinger or not malinger was piloted on 4 individuals, all of whom had 
chronic low back pain. When asked directly how they would approach an interview 
having received these instructions, they said that they would alter their presentation in an 
attempt to gain more compensation, compared to if they had not received any instruction 
or an instruction to be genuine. Similarly, they clearly understood the direction to not 
malinger. For the pilot and participants recruited from the pain clinic the direction to 
malinger or not malinger was sent out as part of a letter but the other participants received 
the direction on an instruction sheet. The content was not altered at all (See Appendix 9). 
Procedure 
Ethical approval was received from Edith Cowan University Psychology Department's 
Research Ethics committee after they considered a proposal for the research. 
The direction to malinger and not malinger, the pain evaluation and MDS interview were 
piloted and modified where necessary. This also provided practice for the researcher in 
the practical aspects of the study. 
There were two methods by which participants were recruited. The reason that the 
community and police sample was involved was that due to a lack of willing research 
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participants from the pain clinic it was necessary to find an alternative source of men 
suffering from chronic low back pain. The former clients of a pain clinic were recruited 
through the clinic whereas the community and police sample were recruited through a 
slightly different method, described below. 
Participants from/he pain clinic 
Initially it was hoped that all the participants could be generated from a sample of former 
pain patients treated by local clinical psychologist, who has worked in the field of pain 
for some time. He provided the names and phone numbers of 88 former patients from 
his practice. All of these former people were men, who were over 18 years old and 
suffered from chronic low back pain. All of these men had suffered from this pain for 
over 2 years. 
Of this total of 88 patients, 42 had previously been involved in litigation while the 
remainder had not. The definition of litigation involved any contact with the legal 
profession as a direct result of pain. Generally the litigation involved motor vehicle 
accident compensation or workers' compensation. 
These two groups were to be generated through contacting patients in the pool and asking 
whether they would agree to be part of the research. This followed a strict set of criteria 
for the phone call (See Appendix 10). People were told that the interview would take 
approximately 20 minutes and then I 0 minutes for debriefing. If the person called agreed 
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to participate an interview was scheduled. All the interviews were conducted either at the 
participant's home or workplace. 
During this phone conversation the former pain clinic clients who agreed to participate 
were told that they would receive a package in the mail that would contain: 
• 
• 
• 
• 
• 
a letter indicating whether they were to pretend to malinger or not malinger 
5 numeric rating scales, one for each day prior to the interview. They were asked to 
fill these out in accordance with their orientation of either 'malingering' or 'not 
malingering' but not until after the interview was completed 
a letter from the psychologist introducing the research and giving his support to it 
was also included (See Appendix 11) 
a comprehensive informed consent form was given, with pertinent phone numbers 
and a tear off consent section indicating that the participants had read and understood 
the purpose of the study (Appendix 12). This was to be signed and returned at the 
interview 
a reminder sheet was given listing the time and date of interview to avoid confusion 
(Appendix 13). 
Participants were assigned to the 'malinger' or 'not malinger' orientation by a third party. 
This was achieved by the third party placing the letter in and then sealing the pack. The 
packages were arranged in such a way that half of each group had been involved in 
litigation. This package was then posted. The address was kept by the assessor for the 
interview, but this was destroyed immediately after as was the name of the participant to 
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avoid identification. A system of code numbers was generated to avoid the use of names 
and increase confidentiality. The only use of names for the remainder of the study was 
for the informed consent forms which were kept separately from the data in a locked 
room. These gave no indication of whether the participant had previously been involved 
in litigation and more importantly whether they were given an orientation of malingering 
or not. This was done to protect individuals who may decide to litigate in the future from 
any repercussions of being involved in a study which assessed their ability to malinger. 
Prior to the interview, the participants were asked for their signed informed consent form 
and then the interview begun. 
Two participants withdrew from the assessment prior to the interview having received 
their information pack containing an explanation of the research. Both noted that they 
were ethically opposed to the assessment of malingering. They were thanked for their 
time. 
Community Sample and Police Sample 
The participants from both the police and within the community were recruited through 
word of mouth. The latter group was largely a convenience sample, where men were 
simply asked by either the researcher's or an acquaintance's social and professional 
' 
contacts whether they suffered from chronic low back pain. If they indicated that they 
did, they were asked whether they would be willing to participate in an experiment 
looking at malingering and back pain. An interview time was then scheduled that was 
convenient for them. They were then asked to indicate whether they had prior litigation 
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experience when the definition was explained to them. As with former pain clinic clients, 
it was stressed that if they intended to litigate, it was probably not appropriate for them to 
participate due to the nature of the experiment (malingering). At this point their name 
was passed on to the third party and placed in the appropriate category (litigating, non-
litigating). An envelope containing a direction to either malinger or not malinger was 
placed in an envelope marked with their name by the third party. This envelope was 
taken by the researcher to the interview in addition to five numeric rating scales for 5 
days, an MDS, and an informed consent form. 
Prior to the interview the researcher asked the participant to read and complete the 
informed consent form. Participants could ask any questions about the research other 
than those that might affect the outcome of the experiment. Next participants were asked 
to open the envelope and read the instructions/directions to malinger or not malinger 
without the researcher being able to see which set of instructions was being read. After 
this, they placed the direction underneath their seat. They were asked if they understood 
the instructions and the fact that this was an insurance assessment interview. All 
answered in the affirmative. They were asked to complete the 5 numeric rating scales 
over the next 5 days with reference to the direction they were given. The interview then 
began. 
The interview 
The interviews were identical for all participants. They were generally conducted at the 
participant's home or workplace. This was done for two reasons. The first being that as 
many were in chronic pain, the necessity and cost of taking transport to participate in the 
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study, seemed unfair and potentially unethical. The second being that in some cases, an 
insurance assessor may come to the home and certainly workplace to discuss the claim, 
and make certain decisions based on what he/she perceives to be occurring. Hence the 
use of the home or workplace rather than a more formal environment seemed appropriate. 
After introductions, it was made certain that the informed consent form was signed 
correctly and that the participant was aware of the ramifications of this. Participants were 
asked again, regardless of their sample group whether they understood the directions to 
either malinger or not malinger. 
The interview generally lasted 20 minutes, with both parties sitting facing each other. The 
participant was asked a series of questions from the MDS, and if necessary clarification 
was requested. Out of the view of the participant the researcher marked 1 or 0 beside 
each behaviour (1 =behaviour exhibited, 0 =behaviour not exhibited). At the 
completion of the interview, the participant was asked to return to the examiner the five 
Numeric Rating Scales for pain severity within 10 days of the interview. In some cases 
an addressed envelope was given to the participant. In most cases the NRS forms were 
left at a mutually agreed place i.e. front desk, researcher's workplace, with acquaintance. 
At this point the researcher asked the participants if they had any questions about the 
study. These were answered in as much detail as possible. The interviewee was thanked 
for his time and told that a summary sheet would be available if he wished to receive one. 
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In this case, his address would be kept, until the results were completed after which they 
would be posted to him, and then his address would be destroyed. 
Concluding the collection of" data 
When the required number of interviews were completed, there were four cells with 8 
participants in each. These cells are: former litigating participants directed to malinger, 
former litigating participants directed to not malinger, non-litigating participants directed 
to malinger and non-litigating participants directed to not malinger. This gives a total of 
32 participants. The third party notified the researcher when this condition was met and 
the interviews stopped. Possible participants in each sample who had agreed to 
participate were thanked for their preparedness to be part of the study. 
The data were analysed using SPSS 7.5. 
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Results 
The data were analysed in three different ways and are reported in three sections. The 
first assesses the stated hypotheses while the second assesses any possible interaction 
effects through multivaritate analyses. The third assesses the effect of different methods 
of generating participants and the effect this may have had on their subsequent MDS and 
reported pain scores. The third level of analysis was necessary to judge the impact of the 
convenience sample. 
Where results for pain measures were missing (n=2), these were coded as missing. This 
occurred for one member of the malingering group and one member from the non-
malingering group. 
Hypotheses 
The six hypotheses were assessed using a variety of statistical measures such as t-tests, 
chi squares and general descriptive measures. These low level analyses are used because 
the relative! y low number of participants in this study would violate the assumption of 
homogeneity if multivariate analysis rather than a series oft-tests were completed. 
Despite this, an analysis using an AN OVA procedure was completed for future research 
possibilities, which is in line with Tabachinick' and Fidell's (1996) assertion that 
multivariate analyses are with less than participants is non random samples does not 
necessarily violate homogeniatity .. This is presented in the second area of the results 
section. 
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Hypothesis 1 which stated that the MDS scores would be significantly higher for those 
participants directed to malinger than for those who are directed to be genuine, was tested 
using a t-test. There was a significant difference on a two tailed test (.035, p<.05) 
between those asked to malingerer (M = 7.37, SD = 3.09) and those asked to be as honest 
as possible (M = 5.31, SD = 2.08). As hypothesised those asked to malinger had 
significantly higher scores on the MDS. 
Hypothesis 2 which stated that the MDS score criterion for malingering (if a participant 
scored over 7.6 he was considered to be malingering) would distinguish between 
participants directed to malinger, and those directed to be genuine was tested using a chi-
square procedure. Participants were classified as malingering (above 7.6 on the MDS 
score) or not malingering (below) and this was compared with the instructions to 
malinger or not malinger. A chi square was applied to the data to test the confidence with 
which the MDS could be used to distinguish between those attempting to malinger and 
those not. 
Table 1 
MDS designation of malingering/not malingering when compared to the direction to 
malinger or not malinger (2 * 2 table) 
Directed to be honest Directed to malinger 
MDS Score - Not 15 9 
Malingering 
MDS Score- 1 7 
Malingering 
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A goodness of fit test with d.f. = 1 gave a result of 5.12 which gives a significant positive 
result (.025, p<.05). This result indicates that there is a significant fit between the 
expected results of J 6 true positives and 16 true negatives compared to the results 
presented in table 1. The reason for this significant result is found in the correct 
classification rates. The correct classification rates for Table 1 are a true positive rate of 
approximately 44% and a true negative rate of 94%. The false negative rate is 60% while 
the false positive rate is approximately 6%: Clearly the significant goodness of fit is due 
to the exceptionally high level of accurate classification of those participants asked not to 
malinger. In fact the correct classification rate for those asked to malinger is less than 
chance (44%). Minium, King and Bear (1993) suggest that when results are discrete (1 or 
0) and the degree of freedom is 1 it is feasible to complete a one-tailed ANOV A. Despite 
the low participant numbers this was completed and found a significant result (.013, 
p<.05) in the between groups measure. 
Hypothesis 3 predicts that the items of the MDS that will significantly differentiate those 
directed to malinger from those directed to be genuine will be those focussing on severity 
of injury rather than description of injury (items 4 and 5) and on the motivations for the 
gain with the pain (part 2: items 27, 28, and 29). Due to the low number of participants it 
is not feasible to complete a data reduction technique such as factor analysis and 
therefore a descriptive form (graph) will be generated to show differences between those 
directed to malinger and those directed to be as honest as possible. Each behaviour, as 
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defined by the 29 behaviours in the MDS, is given either 1 or 0 by the researcher for each 
participant. In the case of figure 1 the behaviours endorsed (given a 1) by the researcher 
for each participants are displayed for both those asked to malinger and those asked to be 
genuine. 
Figure 1 
Number of participants directed to malinger compared to those directed to not malinger 
endorsed for each MDS item 
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From this table it becomes clear that certain behaviours identified by the MDS were 
exhibited for those asked to malinger more so than those asked not to. In addition, 
certain behaviours noted by the MDS as indicative of malingering are endorsed for those 
asked to be genuine at higher rates than those asked to malinger. 
An examination of the different behaviours was completed utilising an arbitrary figure of 
4 (or more) participants to separate the two groups for each MDS behaviour. Using this 
arbitrary criteria an examination of the items where at least 4 more participants directed 
to malinger than those asked directed to be honest exhibited the behaviour indicated by 
the MDS item. These MDS items were: 1, 4, 5, 11, 12, 13 and 18. Those directed to be 
honest had items 7 and 9 endorsed for 4 or more participants (asked not to malinger) 
more than those directed to malinger. These items will not be described in detail on the 
basis of comments by Ben-Porath (1994) and Berry et al. (1994) regarding the ethical 
danger of publishing details of malingering detection techniques. This will be discussed 
in more detail in the discussion. 
[/ems endorsed j(n· more ( = >4) participants directed to malinger than not: 
Item 1 related to the feelings associated with being assessed for pain, and that generally 
they were not very positive about it. 
Item 4 is the use of severity to describe the pain rather than an actual description of the 
pam. 
Item 5 is the catastrophising by the participants of the effect that the pain has had on your 
life. The participant is asked whether they can think of an achievement they have had 
since they have had the pain. 
Item 11 represents the extreme percentages given when a participant is asked for a 
percentage of normal behaviour that they can no longer do solely because of the pain, and 
what new skills they have attempted to learn to compensate for abilities lost due to the 
pain. 
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Item 12 is a negative comment by the participant when he is asked whether he will be 
able to learn new skills. 
Item 13 relates to the negative comments made about medical practitioners with regards 
to their treatment methods and general attitude towards the problem. 
Item 18 represents the overstating of the examiner's ability to help the problem or to 
intervene in the issue. 
Items endorsed for more (=>4) participants directed to be honest rather than malinger: 
Item 7 would ask for other explanations for why the pain might exist. To be endorsed 
this was answered in the affirmative. 
Item 9 asked for any voluntary behaviour that might exacerbate the pain. 
If more participants were available a factor analysis could have been completed giving 
more statistically pertinent results. 
Hypothesis 4 predicts that there will be a significant correlation between MDS scores and 
the level of pain intensity as assessed by the numeric rating scale (NRS). A bivariate 
correlation was completed and found that there was no significant relationship between 
the average level of pain and the score on the MDS using a Pearson Product Moment test 
(r = .253). On the basis of this result a further analysis was completed when the MDS 
labels a participant as a malinger. Using at-test on the pain average it will be assessed 
whether those labelled by the test as malingerers reported significantly higher levels of 
pain than those labelled non-malingerers. The major issue with this test is the disparate 
numbers of those labelled as malingerers (8) compared to those labelled non-malingerers 
(24). This assessment found that those labelled by the MDS to be malingering reported 
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significantly (.20, p<.05) higher levels of pain on a two tailed test than those asked not to 
malinger. The respective pain averages were 21.3 (SD = 14.3) and 35.6 (SD = 9.5). 
This does not necessarily answer the question regarding malingering per se, and so a 
further analysis was conducted using at-test of the pain averages of participants asked to 
malinger and those who were asked to be as honest. There was a significant difference 
(.00, p<.05) between the mean reported level of pain for those asked to malinger (M = 
35.08, SD = 8.3) and those asked to not malinger (M = 14.2, SD = 11.7). The respective 
standard deviations were not wide enough to explain these results with the standard 
deviation for both groups within 3 increments on the pain scale of each other. When 
looking at differences in malingering this appears to be a stronger result than when 
participants are labelled malingerers by the MDS. The reason being that the groups are 
equal and the difference between the two groups is greater than that for people designated 
by the MDS to be malingering or non-malingering. 
Hypothesis 5 seeks to assess whether the experience of prior litigation will effect 
participants' MDS scores by raising them significantly compared to those not previously 
involved in litigation and regardless of whether they were asked to malinger or be honest. 
A !-test was completed to assess the differences between former litigants and non-
litigants on scores on the MDS however no significant result was found (.578, p<.05). 
This suggests that the experience of formerly having litigated did not appear to affect a 
participant's score on the MDS. It is interesting to note that the average MDS mean score 
was actually slightly higher for the participants who had not been previously involved in 
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litigation (M = 6.62, SD = 2.6) compared to those who previously did have litigation 
experience (M = 6.06, SD = 2.9). Therefore the hypothesis is rejected and the null 
hypothesis is accepted that prior litigation does not appear to impact on MDS scores. 
The final hypothesis predicts that participants who were previously involved in litigation 
will show significantly higher levels of reported pain regardless of orientation 
(malingering/non-malingering) compared to those who have not previously been involved 
in litigation. A !-test was completed to assess whether litigation made a difference to the 
level of reported pain and was found to be non-significant (.6, p<.OS). Interestingly, for 
reported pain former litigants did report marginally more pain (M = 26.78, SD = 13.8) 
than participants without any previous litigation (M = 23.91, SD = 15.2). In both cases 
the standard deviation was relatively high (-14). This suggests that litigation is not 
necessarily indicative of higher levels of pain and given the large variance in the standard 
deviation clearly indicates that people respond in different ways suggesting that no direct 
causal attributions can be made to litigation regarding pain or MDS scores. 
Finally, an analysis was completed to assess whether there was a relationship between the 
age of participants and their respective scores on the MDS or the pain rating scale. This 
was not hypothesised however some authors (Hall & Pritchard, 1996) have indicated that 
there may be some relationship between malingering and age while others have found no 
relationship (Mendelson, 1987). A bivariate correlation was completed. The MDS 
scores did not have a significant relationship with age (.447, 2-tailed Pearson product 
moment correlation). The reported pain intensity scores were also not significantly 
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correlated with age (.223, 2-tailed Pearson product moment correlation). Age of 
participants does not appear to affect either score. 
Multivariate Analyses 
Two 2-way ANOV As were completed to assess for any interaction effects that may occur 
between the direction to malinger and former litigation. While some authors have 
indicated that the size of the current sample is not large enough to support the 
homogeneity of variance required for an ANOVA as previously mentioned Tabachinick 
and Fidell 's (1996) indicated that this was not necessarily the case. It was considered 
that for future research it was important to assess the possibility of such an interaction 
existing for either MDS scores or reported pain. An AN OVA table will be used to 
demonstrate the calculations. 
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Table 2 
AN OVA table for MDS scores with litigation (former litigant/non litigant) and 
malingering (asked to malinger/not malinger) conditions 
Process Effect Sum of Mean F Sig. 
Squares Square 
Main Combined 36.5 18.2 2.5 .098 
Effects 
Malinger 34 34 4.6 .039 * 
Litigation 2.5 2.5 .349 .559 
2Way Malinger 3.7 3.7 .552 .476 
Interact * 
Litigation 
Model 40.3 13.448 1.856 .16 
Residual 202.8 7.246 
Total 243.2 7.8 
The results of this clearly indicate there is no interaction occurring, only a main effect for 
individuals asked to malinger(*), as was indicated by the Hest (0.039, p<.05). 
A second ANOV A was completed to assess for an interaction effect of malingering and 
former litigation on reported pain. 
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Table 3 
ANOV A table for NRS scores of pain intensity with litigation (former litigant/non 
litigant) and malingering (asked to malinger/not malinger) conditions 
Process Effect Sum of Mean F Sig. 
Squares Square 
Main Combined 3319.6 1659.8 15.8 .00 
Effects 
Malinger 3199.12 3199.12 30.47 .00. 
Litigation 120.48 120.48 1.148 .294 
2 Way Malinger 50.996 50.996 .489 .492 
Interact * 
Litigation 
Model 3439.2 1146.4 10.9 0 
Residue 2729.6 104.9 
Total 6168.8 212.7 
This table, too indicates that there is no main effect between litigation and malingering. 
There is, as the t-test indicated a main effect(*) only for those asked to malinger (0.00, 
p<0.05). 
Overall these results suggest that litigation does not have an impact on either scores on a 
malingering scale or on reported pain. 
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The effect of drawing participants (men with chronic low back pain) from a variety of 
populations 
To test the possible effect of the sampling a comparison of each group was made on both 
measures. This was done by averaging the results within each group, and not 
withstanding the different sized groups or roles (former litigant or malinger/non-
malinger) a perspective can be gained of possible discrepancies on the basis of the 
population from which the participants were drawn. 
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Table 4 
Summary table showing the number of participants. average NRS pain intensity and 
average MDS score for each condition drawn from each of the sample groups 
Sample Condition Number NRS pain level MDS score 
Former Pain Litigant/Mal 3 37.73 4 
Clinic Client 
NonLit/Mal 1 42 7 
Lit/Nmal 1 26.4 3 
NonLit/Nmal 
Police Sample Litigant/Mal 3 26.7 9 
Non Lit/Mal 5 30.24 8 
Lit/Nmal 5 18.95 4.4 
NonLit/Nmal 
Community Litigant/Mal 2 45.1 7.5 
Sample 
NonLit/Mal 2 41 8.5 
Lit/Nmal 2 11 9 
c 
NonLit/Nmal 8 11.11 5.25 
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While direct comparison is difficult given the different sample sizes and the disparity 
between the conditions it is clear that there may be some problems with deriving some 
conclusions from this research. As the numbers and conditions of participants were not 
controlled by population but rather by what was available some issues may arise which 
will be discussed later. Clearly, there is substantial difference between the groups 
however no one group appears to have altered the results of either the MDS or NRS pain 
scores in any demonstrable way. The lack of participants from each sample present in 
each condition makes conclusions difficult to draw regarding the conditions especially in 
the case of non-litigating and malingering where only the participants drawn from the 
community sample were used. 
If the premise is supported that the use of different populations to draw the sample from 
has an effect on the scores then this is clearly a problem however there appears to be a 
wide range of responses, which is to be expected. As the goal of the experiment was 
never to assess sample against sample, but rather chronic pain patients as a single group, 
this breakdown was necessary only for the purpose of validation due to the change in 
design. Indeed most experiments with pain patients (former or current) do not examine 
the background of their patients this closely, especially when they have all come through 
a pain clinic. 
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Discussion 
The results of this research through attempting to validate this assessment instrument 
have, in some senses, generated more questions than they answer, which leaves fertile 
areas for further research. There are some methodological deficits, however this research 
has avoided most of the pitfalls of previous malingering research as suggested by Rogers 
(1997). In fact, using the approach of all participants having suffered and therefore 
having some knowledge and experience of the condition they are supposed to be 
malingering, appears to be an excellent method of conducting research into malingering. 
Some of theories propounded by the authors of the scale, the authors of the OSM lV and 
clinicians in general, such as litigation being a significant correlate to malingering, have 
not been supported by this research. 
Overall while the MOS did appear to be able to discriminate between males suffering 
chronic low back pain asked to malinger and those not attempting to malinger, there were 
problems in the design involving severity of injury and sampling issues that prohibit 
anything more than tentative support for the continuing use of the MOS. Specifically, the 
fact that some items on the MOS, presumably designed to assess malingering, were 
endorsed at much higher rates for those asked not to malinger raises particular issues for 
some of the bases of the MOS. In addition, the scale does not appear to be useful at all 
for detecting malingering as the name suggests but rather detecting those who are not 
malingering. In this sense it is more useful as a broad screening tool, than providing any 
form of diagnostic clarity. Clearly, much more research is needed with this tool, with a 
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variety of populations and under very strictly controlled experimental conditions, before 
it can be considered valid in any scientifically valid sense. 
This chapter will address the hypotheses in the light of the results, methodological issues 
encompassing conceptual and procedural issues arising from the study, implications of 
the study, future research, and the conclusions that can be drawn from the study. Some of 
the issues regarding the validity of assessing for malingering that were discussed in the 
introduction are highlighted by the results of the validation of the MDS. These will be 
canvassed as they arise. 
Hypotheses 
Three out of the six hypotheses appear to be supported. 
First Hypothesis 
The first hypothesis was supported as those men asked to malinger obtained significantly 
higher scores on the MDS; higher scores being indicative of malingering according to the 
system for scoring the MDS. Based on the results, the only reason for this higher score is 
due to this group of participants trying to malinger. Another explanation could also be an 
effect of the instructional set for malingering, therefore more research is needed that uses 
different sets before it can be ascertained whaf exactly the MDS is finding. 
Second Hypothesis 
The second hypothesis supported the effectiveness of the criterion for malingering (MDS 
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score of 7.6 and above) established by Calion, Jones, Barkemeyer and Brantley (1989). 
The results found that the MDS could discriminate, to a significant level, between those 
attempting to malinger and those who are not. This result is deceptive because it appears 
that the scale was capable of pinpointing those who were asked to malinger, on closer 
examination of hit rates, it becomes clear that the hit rate for labelling a malinger 
accurately (true positive rate) was less than which would be achieved by chance. Instead 
it is the true negative rate that clearly caused any significant relationship in which those 
asked to be as honest as possible were correctly labelled close to 94% of the time. 
The usefulness of this result over a true positive rate is important to recognise, for as 
Mendelson and Mendelson (1993) observed malingering is not a diagnosis but rather it 
represents a legal term. So a diagnosis cannot be substituted by malingering as an 
alternative diagnosis. To further this logic when a diagnosis already exists, in this case a 
high level of chronic low back pain, malingering may negate or lower the credibility of a 
diagnosis but it cannot replace it. 
If a participant's honesty or 'lack of malingering' can be substantiated then the original 
diagnosis can be maintained. So patients complaining of chronic pain can have their 
honesty regarding their chronic pain assessed and if their scores do not place them in the 
malingering category then the diagnosis should remain. However, if patients return 
MDS scores that place them in the malingering category, under the present results, it is 
not possible to label them a malingerer with any degree of certainty (under chance). 
Instead, it can be said that his/her results arc inconclusive and more collateral evidence is 
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required. In many senses the ability of any scale to conclusively label an individual a 
malingerer, given its legal definition, is highly suspect. Only comments stating his/her 
presentation is inconsistent with present diagnosis or complaint can be made with any 
degree of authority. 
This logic is contrary to the American court decision of Boyd v General Industries (as 
cited in Hall and Pritchard, 1996) in which the court conceded that the employee was 
malingering her back injury but that the company would have to pay for her to be treated 
for the problems causing her malingering. In this case malingering effectively replaced 
the diagnosis because the court reasoned that because malingering was present there must 
be psychological problems which needed to be 'treated'. The company defending the 
case was responsible for that treatment. 
Third Hypothesis 
It is with the third hypothesis that many of the strengths and flaws of the MDS come to 
light. This hypothesis was only partially supported. Certainly as hypothesised from the 
comments and results from studies by Leavitt and Sweet (1986), Leavitt (1991), Clayer et 
al. (1984), Hall and Pritchard (1996) and Rogers (1997) it did appear that individuals who 
were attempting to malinger did show a tendency to focus on severity rather than 
description of the pain and tended to catastrophise the effect of the pain on their life 
(Items 4 and5). However, to give a definitive diagnosis of malingering and separate it 
from abnormal illness behaviour, it was hypothesised that the participants asked to 
malinger would have behaviours from part 2 endorsed. These behaviours involve 
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admissions of intent or possible motives for exaggerating pain. Tbis was not supported 
with an equal number of participants from each condition having this behaviour endorsed 
for them. 
Six MDS items were endorsed more for those asked to malinger than those asked to be 
honest, two items were endorsed more for those asked to be honest than those asked to 
malinger and one item was endorsed for both groups at an equal level (See Figure 1 ). 
These differences were not hypothesised, however it is important to examine these 
differences as it gives greater insight into the validity of the MDS. The decision to focus 
on specific MDS items was made on an arbitrary basis by counting the number of 
participants from malingering or non-malingering groups that each item was endorsed 
for. Basically when an item was endorsed for 4 more participants in one group than the 
other, it was commented on. This approach was used due to low participant numbers and 
the subsequent inability to use data reduction techniques, that would have given 
statistically sound arbitration points, such as factor analysis. Before an examination of 
the items is made, it is important to recognise that the major strength of the methodology 
employed in this study, is that as all participants have suffered chronic low back pain at 
some time. This means that the cognitions that might be attributed to only chronic low 
back pain sufferers cannot be used to explain the item endorsement. 
llems endorsed more for those asked to malinger than those asked to be honest 
The items that were endorsed more for those asked to malinger will be examined first and 
possible reasons for this result will be given. The first item on the MDS (Item 1) was 
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endorsed much more frequently for those asked to malinger and related to negative 
feelings associated with being assessed for their pain. While not hypothesised, the high 
level of endorsement of this item for those asked to malinger is in agreement with 
research conducted by Peck, Fordyce and Black (1979) in their discussion of behaviours 
commonly shown by individuals suspected of malingering. 
The endorsement of item 11 was also not hypothesised but certainly contributed to the 
significantly higher scores on the MDS for those asked to malinger than those asked to be 
honest. This item involves an extreme percentage being given by participants when 
asked what effect the pain has had in their life. An extreme result was generally 
interpreted as 50% or greater which is clearly related to the catastrophising and overt 
focus on the impact of the pain that items 4 and 5 assessed. The difficulty was that some 
participants were clearly more injured than others. For example in several of the former 
pain clinic clients, they were clearly relatively disabled compared to other chronic low 
back pain sufferers. 
An interesting item that goes towards assessing motivation is item 12 in which the 
participant gives a negative comment when asked whether he will be able to learn new 
skills and that he has not been trained in other areas. On one level this does appear to 
indicate a disinterest in returning to former function and placing this responsibility on to 
external factors which 'should' provide training; which some participants appeared to use 
as a general approach to malingering. Another explanation can be derived from the 
context in which the question is asked. This question follows on from an estimate of the 
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percentage of behaviour that the participant can longer participate in solely due to his 
pain, which would clearly impact on this question. It is not unreasonable to suggest that a 
patient would be experiencing significant depression due to his chronic low back pain 
(Mendelson, 1984a). The negative response that the MDS suggests is indicative of 
malingering, could also represent depression. 
The response to item 13 that separated those asked to malinger and those being honest 
occurred when participants expressed very negative comments about medical staff whom 
they had contact with regarding their pain.· While not an explanation for why those asked 
to malinger were endorsed for this item, there is some evidence that often the medical 
fraternity does not effectively treat low back pain. A survey of 1200 physicians by 
Cherkin, De yo, Wheeler and Ciol ( 1995) found that while there was some consensus on 
some techniques of treating chronic low back pain there was considerable disparity in 
results. In addition, very few were recommending treatment that recent research has 
confirmed as particularly effective suggesting that many physicians are simply not 
specialised enough to provide treatment for their patients' chronic low back pain. It is 
possible that those asked to malinger chose to focus on the negative experiences as a 
method of discrediting further attempts by medical staff to assess their pain. 
Finally, item 18 related to those asked to malinger, attempting to overstate the ability of 
the examiner (researcher) to intervene on their behalf. This may well be a form of 
manipulation on the part of the person playing the role of the malingerer as Barkemeyer 
et al. (1989) suggest. He makes the assumption that genuine pain patients are sure that 
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their pain will gain them the compensation, and regardless of who the insurance assessor 
is, the truth of their claim will be won out. Malingerers are not as confident according to 
Barkemeyer et al. (1989). Given this, if an individual is not as confident about his claim, 
then he would probably tend to assume that if he could convince this one person from the 
assessing body then he might be able to convince the entire body. It is difficult to explain 
why this result appeared to as to differentiate between participants asked to malinger and 
those who were asked to be honest, especially when there is prior experience of litigation. 
It may be due to the experimental design, where a participant, especially one with little 
knowledge of the insurance industry would assume that if they are told to malinger to the 
examiner for external gain, then by implication the examiner must have some power in 
the final decision for compensation. 
Items endorsed more for those asked to he honest than those asked to malinger 
There is some concern with the items that differentiated those asked to malinger and 
those being honest with the latter group being endorsed more frequently for the 
supposedly malingering behaviour than those asked to malinger. This suggests that the 
item may be measuring something other than malingering. This is of considerable 
concern as it could lead to false diagnosis, and it does suggest that this scale is not 
effective in some areas of assessment for chronic low back pain. This occurred with two 
items; 7 and 9. 
Item 7 asked participants whether there were other explanations as to why the pain 
existed and closely looked at whether there was a cause and effect relationship. While not 
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apparent from the results there were several instances where the assumed aetiology of 
accident or disease was simply not applicable and therefore, using the MDS criteria, 
brings the client into suspicion. For example some individuals, even those being honest, 
discussed different aetiologies for their pain, some of which were seemingly harmless i.e. 
leaning through a car window, picking up a can of soft drink, turning over in bed. In 
these cases the requirement for a specific cause and effect, is not fulfilled because it is not 
unreasonable for the body to be able to perform the behaviour. In this sense the scale's 
inadequacy was highlighted by the complete lack of causality sometimes in chronic low 
back pain (FraudWatch, 1997). This item,.more than any other demonstrated the 
importance of knowing about the condition that is supposedly being feigned rather than 
having a strong understanding of malingering in general. In this instance the MDS is 
perhaps not an appropriate tool for use with this condition. 
Interestingly, item 9 related to individuals who voluntarily engaged in behaviour that they 
knew would exacerbate the pain but were still prepared to engage in this behaviour. The 
reasons for this varied from work to sport, however what became clear during the 
interviews was that often people engaged in such behaviour to retain their self respect. ln 
addition, what constituted a behaviour that would cause pain was strongly related to the 
level of disability. One participant indicated that making a cup of tea caused him pain, 
but he was prepared to go through pain to gain his stated goal. In contrast, participants 
asked to malinger, may well have considered this question with some suspicion, and 
deliberately answered in the negative, however there is no evidence to support this. 
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Items where the level of endorsement was the same for both groups 
Item LO called for several pain or numbness conditions physiologically unrelated to low 
back pain to be suggested to participants as possible symptoms to test whether they 
would falsely endorse symptoms. These were endorsed for both groups in equal levels. 
Why this is important is that it is a technique that is widely used by medical practitioners 
according to Cunni en (1997) and Hall and Pritchard (1996). This result, rather than 
supporting this approach, suggests that it is problematic to suggest false symptoms to 
individuals as a method of differentiating participants exaggerating their level of pain. 
This is possible as the effect of chronic low back is so global (Mendelson, 1984a). This is 
perhaps a more valid technique when assessing for malingered mental disorders, where 
there is less awareness of symptomology in the community. Pain, as Lees-Haley (1986) 
suggested, especially back pain, is widely experienced in the community (Haldeman, 
1996) making its symptomology easier for malingerers to describe accurately. 
Item endorsement in this study compared to prior research 
The items endorsed on the MDS can be compared to the self reported items used in 
Clayer et al. (1984), a study which also used a simulation design. There were three main 
differences: the pain syndrome was not specified, individuals asked to malinger were not 
asked their experience of chronic pain in the past and the items were derived from a 
questionnaire designed to assess abnormal ilhiess behaviour rather than malingering. 
There appears to be a focus on catastrophising and severity rather than description of 
symptoms in the results of the current study, which does support Clayer et al.'s (1984) 
findings. In addition, the distrust or dislike of the medical community was also apparent 
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in the results of the current study, which supports some of Clayer et al.'s (1984) findings. 
This suggests that certain factors may be present, which when asked to malinger, even 
those with the experience of chronic pain, will still over-exaggerate to a significant level 
rather than rely on subtlety. This was despite a warning in the instructions, to attempt to 
be as subtle as possible. 
Hypothesis 4 
This hypothesis was not supported as the level of self reported pain was not significantly 
correlated with scores on the MOS. Participants who were labelled as malingering by the 
MDS had significantly higher levels of reported pain than those who were not labelled as 
malingering. This was confounded by the disparity in participants found to be 
malingering (n=8) compared to those labelled as not malingering (n=24). In addition, 
those asked to malinger had significantly higher levels of pain than those asked to be 
honest. Overall, these results suggest that, to an extent, there is a relationship between 
reported pain and MDS scores, however with generally low MDS scores, this relationship 
is not visible. Future research may be able to investigate this relationship further by not 
asking pain patients to malinger, but rather asking all participants to be as honest as 
possible. This may be feasible, once it can be conclusively shown the MDS can 
differentiate between those asked to malinger and those asked to be honest, which this 
study does suggest may be the case. 
Hypotheses 5 and 6 
Both hypotheses 5 and 6 were positive despite the research to the contrary as clinicians 
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appeared to consider that litigation was indicative of malingering (Leavitt & Sweet, 
1987). Each hypothesis respectively tested whether former litigants likely to have similar 
scores on the MDS and levels of reported pain compared to non-litigants. As a collorary 
to this an ANOV A was completed to assess any interaction effects between direction to 
malinger and former litigation regarding both reported pain and scores on the MDS. The 
MDS scores were not significantly different for former litigants and non-litigants, which 
supports Mendelson's (1987) evaluation of the Conscious Exaggeration scale, as finding 
no difference between former litigants and non-litigants. Both litigants and non-litigants 
reported similar levels of pain which supports Mendelson's (1984a) findings. If 
anything, there was a non-significant trend of non-litigants giving higher reported pain 
scores than litigants. Neither AN OVA found any indication of an interaction effect 
hetween litigation and the direction to malinger/not malinger. 
It is important to note that this research specifically asked only men who had completed 
litigation and did not express any desire to reinstate proceedings for their pain. This 
differs from other research which has looked at pain levels before, during and after the 
court case where results may be quite different. So while not the subject of this research, 
this other research has shown that higher pain and anxiety levels have been shown in pain 
patients during the court proceedings and are reduced but not eliminated once the 
litigation is completed (Mendelson, 1992; Suter, 1998). It has been suggested as 
evidence that individuals involved in litigation are more inclined to exaggerate their 
symptoms for the benefit of the court. Both Mendelson (1992) and the promising 
research by Suter (1998) has suggested that the issues pertaining to the court, cause 
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anxiety levels to rise and in turn, this influences the level of pain. Litigation and pain 
does not appear to be causally related despite appearing to have an association from 
which no conclusion can be drawn. 
Methodological Issues 
As was indicated, there are several methodological issues which have made this study 
difficult to generalise widely. These issues can be broken down into conceptual issues 
and procedural issues. Conceptual issues are: the effect on the results of the population 
from which participants are drawn, the lack of genuine financial incentive to malinger, 
the lack of negative incentives that occur through failure and the loose definition of 
litigation. Procedural issues are: changing procedures midway through research, the 
difficulty in maintaining the blind condition of the researcher and participant numbers. It 
should be said that these issues do not affect the data so much as to negate the results of 
the research, that is, that the MDS did differentiate at a significant level between those 
asked to malinger and those asked to be as honest as possible. 
Conceplual Issues 
The primary conceptual issue is the impact of the population from which the participants 
were drawn. When this research was begun, it was not anticipated that there would be as 
many problems gaining participants through th'e pain clinic as was ultimately 
encountered. As a result, virtually no attempt was made to control for any impact made 
by the different populations when dividing individuals into the different cells 
(malinger/litigant, non-malinger/litigant, malinger/non-litigant & non-malinger/non-
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litigant). As a result the unlikely event has occurred where all 8 members of the non-
malinger/non-litigant cell were drawn from the community sample. This is conceptually 
unsound and the very low pain rating compared to other groups does suggest that such a 
difference may have been at least partially due to the population from which the 
participants were drawn. Other participants drawn from this population appear to have 
pain ratings and MDS scores around the same level as those participants from the same 
conditions but drawn from different populations. 
When the MDS scores and reported level of pain by police officers were examined it 
appeared that police were not necessarily more prone to being deceptive than other 
members of the population. It has been suggested by some writers that police, through 
constantly interrogating individuals who often attempt to be deceptive(Trankell as cited 
in Gudjonnson, 1992), probably learn quickly what works and what does not thereby 
making them potentially very effective malingerers. This does not appear to be the case 
with this sample. 
Ideally, if the research had been completed as was originally planned, all the participants 
would have been chronic low back pain patients treated by the same therapist. In this 
sense there would have been more of a chance that the participants were genuine pain 
patients. At the very least they would have already been assessed for treatment purposes 
rather than relying, as the other groups do, on participants' self report. No screening test 
for malingering was made prior to allowing participants into the study, but, as previously 
mentioned, this would have been useful as a known groups design could then have been 
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completed. However, if such a screening tool were available then there would be little 
need for the current research except to assess construct validity. 
There were two obvious differences between the 5 participants in the former pain clinic 
client group and the remainder of the sample: only 2 of the 5 were working full time, and 
3 of them had their lumber spine fused. Clearly this sample had more severe injuries than 
those from the other sample. The usefulness of using extreme injury for a study into 
malingering is questionable. For example in one extreme case one participant asked to 
malinger stated "how could I exaggerate this, how could it be any worse than it already 
is". In this sense, such participants were not necessarily the target group that this 
research sought to examine. When this point is examined from an external validity 
perspective, such participants would automatically be ruled out as malingerers because of 
the willingness to have surgery and clear physiological damage as determined by 
objective imaging instruments. There are exceptions to this, which will be discussed 
later. 
Overall, it must be said that the approach taken towards the sampling focussed on gaining 
participants who fitted the criteria, and less attention was paid to where the population 
came from provided they were male, suffered low back pain and had either had been 
involved in litigation or had not. It did happen that due to the groups of police used 
(traffic branch) many of the participants had been involved in compensation for vehicle 
accidents whilst working. This lead to requiring more members of the community 
sample who did not have a history of litigation to be used, thus in one cell only 
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participants drawn from that group were included. It is interesting to note that the 
Western Australian Police Service does not have any workers compensation 
requirements, making vehicle accidents the only area where any form of compensation 
will be paid. This may have altered the results, but there seems to be little evidence of 
this in the results as they have heen analysed. 
The commentary by Rogers (1997) and Rogers and Cruise (1998) regarding the need for 
incentives (hath positive and negative) in malingering research is well taken. The 
original design did incorporate some paym'ent for participation, but differential payment 
for participants based on performance was deemed not acceptable by the ethics 
committee at Edith Cowan University, Certainly any attempt to implement the negative 
incentives that Rogers and Cruise (1998) suggested would be met by similar refusals. 
Rogers and Cruise ( 1996) indicate that there are negative consequences for being 
'discovered' exaggerating. Indeed, workers' compensation legislation in Western 
Australia and Queensland both mention fraud or malingering as criminal offences under 
the Act. However I would suggest that proving malingering, just utilising psychological 
assessment would be very difficult when there are terms such as 'compensation neurosis' 
and functional overlay that virtually allow you to have another illness (Main & 
Spanswick, 1995) as opposed to your original diagnosis. The decision in Boyd v General 
Industries (as cited in Hall & Pritchard, I 996) seems to indicate that an American court 
had a similar opinion. 
Regarding incentives to malinger, the present study, appeared to rely on 'dupers delight', 
Validation of the MDS 110 
a term coined by Ekman (as cited in Hall & Pritchard, 1996), to describe a sense of 
achievement through 'tricking' an evaluator/evaluation. When the reasons for the 
experiment were explained, the participants who had been given instructions to malinger, 
often expressed an interest in 'how they went' and would jokingly ask how much they 
could expect to get. With some men they expressed a sense of relief about being asked to 
exaggerate, as often they had to be so careful and und~rrate their pain when being 
assessed, for fear of being called a malingerer. These observations were made by the 
author and have not been recorded in the data. 
The definition of litigation was problematic, partly due to the presence of a 'no fault' 
system (workers compensation & vehicle accidents) in place in which non-pecuniary 
damages are not accepted, and this may have negated some of the original assumptions 
regarding malingering, chronic pain and litigation. There were no participants with a 
common law claim, although some participants went through substantial legal wrangling 
with the insurance company before receiving any compensation. Guest and Drummond 
(1992) have found that there is little difference between the two groups on most 
measures, after the litigation has ceased, which is certainly the case with this study. 
When this research started it was assumed that more participants would be involved in 
common law claims rather just receiving treatment, lost wages and rehabilitation through 
an insurer. 
Part of the impetus of this research was to assess the potential impact of lawyers in 
personal injury claims. Whether intentionally or not, lawyers might encourage their 
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clients to exaggerate their pain in order to gain more compensation. Indeed with the 
advent of contingency fee work for lawyers beginning now in Australia, the potential for 
this sort of behaviour is even greater. Kennedy's (as cited by Mendelson, 1992) 
comments where compensation neurosis is 'stimulated' by lawyers, are probably partially 
responsible for this perspective. 
Under 'no fault' systems, unless the claim is disputed there is often little need for a 
lawyer. Indeed, many of the participants who had involvement with lawyers in their 
litigation expressed considerable disappointment towards both the legal system and the 
lawyer who represented them. This makes conspiracy theories about collusion between 
the lawyer and participant to defraud the insurance company or defendant much less 
likely than was originally thought might happen. To conclude, despite following 
Mendelson's (1987) criteria for litigants this definition of litigation was probably too 
loose, given the objectives of study, and therefore the result of having no effect on either 
levels of pain or scores on the MDS is not surprising. Similar research in a country such 
as America where the society is more litigious, and therefore there are more common law 
claims, may find an effect using the same experimental paradigm. 
The definition of litigation included any personal injury litigation in which a physical 
injury was sustained and duly compensated. J! did not have to be directly related to the 
back injury. At the same time it had to be a personal experience in litigation for an injury 
in the past so a participant could have been a lawyer who specialised in personal injury or 
an insurance assessor, however if they had no prior experience as a plan tiff in a personal 
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injury claim, they would not be considered a litigant. Hence it was not legal knowledge 
but personal experience that decided whether a participant was designated a litigant or 
not. This was another area where perhaps the members of the police service, have a 
stronger than average knowledge of the legal service. As was indicated regarding legal 
personnel the police were not automatically used as litigants, unless they had a prior 
personal injury claim that involved a common law claim or compensation for the injuries 
sustained. Finally, as the results indicate, this did not appear to make any difference to 
the results. 
Procedural Issues 
The procedural issues can be broadly defined as issues in the methodology which were 
not planned for, and could be applied to most experimental research. The first issue 
involved changing procedures during the experiment, which was unfortunate but 
unavoidable due to the lack of adequate numbers of participants within the former pain 
clinic client group. The change in populations has already been discussed, however the 
change in format has not been. Essentially the instructions were changed from a letter 
format to a simple instruction sheet; the actual wording of the scenario or instruction was 
not altered in any way. While the instructions to participants were not altered at all, the 
time given to consider possible presentation strategies was substantially reduced; from a 
week down to only several minutes. The behaviour did not appear to change, indeed the 
pain patients often read the instructions for a second time in front of the interviewer, as if 
to remind themselves of their particular orientation. This did not suggest that they were 
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very well prepared for the assessment, at least no better prepared than those who were 
given the same instructions and several minutes to think about them. Unfortunately, as it 
is malingering detection scale that is being validated it is not appropriate to use this 
measure to determine whether a difference was made by the large increase in preparation 
time that the chronic pain patient population had. Certainly, when asked if they 
understood the instructions there did not appear to be any difference between the 
participants drawn from different populations. 
The former point, to an extent, leads to the· second. In the case of the chronic pain patient 
population, as it was clearly some time since they had read the instructions, virtually all 
the participants took the instructions with them to the assessment. This was regardless of 
whether the assessment occurred at their home or place of employment. Similarly, 
having opened the envelope the participants from the other populations would often place 
the instructions to one side and rarely removed them from the table. As the experimenter 
wrote the instructions, by even only briefly viewing the document, it was possible to 
discern which set of instructions the participant had been given. In addition, participants 
would often ask questions about the instructions, and while every attempt was made to 
avoid being told the 'orientation' of the instructions of a particular participant, it is clearly 
difficult not to take this into account. This naturally altered the blind nature of the 
interviewer and therefore reduced the validity of the results; indeed it could be used to 
explain the results completely. No record was kept of the number of times that the 
experimenter was in no doubt of the orientation of the participant, however is was 
probably close to one third of the participants. 
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The issue is not so much whether the participant made the experimenter aware of his 
orientation (malinger/non-malinger) but rather whether this made a difference to the way 
the items were endorsed by the experimenter. In the community and police sample, the 
participants were often assessed one after another with 6 participants tested on one day 
and 4 on several days. This fact alone meant that instructions/directions, by the nature of 
the research, were constantly changing. This made it extremely difficult to attempt to 
remember whether a particular participant was malingering or not. Even within the 
community sample close to one third were·malingering during their interview, making the 
assessment almost automatic, with little regard for the orientation. Indeed the 
experimenter would often give the participant the envelope with instructions, answer as 
few questions about the instructions as possible, and then begin the interview without 
looking at the discarded instructions. Future research should specify clearly ways to keep 
the instructions from the interviewer as much as possible. 
Finally, a substantial methodological issue was the low number of participants. The 
original intention was to have 60 participants, so a two way ANOV A that did not violate 
the homogeneity rule could be completed. This would have very clearly shown any 
relationship between malingering and litigation for both reported pain and scores on the 
MDS. Instead !-tests have been used, and the ANOVA's have been purely exploratory. 
Subsequent research into validating this, or any other tool, should use more participants, 
for no other reason than it would improve external validity. 
Validation of the MDS 115 
Implications of this Research 
This research, due to the relatively low number of participants, will probably only have a 
limited impact on malingering research, however the design considerations and issues 
arising from this study should be heeded by future research. A range of issues have 
arisen such as ethics in malingering research, subjectivity of pain and injury, the 
similarities between other psychological disorders and malingering, the possibility that 
successful malingering is not being detected by any of the scale currently used, and 
finally the most appropriate methods of utilising this scale in the court, given the results 
of the validation process. These issues are discussed in the light of the results of this 
study, and the commentary from other researchers who have studied the different aspects 
of this study. 
Ethical issues in malingering research 
Several authors have commented on the ethical considerations regarding research into 
malingering, especially when it directly reduces the capacity of professionals to 
accurately identify individuals who are malingering. Berry et al. (1994), Rogers (1997) 
and Ben-Porath (1994) have all expressed concerns with indiscriminate publishing of 
information directly related to a specific tool to assess malingering; or information about 
an assessment that allows individuals to perform better or worse than they otherwise 
would. Ben-Porath ( 1994) describes how the MMPl has lost much of its validity, 
especially in regard to the dissimulation scales, due to the widespread publication of 
results of studies. He states that a tension exists between needing to know problems with 
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tests and providing more information to 'coaching staff' for more efficient strategies to 
'beat' tests. Given the focus on litigation and lawyers it must be recognised that lawyers 
are increasingly becoming psychologically aware; in part due to the journals designed for 
both professions and bodies such as the American Academy of Forensic Psychology and 
the Australian and New Zealand Association of Psychologists, Psychiatrists and Lawyers 
(ANZAPPL). 
All of the above authors indicate that experiments involving the coaching of people asked 
to malinger are of the most concern. Rega'rdless, Berry et al. (1994) has suggested that if 
it is accepted that the knowledge of how to successfully 'beat' tests will help malingerers 
then researchers in this area have three options. The first is to suggest that they have no 
ethical responsibility for this and research that will improve the tests should be placed in 
journals as much as possible for peer review. The second option is that the researcher 
assumes total responsibility, publishes few details and indicates in any publication that if 
explicit results are required then he/she can be contacted. This is clearly time consuming 
and will make follow up research more difficult. Finally, the researcher can choose to 
publish the results only in journals that he/she knows will be read primarily by other 
mental health professionals, rather than those from other disciplines. This, they 
suggested, could be only A.PA publications. As Berry et al. (1994) commented it would 
clearly be very difficult to assume that other professions are incapable of reading 
professional journals for mental health professionals. The perspective taken in this 
research is that explicit information will not be given in the body of this work but the 
author is open to sending more details to other mental health professionals. 
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Subjectivity of pain and injury 
The hypothesis stating that the scale could classify to a significant level, those asked to 
malinger from those asked to be honest, was supported by the results. When one looks 
closer at the results of this study, without doubt, there is a much higher level of correct 
classification of participants who were not malingering (94%) rather than those who were 
malingering (44%). Further examination showed that participants not malingering had 
significantly lower levels of reported pain than those asked to malinger. 
The method used by many individuals who were asked to malinger, when asked after the 
assessment, was as Lees-Haley's (1986) suggested, to remember prior extreme 
experience with pain. This was done to focus their comments on the description of the 
pain. For most of the participants the most extreme situation was nerve root pain, in 
which a nerve is trapped between two intevertebral discs. They described lying on the 
ground unable to move, and in total agony. The sensation left when the nerve was 
released. 
This memory of extreme pain and incapacity may have then impacted on other MDS 
items that separated those asked to malinger and those asked to be honest. MDS items 
which involved: description of pain, severity of injury, estimates of percentage function 
lost and the potential to learn new behaviours may have been affected by this experience. 
This is where sampling might have had an effect. A large percentage (62.5%) of those 
who were not asked to malinger were drawn from the community sample. As previously 
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indicated, the method of deciding whether a person was a possible participant in the 
community sample was to ask them whether they had a 'bad back' or had injured their 
back at some time and the resulting pain had lasted for longer than 3 months. There was 
no other objective opinion given on whether a person had previously received an injury. 
This is in contrast to the former pain clinic clients where 4 out of the 5 participants from 
this population were asked to malinger. As was indicated most of this group had 
undergone significant surgery for their pain and some commented that they found it 
difficult to exaggerate their condition as it was already so extreme. Given this distinct 
difference in the experience of pain and the lack of experimental control for the level of 
injury, the reported percentages of behaviour that can no longer be completed were 
naturally very high for those with prior/current experience of severe injury rather than a 
direct attempt to malinger. This is not to say that some of the community sample had not 
experienced significant injury, and been told that surgery should be considered, however 
the pattern was not as common. 
In this sense, what is being suggested is that a 'pain overlay' may be responsible for some 
of the results where participants' different experiences of pain (based on the population 
they were from) influenced their attempts at malingering in addition to a distinct attempt 
to deceive. It should be recognised that when a bivariate correlation was completed on 
malingering and reported pain scores there was not a significant relationship. This result 
indicates that the instruction to malinger, rather than the general response to the MDS is 
more predictive of increased pain. In this sense, the conclusion that must be reached is 
that while the population that the participants are derived from is an important factor, the 
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fact remains that all the participants had suffered from chronic low back pain at some 
time making all of their experience important. 
In other studies looking at methods of measuring malingering in chronic low back pain 
populations this issue has emerged. In Chapman and Erena's (1995) study all those 
participants with chronic low back pain labelled as inconsistent were inpatients rather 
than in the community. Given this, theoretically these participants may be more injured 
than those receiving treatment in the community. Contrary to this suggestion Leavitt 
( 1991) found that those participants who were labelled as malingerers by his low back 
pain simulation scale, on examination, had less tissue pathology yet reported more pain 
than other participants. This appears to vindicate the inclusion in the current study of 
chronic back pain sufferers with severe pathology or those who have undergone surgery 
as neither has a strong impact on specific items used to assess malingering. 
Future research will need to control for the severity of prior injury and utilise patients 
already diagnosed by other professionals for internal validity, similar to Chapman and 
Brena's (1995) research, to ensure that this participants are not malingering already. This, 
in turn, would probably limit the use of severely injured chronic low back pain patients, 
for to have surgery means that an objective measure must have identified a physical 
deficit, which automatically would negate a label of malingering (Barkemeyer et al., 
1989). A design that would eliminate this problem would have two pain groups, one 
suffering more pain than the other to see whether the group with more severe pain 
differed on the MDS from the less severe, and to see how it would compare with a group 
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asked to malinger. In the absence of such a group, it could be hypothesized given the 
current results from hypothesis 4, that a more severe pain group would not necessarily 
have higher MDS scores, in terms of just pain. The MDS places a strong focus on the 
level of disability directly as a result of injury and it is on this basis that those with 
significant injury (not necessarily reflected in pain intensity) would score higher on the 
MDS than the less injured. The problem here is clearly one of definition, because if pain 
is not used, but rather tissue damage, the argument becomes abstract, as definite long 
term tissue damage would probably not attract a label of malingering by definition. 
Overlap o( indicators of malingering with .1ymptoms ofAbnormal Illness Behaviour, 
Functional Overlay and Factious Disorder with Physical Symptoms 
To take the concept of subjectivity and pain further the I ink between abnormal illness 
behaviour, which certainly includes chronic pain, and malingering will be examined. 
This is not a new link. Clayer et at. (1984; Clayer et al., 1986) have examined this 
concept. Abnormal illness behaviour is a defined as 
an inappropriate or maladaptive mode of experiencing, perceiving, evaluating 
or responding to one's own state of health which persists despite the fact that 
a doctor (or other appropriate social agent) has offered an accurate and 
reasonably lucid explanation of the nature of person's health status and the 
appropriate course of management (if any) with the provision of adequate 
opportunity for discussion, clarification and negotiation based on a thorough 
examination of all parameters of functioning: psychological, social and 
biological, and taking into account the individual's age, sex, education and 
socio-cultural background (Pilowsky, 1994, p. 567). 
Essentially the only difference between malingering and abnormal illness behaviour that 
immediately comes to mind is the fact that malingering is very adaptive rather than 
maladaptive; hence the term compensation neurosis or functional overlay is then used. 
Clearly malingering is caught between these two definitions, and there seems to be no 
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way to separate adaptive from maladaptive except when a specific statement of intent to 
take advantage of a situation is made. 
It is important to recognise that the definitions of functional overlay differ somewhat in 
the Australian legal and psychological arena. In Federal Broom Co v Semlitch (1960) 
119CLR626 the term was used to explain why after a woman had been treated for her 
back injury, she then claimed that the injury had aggravated her schizophrenia, and that 
her employer was responsible for this as well. The reason given was that despite the 
schizophrenia being an existing condition under the legislation the employer was also 
responsible when a physical injury lead to a mental injury. In this sense the dormant 
schizophrenia was functionally activated directly as a result of the workplace injury. This 
then 'overlayed' the physical injury and after the physical condition was clear, the 
schizophrenic condition remained. This case is commonly cited in Australian law as an 
example of functional overlay. 
Main and Spanswick (1995) suggested that "the term function overlay as frequently 
found in medicolegal reports is unhelpful and frankly at times misleading" (p. 750). 
They indicate that it is used generally to indicate a 'non-organic' aspect of the his/her 
presentation of the client's signs and symptoms. Frequently it is made in the absence of 
physical findings considered adequate to explain the level of dysfunction or continuing 
capacity of the client. Overall, Main and Spanswick (1995) suggest that this term should 
no longer be used, and as Giles et al. (1997) suggest that with the advances in imaging 
equipment, what is considered non-organic now may be considered a clear disorder in the 
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future. In this sense, the overlay should be caused by the physical injury whereas the 
legal definition appears to accept a pre-existing condition. This may be due to the older 
reference to neurotic pain, that Clayer et al. (1984) suggested. This is now clearly 
understood to be chronic, which is quite a different entity. 
Main and Spanswick (1995) also advocate not using the term illness behaviour when 
examining low back pain for similar reasons. They suggest that any behavioural signs 
(guarded movements) or non-organic tests for illness behaviour (Waddell, McCulloch, 
Kummel & Venner as cited in Main & Spanswick, 1995) are only testing the difference 
between a distressed and non-distressed patient. 
Pilowsky (1994) expressed the opinion that attempts to utilise items from the assessment 
tool for abnormal illness behaviour (Clayer et al., 1984, 1986) in the detection of 
malingering were "entirely misguided". While Pilowsky (1994) has this opinion, it is 
interesting that Clayer et al. (1984) found that certain scales from the Illness Behaviour 
Questionnaire could differentiate healthy participants asked to malinger from those asked 
to be honest. Such individuals were termed conscious exaggerators. However when 
suggesting the most appropriate method of diagnosing abnormal illness behaviour, it 
seems to involve a disagreement with the doctor over an "inaccurate view of his health 
status" (p. 570). Interestingly, it was a very similar item on the MDS (Item 13) that 
separated those asked to malinger from those asked to be as honest as possible. This does 
suggest that, at least in part, the difference between a diagnosis of malingering and one of 
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abnormal illness behaviour is entirely dependant on the value judgement of the 
assessor/health practitioner. 
As Pilowsky (1994) himself notes 
from the doctor's point of view, the challenge resides in having to convince 
society that a person who refuses to cooperate with an 'appointed agent of 
society' is entitled to the sick role, because the refusal itself represents 
psychopathology and is the symptom of 'legitimate' illness. Society's stake 
in this concept cannot be overestimated ..... For health services (and for the 
legal profession which is so often involved) the concept of an illness 
characterised by a mistaken belief in the presence of illness is difficult to 
assimilate. It goes without saying that lurking in the wings is always the 
spectre of the malingerer (p. 567). 
Overall, this suggests, that as concepts such as adaptive and maladaptive are essentially 
context based there appears to little to separate abnormal illness behaviour and 
malingering. 
Given the difference in the sample group used in this study (all chronic pain patients) and 
Clayer et al.'s sample (1984) (healthy conscious exaggerators, chronic pain patients and 
healthy controls) it is interesting to note what differences occurred. The items that Clayer 
et al. ( 1984) found differentiated between those asked to malinger and either chronic pain 
patients or controls involved: a greater emphasis on a change of emotions (relaxing, 
depression), feelings that others are not accurate in their diagnosis of your condition and 
the effect of the illness on family life. In this sense, Clayer et al.'s (1984) approach is 
flawed as those asked to malingerer are clearly 'guessing' about the possible internal 
emotions and effects on family life. In contrast, the individuals in the sample used here 
know about the effects of chronic pain, and exaggerate the severity of the injury and the 
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impact rather than the internal dialogue about being in more pain than others realise. 
Indeed the difference between the scores of those with chronic pain and healthy 
conscious exaggerators is large. This is because the conscious exaggerators do not know 
what they are exaggerating. As was discussed previously, from a real world perspective 
some injury is likely to occur during an accident, and exaggeration can occur however 
this 'knowledge' of the condition is not taken into account in Clayer et al.'s (1984) 
research. 
Voiss ( 1995) supports some of Pilowsky's ( 1994) comments when he suggests that the 
determination of fraud in a particular clinical case is primarily the responsibility of the 
attending physician. However, he notes from his experience with 900 evaluations 
assessing the validity of occupational injury, that the attending physician has often relied 
on the subjective complaints of the patient and minimal if any objective data is used as 
the basis for conclusions. While this has probably become more strictly controlled 
recently, Giles et al. (1997) questioned even the validity of objective results for the 
assessment of back pain . Ultimately, Yo iss (1995) suggests that collateral data should be 
obtained more often and this data integrated into the available information in order to 
make an accurate comment on malingering. 
Yet another disorder that the symptoms of malingering are remarkably consistent with is 
factious disorder with physical symptoms. In his overview Overholser (1990) suggests 
that factious disorder can be discriminated from malingering through a number of 
measures, the primary issue being that factious disorder occurs when a person simulates 
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or creates somatic problems in the absence of clearly identifiable rewards. Gorman (as 
cited in Overholser, 1990) suggested that as motivation is what differentiated the two 
labels, one could look to psychological functioning rather than environmental factors as 
an indication of rewards. An interesting point that Overholser makes is that "once it has 
been determined that the patient's physical symptoms have been falsified, the 
conceptualisation of the patient's problems often leaves the medical arena and enters the 
realm of psychiatry or law" (p. 56). As was stated in the introduction Overholser (1990) 
suggests that differential diagnosis is possible on based on the course of the disorder over 
time, response to treatment and possible etiological factors. 
When the differences between the two groups are examined again there is a reliance on 
the two premises that motivation can be adequately assessed and that the malingerer is 
not aware of the intricacies of a disorder. Lees-Haley (1986) clearly disagrees with the 
latter assumption in the area of pain. In addition, from any of the reported research or the 
MDS results it appears that given the item breakdown, it is not possible to adequately 
assess motivation to deliberately exaggerate pain for the specific purpose of gaining 
external rewards. The MDS, while attempting to assess goal and motives for the 
exaggerated pain in part 2, was not subtle enough to gauge the goals of participants, 
despite this goal being given to participants asked to malinger. This may have been a 
facet of the instructions to participants, as they were asked to be subtle in their responses. 
Overall, the likelihood of a person admitting that the pain will gain them money, and that 
they would maintain this state by having the pain, is not likely to be high. 
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Successful Malingering 
The question that must be asked with any form of validation, is whether the instrument is 
measuring what it claims to. The nagging doubt that Rogers and Cruise's (1998) study 
generated for this, and indeed all malingering validation studies, is whether malingering, 
if successful, is actually detected. Surely successful malingering requires that it is not 
detected, meaning that the given diagnosis stands and therefore the malingerer goes 
unnoticed. In this situation, the instructions given to those asked to simulate malingering 
would be blamed for not explaining the direction to malinger in clear enough terms. 
Alternatively the participants may simply not have the ability to simulate malingering. 
Even in a known groups design, perhaps the patient who does not attract attention by 
being uncooperative, complaining of absolutely no lowering of pain through treatment 
and not expressing a strong desire to gain compensation is simply a more effective 
malingerer rather than a 'genuine' chronic pain patient. Despite these concerns the 
results of this study do appear to indicate that the participants did exaggerate their pain on 
the basis of the instructions given and the MDS did appear to detect this difference in 
response. 
Presenting evidence of malingering in Court given these results 
It is clear that matters of fact must still be decided by the court and while taking into 
account the opinion of experts, it is the court's role to decide. So Mendelson and 
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Mendelson (1993) suggest 
the task of the forensic psychiatric expert witness should be confined to 
issues of diagnosis of mental disorders, their aetiology, and the degree of 
psychiatric impairment. The psychiatrist may draw attention to 
inconsistencies in the histories obtained and on mental status examination, 
poor treatment compliance, and the lack of cooperation or motivation during 
the course of the treatment or rehabilitation program. However the specific 
question of the veracity of the claimant is for the court to decide (p. 34). 
It is for this reason that Mendelson (1992) states that "the judicial system is paying 
increasing attention to the recent advances in the understanding of mechanisms which 
determine the experience of pain" (p. 122). Main and Spanswick (1995) note that it is 
'customary' that the court will turn to the opinion of a pain specialist (psychologist, 
anaesthetist) in back injury only when orthopaedic evidence is irreconcilable or is unable 
to explain the persistence of pain or dysfunction. 
In regard to presenting evidence of malingering to the court, several authors have made 
comments regarding the format and the credibility that should be given to an expert 
witness. Ogloff (1990) has identified 3 areas used to determine whether evidence is 
deemed admissible or not. First, it must be decided whether or not the evidence is 
relevant or not, and as was just indicated in cases where the identified tissue injury is 
approximately equal to the level of reported pain then it does appear that psychologist's 
discussion of malingering is probably not rele~ant. As Ogloff (1990) indicates, only 
when the issue of pain or the defendant's mental state becomes an issue will a 
psychologist be deemed eligible to enter the field, and within this context he/she can only 
safely comment on the veracity of a defendant's mental condition, not on the issue of 
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veracity in general. In Commonwealth v. Zamarripa (1988) 379 Pa.Super, 10 A.2d 980 it 
was held that 
the veracity of a particular witness is a question which must be answered in 
reliance on the ordinary experiences of life, common knowledge of the 
natural tendencies of human nature and observations of the character and 
demeanour of witness. As the phenomenon of lying is within the normal 
capacity of jurors to assess the question of a witness's credibility is reserved 
exclusively for jury. 
Second, the process of labelling someone a malingerer, by a professional, is problematic 
within the legal system. Most legal jurisdictions accept that the probative weight of an 
expert's testimony value should not be outweighed by the risk of unfair prejudice. This is 
probably difficult to avoid, as the term malingerer, is strongly biased and as was 
previously stated, it is not a diagnosis but a legal and military label. As Ogloff notes 
"courts are especially reluctant to admit expert evidence, for fear of its prejudicial impact 
when the foundation of the testimony is at all equivocal" (1990, p. 38) and labelling an 
individual as a malingerer certainly has that element. At the same time however the term 
'malingering' appears in legislation, so it must be defined and used within the court 
system at some point. 
A possihlc means of countering this effect has been suggested by Mossman and Hart 
(1996) in which rather than a clinical decision of either malingering or not malingering, a 
comment on the likelihood of malingering is made instead. This, it is suggested would 
increase the predictive ability of clinicians, as a probability formulae would be utilised, 
rather than a simple decision made. It is proposed that a distribution be developed by the 
clinician using Bayes Theorem, from which estimates can then be compared within a 
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known groups design. This approach is actuarial in design, but the concern still remains 
about what to do with this information and Mossman and Hart (1996) provide little 
indication. For example does this result mean that if there is a 60% possibility that the 
plantiff is malingering his/her back pain, then similar to contributory negligence, should 
be lower the amount of compensation accordingly? Alternatively, should the fact that 
there is 60% possibility of malingering mean that this is more than the balance of 
probabilities (50%) and therefore in a civil case, the plantiff should lose the case? 
Clearly the answer does not necessarily lie with psychology but the way the courts 
choose to usc the information. 
One of the foundation premises that Mossman and Hart (1996) use is that "many 
malingering measures are highly accurate" (p. 286). The evidence presented in much of 
the research suggests that this is due to the types of validation procedure since no one test 
has been shown to be 'highly accurate' (Rogers, 1997). Ultimately, Mossman and Hart 
(1996) acknowledge that the tests used to assess their theory, assess misrepresentation 
rather than malingering. Given the previous discussion on conscious and unconscious 
motivation it appears that an assessment for malingering should assess the motivation for 
attempting to appear impaired before giving a conclusive label. Indeed, Rogers, Sewell 
and Goldstein (1994) have suggested that there are different types of reasons behind the 
motivations to malinger: pathological, criminological and adaptional. Their research 
indicates that medicolegal evaluations are generally adaptional which makes it applicable 
with the techniques employed by the MDS to assess malingering. Specifically, part 2 of 
the MDS does seek to assess the motivation, albeit very simplistically, and given the 
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range (0-29) of scores it is possible to generate, Mossman and Hart's (1996) probability 
approach might work with this scale. This presumably would replace the cut off point of 
7.6, which might be more amenable for the court. 
The final point is that the evidence given must satisfy the Daubert rules (Daubert v 
Merrell Dow Pharmaceuticals, 1993) in which the expert must have some special 
knowledge not generally available, the assessment procedures used must be based on 
research commonly accepted by the majority of the scientific community and above all 
they must be falsifiable. This is part of the problem because, through the use of known 
group designs where another professional has given some participants the label of 
malingerer this research indicates that it is not falsifiable, as it based on opinion. 
Similarly simulation designs may not sufficiently motivate participants to attempt to 
exaggerate their condition, to the same level as 'real' malingerers. Overall the reason for 
this problem is that evidence of a specific intent to deceive solely for the purpose of 
external gain is required for the label of malingering to be applied and currently, no study 
has assessed for this. Instead, many theorists have extrapolated from the context of the 
injured party, generally litigation, and assumed that the person is malingering for this 
reason. The result is that a number of diagnoses can be applied, such compensation 
neurosis or abnormal illness behaviour, which suggests that malingering as a concept has 
not been shown to be falsifiable. 
The case of Frye v United States ( 1923) 293 F.l013 from which the rules regarding the 
admissibility of scientific evidence were developed prior to the Daubert decision, is of 
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interest as it concerned the ability of science to detect deception through an early lie 
detector. In Frye v United States it was noted that 
just when a scientific principle or discovery crosses the line between 
experimental and demonstrable stages is difficult to define ... somewhere in 
this twilight zone the evidential force of the principle must be recognized 
.... the thing from which the deduction was made must be sufficiently 
established to have gained acceptance in the particular field in which it 
belongs. 
Research into malingering, while having generated considerable levels of research, has 
largely failed to show that clinicians have effective means by which to assess deception 
(Ogloff, 1990). Indeed Oglotf (1990) concluded by saying 
trouble may be brewing for clinicians and attorneys who attempt to admit 
testimony about malingering and deception ... although expert testimony 
regarding the admissibility of malingering and deception has not been 
challenged too frequently in the past, attorneys who become aware of the 
inherent limitations of clinicians to accurately identify malingerers may begin 
to challenge expert testimony more often (p. 41). 
Overall, Ogloff ( 1990) indicated that the rules of evidence are still probably broad 
enough to allow the admissibility of expert testimony regarding malingering, if the expert 
has first hand knowledge of the suspect or plan tiff, but not as a concept in general. What 
is important therefore, is that an expert must not misrepresent his/her skills to the court, 
and given the current state of research into malingering and deception this criterion does 
appear difficult to fulfil. 
Future Research 
The results of this study and the comments by some participants, in the light of the 
literature, suggests that there is some scope for future research into the malingering of 
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pain conditions. The areas of future research cover both conceptual and procedural issues. 
While there are many potential areas, the specific areas identified are: the relationship 
between age and motivation, the use of money as an incentive, asking a participant to 
differentiate between their responses when asked to malinger and when giving a true 
response, and finally, what the best method is of assessing whether a client presenting 
with chronic low back pain is exaggerating or not. 
Age and motivation 
Areas that were not directly related to the research questions such as the effect of age on 
malingering and age on pain were assessed to look for possible covariates to the main 
effects. Hall and Pritchard (1996) suggested that generally malingerers are in their late 
20's and early 30's. The current study clearly does not represent this group with the 
average age around 40 years old. When bivariate correlations were completed on age for 
both MDS scores and reported pain levels neither showed a significant relationship. This 
result was supported by Mendelson (1987) who also found no relationship between age 
and the conscious exaggeration scale. As one participant, who admitted exaggerating an 
earlier wrist injury, suggested when you are young you want to work again and just want 
to have an extended rest. He then made the point that older people (specifically workers) 
when they near retirement age, may exaggerate an injury to get out of the work force 
earlier than they would if they retired. Several authors have suggested that the rate of 
workers' compensation claims rises when a company announces it is downsizing for 
similar reasons (Bowles, Duggan, Forbes & Tongs, 1997). This suggestion does have 
some intuitive appeal and while it was not a significant correlation in the current study, 
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this was probably due to the homogeneity of the sample age and the impact of the 
instructions to malinger. 
Future research should firstly assess whether an age effect does exist on MDS scores and 
levels of reported pain with those relatively early in their career and those towards the 
end of their career. Measures such as the MDS without the direction to malinger could 
simply be given and the scores assessed as to whether a difference does exist on the basis 
of age. If this were so, further interviewing could be completed to assess the different 
goals that individuals have on the basis of age. Then the different strategies employed by 
individuals of different ages when attempting to malinger to gain these goals could be 
assessed. 
Money as an incentive 
When this research was proposed the possibility of positive incentives for malingering 
was canvassed on the basis of Rogers's (1997) discussion of external validity. The issue 
immediately arose of how could this be done? Should money be used as the reward for 
(un)successful malingering in which a client does score highly on a malingering scale, 
and if so how much? Certainly the $50 incentive Rogers and Cruise (1998) offered 
students is a good reward for this population, but how does this compare to individuals 
who are attempting settlements worth hundreds of thousands of dollars? The conclusion 
was that very little could be offered in financial terms for incentive and as was previously 
indicated the University ethics committee would not allow such action. Future research 
may have to conduct interviews as part of any pilot research for simulation designs so 
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accurate rewards can be defined on an individual participant basis. Overall, it does not 
appear possible to use direct financial reward as a means of motivating participants 
familiar with the system of compensation, as no researcher would have the financial 
resources to make the positive incentive as great as it is in the litigation system. 
Ask participant what a true response would have been to differentiate responses 
Currently a control group is used to denote what would have been expected for a person 
asked not to malinger. However, it seems appropriate to ask participants who were asked 
to malinger what their responses would be. if asked to be as honest as possible. This 
could be completed in a repeated measures design. This does not appear to have done in 
malingering research yet which is problematic as it is still not entirely clear what aspects 
of behaviour alter due to the instruction to malinger. Indeed, such research would allow 
greater insight into the most effective method of asking individuals to malingerer when 
validating instruments. Even with Rogers, Cruise and Sewell's (as cited in Rogers, 1997) 
instructions, it is not conclusive whether instruments are measuring an attempt at 
malingerer or some other behaviour. This differential is critical given the overlap that 
this research is suggesting exists between abnormal illness behaviour and malingering. 
What methods does this research suggest may make it possible to detect malingering in 
individuals presenting with chronic low back pain 
There are several points that can be made on the basis of this research and the arguments 
made by some researchers, which allow psychologists, to some degree, to detect 
malingering. The first point that is that the goal of the malingerer is to perform in the 
assessment, but then quickly remove himself from treatment, as he/she wants the 
Validation of the MDS 135 
pecuniary benefits rather than the problem solved. Given this Ogloff (1990) suggests, as 
a means of separating individuals with factitious disorder with physical symptoms and 
those who are malingering, that the client who indicates a readiness to undergo surgery is 
more likely to be presenting with a factitious disorder with physical symptoms than 
malingering. Australian courts may not accept this however, according to Mendelson 
( 1996), and he cites the case of Basili v Australian Telecommunications Corporation 
(1991, Unreported Federal Court). In this case the plantiff developed low back pain at 
work and subsequently had a spinal fusion. It was held that despite the plantiff 
undergoing, what the AAT (para 20 Administrative Appeals Tribunal) noted was "the 
most painful and, indeed dangerous, surgical procedure of spinal fusion" they held that 
this had been "a deliberate and calculated attempt to obtain compensation for an injury 
which has long since recovery" (para 19 of Federal Court decision). 
A second point is that of the participants interviewed for this research often had complex 
symptoms and aetiology's which unlike a malingerer, they were very keen to talk about. 
The third point is that all the participants could precisely identify behaviours which cause 
them pain, and would show some fear-avoidance behaviour when asked to show where 
the pain occurs. The fourth point, is that contrary to the presentation of constantly high 
levels of pain, all participants reported significant variation in the level of pain, and that 
with some treatments short term relief was experienced. In this sense, an unsophisticated 
malingerer would probably attempt to show that no relief has been gained. The results of 
the MDS, even those asked to malinger, do not show this occurring. 
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The importance of assessing motivation is crucial and measures must go beyond 
establishing just a need (i.e. individual is not wealthy) but rather establish intent, just as 
in criminal trials. There needs to be a greater focus within the definition of malingering 
on the difference between external and internal goals and the use of pain as a tool for 
manipulation. In the case of malingering, it is deemed to be fraud under workers' 
compensation legislation, because the community is having to pay money to an individual 
who does not deserve it, however in factitious disorder with physical symptoms a person 
who uses his pain to avoid housework is seen as lazy. Conceptually I consider the same 
intent is operating, just with different consequences. Part 2 of the MDS showed this in 
the types of goals mentioned by participants, very few were directly related to money 
which is what compensation neurosis assumes. In short, while the same techniques of 
emphasising pain behaviour are occurring; it is the social context of where it is occurring 
that dictates whether the label of malingerer is applied. There needs to be more 
discussion on what the underlying factors of deception are, and what they attempt to 
address rather than allowing the social context to dictate whether a person is malingering 
or suffering from abnormal illness behaviour. Currently, the researchers are not tapping 
into this area of motivation, and instead both labels, from the research appear to present 
in the same way. 
Conclusion 
This research, rather than validating the MDS has given valuable insight into the 
possibilities for future malingering research. Forensic psychology currently has 
considerable research into this area, however there is an over reliance on so called 
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'known groups' designs, by targetting those with litigation and the assumption that the 
potential malingerer is operating from a completely ignorant standpoint regarding his/her 
faked/exaggerated condition. This has made much of this research unusable for the 
courts. Overall, the results do indicate that the instructions, which Rogers (1997) 
suggested are often the weakness in a study, do appear to have had some effect on the 
participants' performance. Certainly, these results are only applicable to men with 
chronic low back pain with more research required before any comment can be made 
about the MDS with either females or other pain/neurological disorders. The MDS, 
appears to successfully differentiate between participants attempting to malinger from 
those who are not; essentially on the basis of an over-estimation of pain and severity by 
the participant. This subjective response clearly, overlaps with many of the concepts of 
abnormal illness behaviour and it is only through researchers strictly controlling the level 
of injury (and the population from which the participants are drawn) and focussing on 
motivation that this will any method of differentiation can be reliably developed. 
A difficulty with the measurement of pain and malingering is the reliance on self report 
which would appear to lend itself to malingering. The subjectivity of pain sensation is 
well documented (Dworkin & Whitney, 1992) making direct objective comparison 
difficult and the point must be made, that pain does not necessarily involve tissue 
damage. Perhaps as Giles et al. (1997) suggest, it is only through the progression of 
imaging technology, that patients accused of malingering will be vindicated and those 
attempting to malinger will be less confident. Finally, the greater the level of 
understanding about the different qualities of individual pain syndromes, the more 
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difficult they will be to malinger. However, attempting to assess malingering of pain as 
an individual entity, in the absence of a specific diagnosis, is, on the basis of the current 
research and at a level accepted so it would accepted by the court, virtually impossible. 
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APPENDIX B 
SCREENING TEST -JOHN HOPKINS CHRONIC PAIN CENTRE 
DESIGNED SPECIFJCAU.Y FOR BACK PAIN (Dr Donlin I.oog) 
l. When did you first notice the pain that you now experience? 
a) Sudden onset after/with an accident or definable event. 
b) Slow, progressive onset with sharp accompanying pain. 
c) Slow progressive onset without sharp accompanying pain. 
d) A sudden onset of pain without an accident or event to which you can tie the pain. 
2. Where do you feel the pain? 
a) One specific well defined place. 
b) Several different places. 
c) One place but hard to tell exactly where. 
d) Its hard to describe exactly where the pain is and it feels differently in different places. 
No physician has ever been able to tie it to a specific source., 
3. Do you have trouble sleeping at night? 
a) If yes then go to question 4 
b) If no then go to question 5 
4. What keeps you from falling asleep at night? 
a) I have trouble falling asleep at night because of the pain an<! I'm awakened by the pain 
at night. ' 
b) Because of the pain I have trouble falling asleep about three times a week or more and 
I'm awakened by the pain from sleep more than three times a week. 
c) I have trouble falling asleep more than three times a week but I'm not awakened from 
sleep by the pain more than '!Wice a week. 
d) I have no trouble fallins asleep because of the pain and it does not wake me once I am 
· asleep. 
e) I have trouble falling asteep or I'm awakened early in the morning -but its not because 
of the pain. 
5. Does the weather affect your pain? 
Cold and Wet- Doesn~ affect 
6. How would you describe the type of pain you have now? 
Burning sharp - Excruciating, unbearable 
7. How frequently do you have pain? 
Constant - Occasionally present 25% of time 
8. How does movement of position have an effect on the pain? 
• 
Unrelieved by position change or when don't use part of body that hurts. Numerous 
operations for the pain. --- No change in pain with position change or not using hand but 
there is no operations for pain. 
9. What medications have you used in the past month? 
No medication at all 
Non narcotic pain reliever or a mild tranquillizcr (non~benzodiazcpam) or an 
antidepressant. 
Strong pain killer or a sleeping pill less than 3 times a week or I've taken bcnzodiazepam) 
tranquillizer less than three times a week. 
I've used either a pain killer or sleeping pill or tranquilli1.er more than four times a week. 
10. What hobbies do you have? Can you still participate in them? 
I am unable to participate at all in any hobbies I used to enjoy. --- I still participate the 
same as before. 
II. How frequently did you have sex and orgasms before the pain? How frequently do 
you have sex and orgasms now? 
Formerly good (3 to 4 times a week) Now less than once a week----I am unalble to have 
any sexual contact since the pain and I had difficulty with orgasms or erection prior to the 
pain. 
12. Are you still working or doing your household chores? 
I work every day at the same job prior to the pain at the same level with the same duties.--
~1 don't work any more someone else does my household chores. 
13. What is your income now compared to the time before your injury or beginning of 
your pain? What are the sources of your income? 
rm experiencing financial difficulty and my family income has been cut in half or more 
since the onset of pain. 
b) Family income 50- 75% prepain 
c) I am unable to work and recieve some compensation and my spouse works. My income 
is at least 75% or prepain. 
d) My income is about eighty percent or more of my gross pay before the pain and my 
spouse does not work. 
14.Are you suing anyone or is someone suing you or do you have an attorney helping you 
with compensation or disability payment? 
a) I have no suits pending and do not have an attorney 
b) I have a suit pending but it is not related to the pain 
c) I am being sued as the resuit of an accident 
d)! have a suit pending, or workers compensation and I have a lawyer involved. 
15. If you had three wishes for the world for anything in the world what would you wish 
for? 
a)Get rid of the pain would be the only wish 
b)Get rid of pain would be one of the three wishes. 
c)Something of a personal nature such as more money 
d) Something for others such as an end to world hunger. 
16. Have you ever been depressed and thought of suicide? 
a) Depressed or have been depressed in addition to having pain. My depression makes me 
cry sometimes or think of suicide. 
b) Because oft he pain I have been depressed and felt guitly and angry 
c) I felt depressed before the pain as l suffered a financial or personal loss and now with 
the pain here I also have some depression. 
d) I don't feel depressed, l don't have crying jags or I don't feel blue. 
e) Before the pain l had a history of suicide attempts. 
17 points- Coper: 94% you have a physical problem that would be identified by at least 
one objective test. 
18-20 points Exaggerator/Coper: 75% you have an organic problem that will show up 
with testing but you may also have had some problems prior to the pain 
21-31 points Exaggerator: Surgery recommended with caution. Test shows you may have 
found a use for chronic pain. Treatment emphasis on attitude change toward chronic pain. 
32+ points Psychiatric consultation needed. Surgery should not be carried out without 
psychiatric evalUation as you freely admit that prior to the pain you had many problems. 
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SELF- ADMINISTERED FOro.! 
,,, ... , ...... :.,-:;;;';": 
,,:. : :~MliRKlNG~·INSTRUCTION.s· .. 
~;~~~;~4il~tt~~~:~~~e~;~~~:;i'ui~·:~J.~~~~- · ·-:·: -·-- -·· 
~'f. --·~;-.\M~-::d~:fr\artt&.'itiafllll 'clrc~&.i~l!r.ily:·· 
t>~·~:·::~t~~:~!!~-~\~>~~~~~::~-~:::'. , .... 
-J~C~t~r;-.; ----- ·-WAOHIU&ASIIC!II•,·'-
~-L -.:.~;--~ <<*-;;~:L_ ··.)_~iR~~ON~ i,,:, ~i~- -.:i·-~; __ , 
;·,:;-::;_~_,jAerk:onilfQNE:ANswEa-to.~~~on~ ... · . 
: _-_~: ;~ "·'·'1~~~ .. ~-tj'l~~lt.lri_ii:~~-.-~---:_:~:---:.;· :· .. 
How long ban~ ~oul12d (Niin7 
0 0 • 6 mt~nlhs (STOP k$t) 
0 Longer (Gr~ Dn) 
SECTION I 
1. H()1't' dhl your p;t;ln n~l b~Rin': (Mt~rk t~nfY Qlltnll.snw) 
Q: An aocidcm or lnjlll1' 0 Slowly .sot wone cw~t lim~: ;:mil $\lddcnly ;at tn'tTI 'l'.«s~ 
0 Af\er Stii'ECfl-' 0 Came- on S~ddenl)'. bur I don't knaw bolv or ._.-by 
Q.SJcN-·ly got WONe O'o'Cf time 
SECTION II 
;f, Wb~~ do you bave- p1!n most ofJhe t1m~~ (Po NOT ln('lltde-llms uC I he budy "'ben: )"OU haw anly 
oeeJ!tkltlol ,_hi) (>'of11rk rtll tffirr 41/!JTM 
0 Face b:cl~'-1 
0. H~ 0 Abdomen 
3. \Ybtf'e do ~u have JIIIIIIMsl orlhe lrme1 (Mark aU tltur lfllpi.J? 
O:JoiniY 0 !'l~ck 0 Othe-r 
0 fingco. nr IOC5 0 Upper badt unti!«shouldcn 
A. Wbere da }'<IU b:Wc Jlahl motl or lllc.dmf1 U1tark-alftfmr nppiJ') 
Q Rig b. IIIITI 0 Rlsht illtlld 
0 Left ILflll 0 l.~n hand 
5. Whl!tO dn )OU Juwepala most of tho llmt'! f.M111-A t~ll thflf nppiJ~ 
0 ~gl11lcg 0 Ri;ht lOot 
0 Lelt k!a· 0 l,cft ft:~m 
09120 
0 Low b~k andlor bullookl 
0 0\htf' 
0 Oillh' 
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- SI!CTlON [1!--------------------
-- 6. Do you bnoe trouble.r~lllng u.l.r~:p 111 niuht'l' 
- 0 Ntl (Slip questions 7 & K.. o1nd go to J1UC.~!lol'l 9' 
- Ov.:~s 
-- 1. HO\¥ m1ny nltthh l! w~k'! (Arm.-u orrly IJ~ovu mar~ .,Yir"' Ju lfllnllan 6) (.tlftrk #Jilyflt!!!, tul~tJ 
- 0 EYeJ)' night 0 J • 6 ni&Jtt:s 0 2 or fewer 
-• 8. \\obllt ketps ;."Vu 111wakc'f (Arm..,.,. rmlrlfJiltlmarUJ •t't:f" tn 'flwtlon 6) (r\111,.. turf)' fZllLIItr.two) 
• 0 P.1h1 0 ~o trouble ;cuing 1CI sleep 
- 0 Ju~1 lie in bed ami CliD'l Jl:llo slccp · · 
-- 9. J)o .)'OU ~~~ durillg, Usc hfJ,oftt': 
- {)~. 0:N(l (SJ:ipqiiCSiiON 10 & JI.OUld~;t~ on toqoc:s~ion 12) 
-
-
10, Jllwr llUlDyDf~IS a ~1.."! (AM.lrn"OnlJI if1(lU nuriN "'J}.I".,.I(Jftlt:Srffln 9) (Jfarfl: tNIIj• f/JUIJJUWr) 
-
O. E.vci-y uij!lu 0 1 -<fi ni!;bts 0 2 or f&:WCt 
-
-
II. Wllau"ilken.' )'Oil ftt~m Jlctp~ (Amw~ M/J ifJOtJ m~tl "~, ... to 'fUI!Jdlm 9.1 (Mttrlr ~M/yraft!iltl.rtNr} 
O·r.un wale~ me up 0 w.1kt: up tf.l 1:0 to the batJuDilm 
Q Oort't bow. but l11"tll:.: up r:!Drly 0 Not aTIIlkened from sleep 
1Wllle. m=illgsillld c::m't gel h:Jck to sl~p 0 Sl<..'t'p is ~1lcu. I ton mtlllltll. bill. rm.DOt n'JIIIy aw.Uctnn 
.,. 
-
-
-
-
.. SE<:TIONJV .. BI .. IERmRIIEIEIBIRBIIEIEIBIE .. DIIBBIBIBI .. BIBIBIBI .. 
-
- 11. Do~ th~:".weatber aaee~ yottr p;~irt'! (,\lark offfy aM ans•~J 
- 0 My p;r.[n is~ worse wilh BOTII damp and enid '>"ealhcr 
- Q My pain!%~ warne with EmffiR datnpt.tr(old wcalhl:l' 
- Q 1\o,ly]lllin i~ ooon;tjmcs WOflie with EITHI!R dllrlpDr cold \\ctllltr 
- O·WCIIihcr fm ~ 00 rt'lf poin, ;md r I lA VIi ltltd ~urgery in the II'Je<t "'bm: I AOW ha>,c. pain 
-· Q.Wc,,tlklr has~Uil myp<lin,.md I HAVE NOT h:1d ~Wb'l!fY in the~ -.whcrc I no\V him~ p;1in 
-
-
- SECTION V lllllllllml\'O!l!I!IDII!llla _________________ _ 
- 13~ \\!:bat da"" J-'Dilt" p:WJ rm llb1.(rJ/Iolr411niJ•JIJU ~~Jwr) 
-· 11}e. PQio !. hav..:: 
- 0 ·reds like- a buming Pf!in 
- 0 feel,. like c~!<tnt $l!arp. slauoting paill 
- .0· fCds.like coldnes.;. 
_. 0 · r.eel$1ike numlme~ 
- 0 tecbllkeplnsandnccdlcs 
- Q. rallll~.e II <MI. ~dting ~n with.O(."CASIP:Ml sharp. shootiiiB: point 
- Q iJJ BES'f dtscrlb:d as .a $p:1Sm-l}'j1C'fl:lift 
- o~ is:..~[ll~both~~WMCpr;\ln 
- 0 ls:Bt:!-'T <k::;cribcd ~nmbc:lrablc m-·muwhl!ll'liing. or ~o;ippling or.dC"ltlllatinlnr Qn'{be.~S~ 
- 14. Jleu,.aacUilr m:mage fldp m.y pliln1 
• 0 liuc 
- 01'1'11~~:. 
.. 
-
• ~ECTIONVI ______________________ _ 
-
-
[5. l)Jiml·.at tea$t on~type of.a~e- or: patn lbnl b.pmM.'tlt:·(,Ur~riA' lltfiy·~ IIIU'INr) 
-.. 
~­
-
-··· 
0. 80 ~Ill()% of llw-lirno b:2s, .. 5Q% of.lhelinw 
O~o..:lnl%of* tim~: .0-t.c.ahwr25"..t. oflf~Qortmc (omlkinally) 
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SE:C1'IONVU----------------------tiL \\'Wdl $hftDM11t·baf drsa:ibft die rff«t !)f'm~m;mt ot~ J'IIUrpa1 t;11M:tfl4i!IJ' f1JJ.C «imml 
o Jt.v ~ttAUtrmll!tPQ$itfarl nu m. ~~l"lm ~'51lr~ 
ClWatkint, ur llUing.-or IX:ndin;g, or A't.'Uidfr~tim~ 8ty-~iD W~ml: 
0 -llli\11l - t~ll -ifm>l\"Cn:;eJ)t11l>1kes. !0)1 p(lin.wqrsc: · Q: Shtf)JfiJJl~$:lliOJi. r~lie'."t'li. n1y pull\ jhr-11 vi•hile 
C) leQniuy.baekwar$;()f IO ·Q~it 8id@ WOM!JI~ IDY pain 
17. Jft~W' }illi tu!id -~my opemiolii ro tey ro nUWtt rJn.· ~a? 
0 Yl:s 0Nn 
Jlt~ C.ok1:1i1tt#.Or ~~ncmn~ ~f' b®d mli~ts -Hrwa ··~iif ~ibi. 
. 0 Trnt 0 · FD't~~ 
SECTlON'Vllt ----------------------19.1 lta.v~t yo!Hlik~:<n :.my mtdkntiOil.!! durin~ th~ ·IJ'll$ t !*11)!1111;~ , 
0 Nu ~lp JQ-q.u~mott 21} 0 ~f.Gq,~wq!JeHi/.w til,)) 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-19..1 lklw· i~o a Uu ~tTmriiK:ati!DIIS uHd 0 ~ p;tiLamid}<lllliHfU.~~ #'tllri*-•114 ~ 
ibft')'IU lditl <*It)" ofttif:kl dUriti;: CM past'JiltiiQtll? -
0 ·so ~lflt Jjl o1UfSlipu 26!J !i o· Yet (lJycs.; if;~ -lif'l'lr* /M fftN#lt#i!>i:.ti )~ Jli!ve ~17M ~ tlie JitUt liHMtlt -
· 4Ard.11ien gtJ i111 (IJ' ·!fU~rs?ttllf 'l(Jl2J) -
-
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- SECTlON VIII -----------------------· -- lOJ!t, JUnk lurw onrn ynu·MVC! f1ktn tllo 1J1edldne1 lld«< brlow darin11 tb' pill monlh. 
- (,1/urft >~nly IAf!,'U:)'U/1 !JWd ldt1r1 
-
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LIST OF MEDIC.\TION.') (Mark 11/l til at llpp/JJ 
iil'~="'fl.'f'<7·'"''"" i ·:""'""""" £''71 q;·~ "4i#J.:'~'WsliJil~ 1-.iiWi!:,~.~~~JX~~77J;~ :::~ ~~'·"" "' .. ~=-"'"""" _,'Ja. 
·"ft.' :;~ -"-,,..,_., .... ,.,""''"'•:·,,, .. ,,., .. ~ .• -,.....,..,,!I!'· 
''·JL'· ,-~"oJ"'-~"~e.i·4tf""""'''l~ ~~ ~~'f?~~~~~~~Y*--~}Y.~L~l/ ~;">:!.· i!11'11 aE:rH _ ;[)A'tS'· 'W . '\~Ai f~·"'"r-''-·.t..<•·~ ... ,, .. ...,_..,. • .....,._.,.. r-l"'i ' ... ____ ~{j· ·:-c~--< f.'i}. ~(}'; Anl:;tsill~ 1hvdru~ud. bil. & at:el) '·g NcmbUia!f' (pmtchillbltal110dium) :;o: ~at AlfcnuJ-(JJt~mamt HcL·I ;gi 'ci Nolud:tr'i (mt!hprylon) ;a .o~ Alut;li.Y·<nprohlubit:lll Nub.1in« (lllllbuphine HCL) 
-5:Ji 0~ A~tmmorph ?P' (morphine sulf~te) ri ;o: Numm-phan» (O!ynlntphollll HCL) 
.. J '·'"' 
'q_,', :C;Y' Ari~an1' llnr::l<:~p:lln) '-"i!,n ·-~· '" 
'O; :(jf P;wopsn" (HCe~ of opium alk,) i& i:r . _,/,: Ball~-..p--1 (lrydf«od, bit &-,..-cr.) 0: B· P-.u;ip-.ul't~ (lml:zzep;im) 'a' ', " :_ ,: 0:, ··a· '· :· J.l & 0 Supp~n~~ tbeO.::sdonlUI) h' rJ~; f\'rco~r" {oxycGdone HCL) 0'0' Rupn:nL'.ll"" !boprenoi'J'hiru: HCL) Pen:.odarrll (oxycudone JICL & ttrep,) ~;~·_1: ,;:_:.:;: 'pj '0' Pltem'lpthcnl (:w::cnminopbcn) . ' ti O;Q C~rurax-10 {pr:t:?~~~n) '0' PLI!:"idyt" ((thchl~l) :'0'.: ~· ' ·( ,..,_. __ q_, tu-Gc::rie~' (hydrocodi biL & uctt.) D, 0' Po~ (mefenumlc add) 
7&1 
,.,,_-' 
\8' §• Dalmme" ( flumzcp:un HCL) ii)\ Re!lorH~~'-Itama:zepamt §t{! 'b~ :_ -') i);!Joo.wn- PJ' {hy!lmc()!l(lne blt:tnm~) 0 u, Rrn:ur.:.l~ (mcrphine $Uifone) \djd D:trvoret- N"' /JliVpox.ypbento nap!.) a tr1 R~kodone~ (oxywdane HCLt 
',g'O' --·,.:;: .,.,-_1 ·•· ' . "' Dememl" (trll!pffidine HCI.j -:<J~ '6; ~ ~ '0:.~ !):pro!* (mcprolr.l~t &. bemact.) Scl'ilx"' {OXO!zqlOm) 
f:SJ ~.B:J Dli&JdidJJ (hydnJmQrphooe. HCL) (} ~o~ Starlnl"' (butorpiW~ol tnrtr.att) Du!IJphiD;"' {mct~don~: IICLI (o; 'Q; Sublim:rz~ (ft:ntmry) citm:l 
r.o~·-o_:\ Dorilknl' {.gllllcthimlde) '0' 0'· Sufent.:t~ 1sufunt.mil citr.l~) ro·) ~a:o Dur;nnorplr~& (ntllrl'hirl>:! ~ulf<~lel 'Q' Q' Synaglos. oce (drot.-odc- biuut.) ' ,, ' :7~~d ;:<1 - .. , ·. ,, ,, ... ,-~ ·-·~ '·~ 
·'b:i :o: ~aj ·:a: Talwin• fpe~tazocin~: hydrodllorirlc) ):,. ,·.\ -' .... :'i E'gic-11 ' ' •Qii ~-~ Ell. T~ene'Z {chluniXI:piUC) ;;· ~ 1j • ~ . •t Fiorinal• .. ' i~lux" (o~tyt;udclll:' &. ~minophcn) ~ ~f.f~~ ,).·X :cc·f.'j :o,; H~l<:ion~ (JtW.ollrn} tl} y~~- V;tJium-.o Cdi.w:p:tml 
'QI Q< ' . ; '.§! i~~~ >~; Uydrno~ [hydnlcad.- bit, &.·aoct:J 8: a' V:tlmldf> (cthi~mmete) -" - . •,. \lalll).l;:as~ (dill:o!:epnm) 1'6J'C/; , -(· ·-o: J·' . :: / L~fll_onlll" {lcrorph.lno{ tart.) .q-;, .-i Vioodhta (bydrotod..blt.. & acct.) ·~:0; Libri1~• (chlol'di~.ept'r.•idc) '~~· ~g Llbri'llllt" (cltlotdinzcpo::ddc 1K1.) Wy"gCSle-*' (propi:JxyJtheM HCLI ~ ' ' ·, Limbitrol~ (~:hlmdlaz.. &.uml!t.J . _, "1 i .; lo11:<:tiiD-" (byclrooodonc:l X~~~m . ,;"' {alpruolmn) :_._-~ ·;8;l ?2· p . Li!ICl!t Flu.~" (hydrncOO. &.u~l.J ·;, . ! ;,.;\\". 
Oi co': LllJtab'J! (hydrotod~ut:~} -r(jf 'Ql Zydoncl' (bytlro-cod. bit. &-~~;CI,) ~ ... ,., ·- .-, ::A:,.,* 
·,r,::7; e.: I, ;tt .· " .,.,.,J n!" .. Mcnriulfl'~ .,, ,.., t 
'· :, ,' ;.:: ~~b -,iM~ ~§! Mcpcrg:mD (mcperidiPC & pmmu .. } iJ<· \1m:) \' - .1 M~prospan-' (rneprob:amato) 'I. "J . . t:f' Mt!Jl:ldoiral> rt Ll<Ji '~d Miltow'n*'(m~prilbrunate) ;~ '~ :"' ;a') Morphine& -.;J -tl . tl' MS Cominc rmorphitse.sUiffltt) ~~~ (;t2l1 ;; - ' . 1 MSfR.e rntarphin~ rulf11tt} · 
' "l " MyrunbriloJ'll (<lll4mbuto_l ACL) :"J~J;-' !J:;,;;~ . _, :P:. Sl.ii;J ,&;. 
""""=d........,.oollhl_..~,....v·~-fllllla-~'IIIII,......JIIPL 
~·~..-.--m~ 
•• 
w.o&'4• 
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SECTION IX ............................................ .. 
lZ.. To wbac dqtrct do you part!dp:r.te In !tohbl~ I hill )'flU ouco enjoytd? (Jiarkunly UJJZ.III'nrwr) 
0 C;~n'l do any o(thcm anym:ort! 
-0 J dill de~o it bul it hurts a lnt 
0 Do the s:ame ltubbie; il$ before 
SECTION X ........................................ .
'23. trow has ~mtr P•lrt-.ltfrn:lt'd your Sl.':\: life:'! (;'rlnrl: an th11t applj) 
.0 l"hiM't\l'Srop ~~~. 'itlthc: middlie'b.:r;ause ofpniu 
0 Had rcgWar se~unl ~unt:.~;:t ~fore p;Un; Now $C11Ulll c011tartis less frtqucnt, 
prvbiibl).-cut m halfbc:rnuse ufp!lln 
0 No- clttm;e in the nlll7lbcr of time~ per weeK-of sex Md'Of81lJnl 
0'1-l:r.'lll tnrubl!;l; witb ID\lo' so: int~rt'st and olpsm far th.: nm.tim~ Ill ftl)l lifo ~ince pain ~rortl:d 
Q-.f-ICM: had trouble with Unle s.c:t bof= k ptin OR 
have :livoey~ h:td trouble wilh OtgaSit11 C\1:11 be!(lrc th~ pcln. 
0 HM h!td:no scxu:!.l eont11ct -si~ tbe p11itl bcg~~H A%-!1> 
. h~ diffii!UII}' wi1h IM'gtwn or. Cl"':l;liou beJDK- tbc pl!ia btgap 
·CiReli@IHI!YOWS, ot p;~rtW::r't illm:n or ckath pn:venu:dscx-
SECTION'XI __________________ _ 
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APPENDIX D 
Summary of Malingering Techniques 
l. The malingerer may express an exaggerated degree of confidence in the physician· s ability 
to diagnose his alleged neurological disorder. 
2. The malingerer may make self enhancing statements . 
3. The malingerer may make denigrating statements about the competence of other 
physici'ans and/or denigrating statements about the character of other patients. 
4. The malingerer may emphasize the severity of his alleged neurological symptoms. 
5. The malingerer may emphasize the severity of his alleged neurological impairment. 
6. The malingerer may emphasize a specific etiology of his alleged neurological disorder 
without the consideration Of alternative etiologies. 
7. The malingerer may emphasize a temporally associated event, not known to have a cause 
and effect relationship with his alleged neurological disorder, as the etiology of his alleged 
disorder. 
8. The malingerer's symptoms may not be improved by symptomatic treatment. 
9. The malingerer may allege that his neurological disorder is responsible for what was clearly 
a voluntary act. 
I 0. The malingerer may present a constellation of symptoms not consistent with those of an 
established neurological disorder. 
II. The malingerer may emphasize his alleged inability to perfonn his job related activities .. 
12. The maiingerer may deny the ability io learn new skills to compensate for those allegedly 
lost from his alleged neurological disorder. 
13. The malingerer may emphasize the certainty of another physician's diagnosis of his alleged 
neurological disorder. 
14. The malingerer may emphasize the prestigious status of another physician who allegedly 
diagnosed his alleged neurological disorder. 
15.. The malingerer may quote an alleged authority mi the subject of his alleged neurological 
disorder. 
16~ The malingerer may use an irrational analogy to stress the seriousness of his alleged 
neurological disorder. 
___ , ___ -_.- , __ :· -~ ' -. 
--- ' ·' 
-:· .. _ : . ;' ,' -;:~ 
Pain Intensity Scale 
Please rate your pain by circling the most appropriate number 
at 4pm, every day for one week. 
012345 678910111213 1415161718 19 20212223 2425 26272829 3031 3233 3435 3637 383940414243444546474849 50 
No Pain Worst Pain Imaginable 
Day One 
APPENDIX F 
Instructions 
For the purposes of research, you have been asked to participate in a 20 minute pain-
evaluation interview. Please pretend that the interviewer is an insuran('e appointed health 
practitioner with the purpose of dctCnnining what compensation you will receive for your 
chronic low back pain. The more realistic you can make this interview the value of the 
research increases. You do not have to plan what you are going to do, but rather do what 
you would think would best meet your goals. 
During the interview, try to convince the assessor that your pain is very bad, worse than it 
actually is, in order to gain more compensation. Use all your experiences, if you have 
involved in workers' compensation or litigation use these experiences to increase the 
amount of your claim. Use any experiences that you have had in your life, or advice you 
have received from other people. Subtlety is important. Remember that the pain rating 
scale sheets with 1 - 50 are part of the evaluation so also use these to show how much 
pain you want the assessor to think that you have. Overall. keep in mind that the more 
pain that the health practitioner believes that you have, the higher your claim will be. 
If you have any questions at the end of the interview the assessor would be more than 
happy to answer them and to explain fully the goals of the research. 
APPENDIX G 
Instructions 
For the purposes of research, you have been asked to participate in a 20 minute pain 
evaluation interview. Please pretend that the interviewer is an insurance appointed health 
practitioner with tht! purpose of determining what compensation you will receive for your 
chronic low back pain. The more realistic you can make this interview the value of the 
research increases. You do not have to plan what you are going to do, but rather do what 
you would think would best meet your goals. 
During the interview, try to be as honest as possible about your pain. When you fill out 
the five 1 -50 pain rating scales prior to the interview, try to be as accurate as possible. 
Overall, you feel confident that you will gain the compensation that you are entitled to. 
If you have any questions at the end of the interview the assessor would be more than 
happy to answ~r them and to explain fully the goals of the research. 
APPENDIX H 
MALINGERING DETECTION SCALE INTERVIEW 
SCHEDULE 
Greetings 
Preferred Name: 
Code Number: 
PART ONE 
Introductory Phase 
Date ofBinh ____________ _ 
How long have you been in pain?, _______ _ 
1. How do you feel about me assessing you for your pain? 
2. Do you think that it will make a difference for you (Exaggerated Confidence) 
3. What is your position in society? (Increase his social status) (Denigrate others) 
Must be Spontaneous Comments by Patient 
History Taking Phase 
Focus is on the Severity of the Pain 
1. Tell me about the pain (Evasive?) Can you describe the pain (Describes using 
severity instead of actual description) 
2. What has the pain affected in your 1ife, what have :·<:hievements have you had in spite 
of your pain (Exaggerates degree of impairment, G.;nuine patient can and will 
describe achievement) 
3. Tell me about how and when the pain began ([s this a cause and effect relationship 
that has some validity or does this give no rationale for the pain) 
4. Are there ~y other explanations for why the pain exists (Consider alternatives when 
not obvious,.can y.ou describe wba\ occurred before the pain began) .. 
5. Have you attended treatment previously and how did you respond (Beneficial 
response does not help the malinger, no improvement at all) 
6. Did you have any unusual responses to treatment (Again is this rational, or does this 
indicate perhaps a reason to avoid treatment) 
• (In general are they denying responsibility for clearly voluntary acts despite 
behaviour clearly being motivated, provoked, directed or complex) 
7. What other symptoms do you have because of your condition (Are these symptoms 
reasonably connected to the pathology, and can they be explained in a rational 
manner) 
Leading Questions: a) Do you feel pins and needles in your hands 
b) Do you get a aching feeling in the soles of your feet 
c) Do you get a burning sensation in your eyes 
9. Can you give a percentage ofnonnal behaviour that you can no longer do solely 
because of your pain. 
(Look for extreme results "can't do anything") 
10. Have you attempted to learn new skills to compensate for those abilities lost due to 
pain (Malingerer has not attempted to learn new skills) 
11. Do you think that you will be able to learn new skills 
12. If not, why not. Have you received training in other areas (He will stress that he has 
not been trained in other areas) 
History Taking Phase 
Manipulation Attempts 
1. Have you been to other health practitioners- Were they good? 
2. (Emphasises the prestige of another examiner who has allegedly found a pathological 
condition and/or quoting an authority on the subject.) 
(Any attempt to create self doubt in the examiner. Should question whether history 
and examination are consistent with these alleged authoritative quotations.) 
3. What were their findings (Were their findings positive then say that they were the 
best or denigrate them if findings were inconsistent with patients views) 
4. (In general did the patient irrationally suggest other situations or examples where an 
examiner ignored similar symptoms and the patient suffered or died. This forces the 
examiner to disprove an irrational analogy thereby gives the malingerer control and 
demonstrating a lack of knowledge and reasoning ability) 
4. What will you do if relief cannot be given (Threatening selfhann or banning others, 
and maling~er is responsible for the threat not the examiner) 
5. What do you think that I can do (Overstating the examiner's authority for intervening 
on the patient's behalf, common technique- based on inadequate information by the 
malingerer. Gennine pain patient concerned with truthful authoritative position as 
this allows him to anticipate the benefits of working with this examiner. Or the truly 
ill may lack concern for the examiner's authority believing that illness or impairment 
is an adequate reason for appropriate support regardless of the examiner's authority. 
No benefit is made to the truly ill patient by falsely inflating his examiner's authority) 
6. What will you do if! choose to say that you have less back pain that what you claim 
(The malingerer may threaten the examiner with legJI retaliation for a missed 
diagnosis or improper care which can cause self-doubt and fear of retaliation in the 
examiner. This attempt at manipulation should increase examiner's degree of 
uncertainty regarding the patient's diagnosis. The results alone should be able to 
justify the examiner's decision.) 
Remember: Patient's answers to questions 
• General: Patient questioned the competence of the examiner to avoid answering 
questions 
• Patient gave an affirmative response to an inappropriate leading question: Sec before 
Examination Phase 
1. What actually causes you pain. Can you suggest some activities and show me why? 
(Any physical effort resulted in enhancement ofthe patient's presentation of 
symptoms) 
2. Patient's responses during the examination did not support a physiological 
explanation. Explanation is given but is irrational and clearly manufactured. 
Patient's response to disagreement 
• Patient's response to the examiner's explanation suggested a distorted meaning of the 
examiner's statement. Continuously misunderstanding examiner's statement to avoid 
acceptance of the examiner's explanation, despite the explanation provided on an 
appropriate cognitive level for the individual. 
• Patient demanded an explanation based on inadequate data. They demand an 
explanation of symptoms based on inadequate data, not possible to give as diagnosis 
is unjustifiable 
I. Why do you think I am asking you these questions? (This is another mechanism to 
avoid acceptance of the examiner's impression. If the examiner is discredited then his 
impression becbmes invalid. The examiner should question the reason why the patient 
would reject his impression especially if the examiner's impression carries a good 
prognosis. 
PART TWO 
Apparent goals for patient's behaviour 
1. By having this pain what responsibilities or activities, that you do not enjoy, can you 
uo longer perform. 
2. What will you gain by having this pain? (A goal was identified for all the patients 
classified as malingerers by the MDS i.e. money, disability status, narcotics) 
3. What do you maintain by having this pain? 
APPENDIX I 
Dear _______ , 
EDITH COWAN 
UNIVERSITY 
PERHl WESTERN AUSH1ALIA 
JOONDAI.UP CAMPUS 
II)(} Joondalup Drivr.. Jrmndalup 
Western Ausrralia 6027 
Telephone (08) 9400 5555 
Facsirnllr. (08) 9300 1257 
With regards to our phone conversation I wish to thank you for agreeing to be part of 
this research by Edith Cowan University in association with Brain Suter and Dr. Phil 
Finch. This research is part of a Master's thesis and should be useful in reducing 
conflict between patients and the insurer. 
For the purposes of research, you have been asked to participate in a 20 minute pain 
evaluation interview. Please pretend that the interviewer is an insurance appointed 
health practitioner with the purpose of determining what compensation you will 
receive for your chronic low back pain. The more realistic you can make this 
interview the value of the research increases. You do not have to plan what you are 
going to do, but rather do what you would think would best meet your goals. 
During the interview, try to be as honest as possible about your pain. When you fill 
out the five 1 -50 pain rating scales prior to the interview, try to be as accurate as 
possible. Overall, you feel confident that you will gain the compensation that you are 
entitled to, 
If you have IDly questions at the end of the interview the assessor would be more than 
happy to answer them and to explain fully the goals of the research. 
Please find enclosed: 
a) 5 pain rating scales, to be completed daily, and started 5 days prior to the 
interview. I will take these at the interview. 
b) An informed consent form, Please read this and sign the tear off section, I will 
take this at the interview. 
c) A reminder slip for your fridge, with the interview time clearly stated. 
d) A cover letter from Brian Suter and Dr. Phil Finch, explaining their role in, and 
endorsement of, the research. 
JOONDALUP CAMPUS 
100 Joondalup Drtve, Joondalup 
Wes1em Allsttalia 6027 
Telephone (08) 9400 5555 
MOUNT LAWLEY CAMPUS 
2 Bradlord Street, Mount Lawley 
Weslern Australia 6050 
Telephone (08) 9370 6111 
CHURCH LANDS CAMPUS 
PearSon Slreet, Churchlands 
Weslern Australta 6018 
Telephone (08) 9273 8333 
ClAREMONT CAMPUS 
Goldsworthy Road, Claremont 
Weslern Australia 6010 
Telephone (08) 94421333 
SUNBURY CAMPUS 
Robertson Drive, Sunbury 
Western Australia 
Telephone (08) 9780 7777 
APPENDIX .J 
Telephone Contact with potential participants 
I. Ask for individual by name (Mr ) 
2. Greetings- Full Name 
3. Masters Student in Psychology at Edith Cowan University 
4. Conducting research in association with Brian Suter and Dr Finch. 
5. Asked for a list of individuals who have suffered chronic low back pain 
6. Have not seen personal files, only been phone numbers. 
7. I am ringing to ask you to participate in this study 
8. The study is designed to "reduce the conflict between health practioners conducting 
assessments of pain for insurance conflicts .. 
9. Many of the claims made that a person is faking pain is made on the basis of the 
practioners 'gut feeling', which is not acceptable. 
10. It will involve filling out giving an indication Of how much pain you are feeling at a 
particular time each day (from 0 to 50) and a 15 minute interview to be conducted at 
your home, Brian Suter's office or Edith Cowan University at the best time for you. 
11. Some of the patients will be asked to pretend that they are in pain while others will 
not. People who are pretending wil1 be asked to try and convince the interviewer 
using whatever means they wish. This will be an opportunity to use some of the 
negative experiences you have had, especially in the Workers Compensation arena. 
12. Your participation will not affect your current treatment whatsoever and no one else 
will have access to this information. You can pull out of this research at any time, 
even after you have agreed. 
13. Are you interested? 
14. No- thank you for time, if you become interested later my contact number is 
94005418 
15. Yes- Thankyou for agreeing to participate. 
16. You will be sent a package in the mail containing an informed consent form, a letter 
giving you instructions to either pretend to have more pain or give honest answers, 5 
pain sheets which are to be filled out starting from the day that you receive the 
package, a reminder sheet for your fridge for the time and day of the interview and a 
letter from Brian Suter and Dr Finch explaining their role and support for this project. 
l7. What is your address so I can send you the package? 
18. We need to set a time for the 15 minute interview to take place. A time preferably 
when their will not be too many distraction would be ideal. I have fairly flexible 
times both during the day, at night or on the weekend. What time best suits you? 
19. That time will be fine, is your postal address different from where you Jive? If so 
where do you live? 
20. Thankyou for your time, if you need to change the time please ring me on 94005418 
or 92444012 as soon as possible so we can work out a mutually agreed time. I look 
forward to seeing you on ----------- at-----------. 
Bryan Suter 
B.Soc.Sc.(Hons), M.A.(Ciin.Psych.) 
Cl1mcal Psychologist 
BS:vg\cunrd25.S05 
25 May 1998 
Dear 
APPENDIX K 
This is to introduce David Cunrow, a second year Masters student in the School of Psychology at 
Edith Cowan University. I was approached by David and the university to conduct research on 
the ways individuals express their pnin in and outside of a litigation situation. I agreed to 
participate and provided him a list of names and telephone numbers of previous patients whom I 
felt would be motivated to participate ir. tnis study and who met the requirements of the study. 
No further records were accessed, nor was infonnation regarding your. presenting problems, 
history or treatment shown to David Cunrow or his supervisor. At no stage will he nor anyone 
associated with this research have access to this or other confidential treatment infonnation. 
As you may know, I am a finn believer in ongoing research. I appreciate that this research 
project involves a reasonable· time commitment. Nevertheless I would request your favourable 
consideration of participation. Shoulrl you agree to participate, you are elcome to withdraw 
your participation at any time. 
Should you have any questions regarding this research, please do not hesitate to contact me on 
the number below, or alternatively contact David or his supervisor, Dr Irene Froyland, on 9400-
5414. 
I hope this letter finds you well. 
With best wishes 
Yours sincerely 
BRYAN SUTER 
cc Psych File 
18 Hardy Street (PO Box 734) South Perth WA 6951. Tel (08) 9367 4466. Fa ( 7 
APPENDIX L 
Information and Consent Form 
My name is David Curnow ami J would like to thank you for your decision to 
participat~ in research, for my Masters thesis, in the School of Psychology at Edith 
Cowan University, into chronic low back pain and malingering. The research itself is 
being undertaken in association Brian Suter's clinic. 
This research is not related to treatment in any way, and if you are still in treatment 
then this research will have no bearing on your future treatment needs. The research 
is interested in the methods that people with chronic lower back pain would use to 
'pretend' that they have more pain than they really feel. In addition, it seeks to reduce 
the conflict that often occurs between an insurance appointed assessor and chronic 
pain patients in workers compensation claims. As all the participants will have 
chronic low back pain there is a sense that they are the experts, and the researcher is 
trying to learn from them. Basically you have been asked because, you are male, have 
chronic low back pain, have previously attended Brian Suter's clinic and may or may 
not have been involved in litigation. 
Having indicated on the phone that you are willing to participate in the research you 
will find enclosed a letter which asks you either to attempt to exaggerate how much 
pain you feel or to give an accurate indication of your pain. It is important that you 
understand that you will be designated either as an "exaggerating" or "accurate" pain 
patient on a purely random basis and no prior testing or medical records have played a 
part in this decision. 
Also enclosed are five numeric rating scales for pain. You will be asked to fill these 
out each day, for one week prior to going to the interview. The numeric rating scale 
involves noting which number best represents your pain and is probably similar to 
other pain measures you have completed. 
Finally, as was indicated in the introductory phone caU, a twenty minute pain 
evaluation will be conducted at a place most convenient to you. This may be your 
home, Brian Suter's clinic or Edith Cowan University. This interview will be a 
simulation of the sort of interview you would have to undergo for compensation. Your 
daily pain rating scales and consent form will be coliected by the interviewer at the 
conclusion of the interview. 
When being interviewed you may use your own history or alter it slightly; provided 
the basic facts and feelings surrounding your pain experience remain relatively 
accurate as thls is major reason for the research. Whether or not you give an accurate 
personal history, is largely irrelevant, as the focus on the research is how you depict 
the issues involved. The results of the interview and the pain rating scales will be 
stored in a locked cupboard in a security-coded room at the Edith Cowan University. 
Once this study has enough participants the list containing the names and addresses 
will be destroyed and only identification numbers will be used. Hence, the 
participants in this study will be anonymous. The results of this research will only be 
available to the researcher, David Curnow ( z"d Year Masters student) ana his 
supervisor, Dr Irene Froyland. The results of this research may be published, at least 
as a thesis, but in a form, where group results will be used making it impossible to 
identify participants in the study. The processed data will also be available to 
participants who ask for copies. 
No individual data will be made available to the clinic or Brian Suter or any other 
person or institution, unless there is a legal obligation to do so. However due to 
certain procedural mechanisms it will very difficult to tell which responses were made 
by a particular participant. 
During the research you may withdraw at any time. You do not need to give any 
explanation. If you do not wish to answer a question then you do not have to do so. 
In addition, if you wish to ask questions, you may so at any time. It is important to 
recognise that Brain Suter's clinic is not directly participating in this research, and it 
is a researcher from Edith Cowan University that is completing the research. 
If you are still involved in any legal action, or contemplate future legal action, in 
regard to the incident related to your pain, you must preferably not participate in this 
research project. If at any stage you need more information about the study you can 
phone myself, or my supervisor, Dr Irene Froyland, on 9400-5415. 
All participaots will be debriefed after the interview. Participants who have chosen to 
withdraw from the study will be given the opportunity to be debriefed when they 
withdraw. 
If ao aspect of this interview disturb you then please contact Dr Irene Froy laod >.t 
Edith Cowao University on 9400-5415 regarding your concerns. If there are 
problems that arise during the interview, then Brian Suter will be available for 
consultation. 
When you have decided to be part of the research please detach the consent form 
underneath and give it to the interviewer. These forms will be kept, but through the 
use of code numbers as identification it will not be possible to identify the results of 
individual participaots. If you have decided that you no longer wish to be part of this 
study please ring David Curnow on 9400 5418 at the earliest possible time. 
Thankyou for your support, 
David Cumo'f 
This will be collected at the time of the interview 
!, _________ _ (Please print) 
* have read and understood the consent form 
' have had an opportunity to assess what is being asked of me 
* have received adequate information 
* can show that I understand the implications of this research 
!, _________ _ (Please print) wish to participate in,this study. 
Sign: --------- Date: _____ _ 
Witness:---------- Date: _____ _ 
I 
APPENDIX M 
Don't Forget your 
Appointment 
Remember that you have a 
pain evaluation interview 
for compensation on 
____ at ___ _ 
